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Abstract 
 
Abstract 
  
The ability to control the cellular microenvironment, such as cell-substrate and cell-cell 
interactions at the micro- and nanoscale, is important for advances in several fields such as medicine 
and immunology, biochemistry, biomaterials, and tissue engineering. In order to undergo fundamental 
biological processes, most mammalian cells must adhere to the underlying extracellular matrix 
(ECM), eliciting cell adhesion and migration processes that are critical to embryogenesis, 
angiogenesis, wound healing, tissue repair, and immunity response, to cite few. For instance, upon 
receiving and responding to complex molecular signals, cells migrate from the epithelial layers to 
target locations, where they differentiate to form specialised cells that make up various organs and 
tissues. However, improper cell adhesion and migration have been implicated in disease states such as 
tumour invasion and cancer cell metastasis. 
 In the past few years, several tailored surfaces that aim to mimic cell-ECM interactions have been 
developed, including biodevices based on proteins and shorter peptide chains, DNA, RNA, and lipids. 
 Among the different nanomaterials employed in such studies, those resulting from self-assembled 
monolayers (SAMs) of alkanethiols on gold (Au) probably represent the most useful and flexible 
model systems of surface engineering for cell biology evaluations. These platforms are promising for 
tuning surface properties or to introduce novel biofunctionalities via coupling reactions with various 
alkanethiols tail groups that can be exposed to the solution phase. 
 Deeply involved in this research field, the aim of this doctoral work was to gain a basic 
understanding and develop chemical strategies towards the controlled multidirectional  
(i. e. bidirectional) cellular migration on tailored Au surfaces. As already described, several artificial 
substrates were prepared in the last years to better understand the cellular responses to different 
mechanical and biochemical surface properties. To date, however, no reports concerning the 
bidirectional movement of the cells along a defined substrate have been published. The controlled 
multidirectional migration offers several advantages respect to the monodirectional approach, since the 
cellular functions can be obtained and, in principle, recycled with spatio-temporal control. In fact, 
once the cells reach the target position along the surface and perform specific biochemical or 
physiological cellular functions (repair, growth, movement, immunity, communication, and 
phago/endocytosis), the reversible movement could allow to recall them back to the starting position. 
By this way, also studies of dynamic cell-cell interactions can also be exploited allowing for a deeper 
knowledge about the fundamentals of the cell biology and biochemistry.  
 The multidirectional migration can be determined through the production of dynamic haptotactic 
chemical gradients along Au surfaces. Specifically, the long-term idea of this project is to use SAMs 
of thiolated DNA chains (DNA-SH) adsorbed onto Au surfaces as a template for the hybridisation 
with complementary peptidic nucleic acid (PNA) strands functionalised with peptidic motifs able to 
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stimulate cellular motility. By this way, supramolecular chemical gradients of motogenic motifs can 
be bound in a directional manner onto Au surfaces and dictate a dynamic bidirectional cell migration. 
Framed in such research project, this doctoral thesis focused on the production of a static, 
monodirectional and motogenic gradient along Au surfaces, to prove the efficacy of a specific peptidic 
motif, and generate modified PNA strands necessary for the production of the corresponding dynamic 
gradients. 
  Chapter 1 deals with a careful description of the biochemical mechanisms involved in the 
cellular migration process, focusing on the chemotaxis and haptotaxis phenomena. Through a 
comprehensive overview on the state of the art concerning the biomimetic approaches for studying the 
cellular migration, the main strategies towards the engineering of different surfaces, have been 
thoroughly reviewed by means of key examples reported in the literature. 
 Chapter 2 is centred on the results obtained by producing and using the thiolated peptide 
isoleucine-glycine-aspartic acid-glutammine-lysine-1-thiol decanoic acid (IGDQK-SH) as a 
motogenic motif for both cells found in physiologic environment (fibroblasts) and phatological 
conditions  
(MDA-MB-231 cancer cells). Upon synthesising IGDQK-SH (1), a systematic approach for the 
generation of the motogenic chemical gradient along Au surfaces has been developed. Evidences of 
the success of the preparation of such static chemical gradient were obtaining by engaging specific 
characterisation methodologies, such as water contact angle (WCA), Atomic Force Microscopy 
(AFM) and X-ray photoelectron spectroscopy (XPS) analysis, along with computational analysis of 
peptide’s conformations once bound to the different Au surfaces. This allowed determining the 
biophysical properties, morphology, chemical composition and possible structure of the resulting Au 
surfaces, respectively. IGDQK-SH chemical gradient was able to induce and control the cellular 
migration of the two different cell lines showing interesting differences related to the surface 
properties and peptide’s conformations after the formation of SAMs in the presence of filler molecules 
with different hydrophobicity. In particular, the experimental findings suggested a pronounced 
migration attitude of the cancer cells upon their exposition to the IGDQK-SH-bearing surfaces, 
compared to the fibroblasts. This result might suggest a role of the IGD motif in the stimulation of the 
cancer cells towards their enhanced motility and metastatic progression in vivo, and is currently under 
investigation.  
 Once proved the efficiency of the motogenic peptide, we moved towards the final goal of the 
project synthesising two functionalised single-stranded PNA dodecamers (ssPNA 12-mers) 30 and 31 
bearing the Rhodamine B and the tetrapeptide IGDQ for characterising the chemical gradient through 
microscopy-based investigations and stimulate cell motility, respectively. Chapter 3 indeed provides a 
general overview on the different methodologies available for the solid phase peptide synthesis (SPPS) 
describing the synthetic attempts to produce the desired PNAs. Attention will be focused on the 
Fmoc/Cbz protecting group strategy, which allowed us to isolate the target PNA oligomers.  
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Riassunto 
 
 Lo studio e il controllo dei microambienti cellulari, quali interazioni cellula-superficie e cellula-
cellula, assumono particolare rilevanza in diversi campi scientifici come medicina e immunologia, 
biochimica, ingegneria dei tessuti e dei biomateriali.  
Al fine di svolgere le funzioni biologiche fondamentali, le cellule dei mammiferi devono poter aderire 
alla matrice extra-cellulare (ECM) sottostante,  provocando adesione e migrazione cellulare che 
risultano essenziali, ad esempio, nei processi di embriogenesi, angiogenesi e riparazione dei tessuti.  
Infatti, stimolate da complessi segnali molecolari, le cellule migrano dagli strati epiteliali verso il loro 
target,  raggiunto il quale si differenziano e specializzano formando organi e tessuti. Al contrario, 
anomalie nell’adesione e migrazione cellulare possono dar luogo al sorgere di diverse malattie, quali 
tumori e metastasi cancerose. 
 Negli ultimi anni sono state progettate e sviluppate diverse superfici, compresi biodispositivi 
basati su proteine, DNA, RNA e lipidi,  con lo scopo di mimare le interazioni cellula-ECM. 
Tra i nanomateriali impiegati in questi studi, quelli derivanti dalla formazione di self-assembled 
monolayers (SAMs) di tioli alchilici su oro (Au) rappresentano probabilmente il modello più adatto e 
flessibile di superfici ingegnerizzate al fine di valutare i fenomeni biologici. Questi sistemi permettono 
di modulare le proprietà delle superfici o di introdurre nuovi gruppi funzionali attraverso reazioni di 
coupling, sfruttando la presenza  dei gruppi terminali dei tioli che risultano esposti al solvente.  
 Lo scopo di questo lavoro di dottorato è quello di acquisire le conoscenze di base e di sviluppare 
metodologie chimiche al fine di indurre e controllare la migrazione cellulare multidirezionale  
(i.e. bidirezionale) su superfici di Au funzionalizzate. Come già descritto, negli anni sono stati 
impiegati diversi substrati artificiali con lo scopo di meglio comprendere le reazioni cellulari alle 
differenti proprietà meccaniche e biochimiche di tali superfici. Tuttavia, ad oggi, non sono stati ancora 
pubblicati studi riguardanti il movimento bidirezionale di cellule lungo un substrato. Rispetto 
all’approccio monodirezionale, la migrazione multidirezionale controllata offre diversi vantaggi, 
poiché in questo modo le funzioni cellulari possono essere indotte e, in principio,  replicate attraverso 
un controllo spazio-temporale. Infatti, una volta raggiunto l’obiettivo sulla superficie e svolte le 
funzioni cellulari specifiche (riparazione, crescita, movimento, immunità, comunicazione, fagocitosi), 
il movimento reversibile permette di richiamare le cellule alla posizione iniziale.  
Pertanto,  anche lo studio delle interazioni dinamiche cellula-cellula potrà fornire una più approfondita 
conoscenza della biologia e della biochimica cellulare. 
 La  migrazione multidirezionale può essere determinata attraverso la produzione di gradienti 
chimici dinamici aptotattici su superfici di Au.  Nel dettaglio, l’idea alla base di questo progetto è 
quella di utilizzare SAMs di catene di DNA aventi un tiolo terminale (ssDNA-SH) per la 
funzionalizzazione di superfici di Au, e usarle come template nell’ibridizzazione con catene 
complementari di acido nucleico peptidico (PNA) aventi un peptide in grado di stimolare la 
   IX 
Riassunto 
 
migrazione cellulare. In questo modo è possibile generare un gradiente chimico supramolecolare 
direzionale lungo le superfici di Au al fine di ottenere al migrazione cellulare bidirezionale. 
Questa tesi di dottarato è focalizzata sulla produzione di un gradiente statico, monodirezionale e 
motogenico su superfici di Au, per provare l’efficacia di un motivo peptidico specifico, e generare 
filamenti di PNA modificati, necessari per la produzione di corrispondenti gradienti dinamici. 
 Il Capitolo 1 riporta un’accurata descrizione dei meccanismi biochimici coinvolti nei processi di 
migrazione cellulare, concentrandosi sui fenomeni di chemiotassi e aptotassi. Dopo un’esauriente 
studio dello stato dell’arte, le principali strategie di funzionalizzazione di diverse superfici sono state 
dettagliatamente riviste attraverso gli esempi chiave riportati in letteratura. 
 Il Capitolo 2 è centrato sui risultati ottenuti producendo e utilizzando il pentapeptide composto da 
isoleucina-glicina-acido aspartico-glutammina-lisina-acido decanoico-1-tiolo (IGDQK-SH) come 
motivo motogenico per le cellule presenti in ambienti fisiologici (fibroblasti) e in condizioni 
patologiche (MDA-MB-231 cellule cangerogene). Una volta sintetizzato l’IGDQK-SH(1) è stato 
sviluppato un approccio sistematico per la produzione del gradiente motogenico sulle superfici di Au. 
Al fine di verificare l’effettiva presenza di tale gradiente sono state utilizzate differenti tecniche di 
caratterizzazione, quali water contact angle (WCA), Atomic Force Microscopy (AFM) e X-ray 
photoelectron spectroscopy (XPS) analysis,  oltre all’analisi computazionale per stabilire la 
conformazione del peptide una volta legato alla superficie di Au. Questo ha permesso di determinare 
le proprietà biofisiche, la morfologia, la composizione chimica e la possibile struttura delle superfici 
finali di Au funzionalizzate. Il gradiente chimico di IGDQK-SH ha permesso di indurre e controllare 
la migrazione di due differenti linee cellulari, mostrando interessanti differenze relative alle proprietà 
della superficie e alla conformazione del peptide dopo la formazione del SAMs in presenza di 
molecole filler aventi diversa idrofobicità. In particolare, i risultati sperimentali suggeriscono una 
maggiore attitudine alla migrazione da parte delle cellule cancerogene su superfici di Au 
funzionalizzate con il peptide IGDQK-SH rispetto ai fibroblasti. 
 Questo risultato potrebbe suggerire un ruolo del motivo IGD nella stimolazione della mobilità e 
della progressione metastatica in vivo delle cellule cancerogene, ed è attualmente oggetto di ricerca. 
Una volta provata l’efficienza del peptide motogenico, obiettivo finale di questo lavoro è stata la 
sintesi di due singoli filamenti di dodecamero di PNA 30 e 31 funzionalizzati rispettivamente con la 
Rodammina B e il tetrapeptide IGDKQ al fine di caratterizzare il gradiente chimico utilizzando 
tecniche microscopiche e stimolare la migrazione cellulare.  Il Capitolo 3 offre una visione generale 
sulle differenti metodologie impiegate nella sintesi peptidica in fase solida (SPPS), descrivendo le 
strategie sintetiche utilizzate per produrre gli oligomeri di PNA necessari, con particolare attenzione 
per la strategia dei gruppi protettivi Fmoc/Cbz. 
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 La possibilité de contrôler le microenvironnement cellulaire, telles que les interactions cellule-
substrat et cellule-cellule à l’échelle micro et nano, est importante pour les avancées dans certains 
domaines tels que la médecine et l’immunologie, la biochimie, les biomatériaux, et l’ingénierie 
tissulaire. Afin d’être soumis aux processus biologiques fondamentaux, la plupart des cellules 
mammifères doivent adhérer à la matrice extracellulaire sous-jacente (ECM), en induisant des 
procédés d’adhésion et de migration cellulaires qui sont critiques à l’embryogenèse, l’angiogenèse, la 
cicatrisation des blessures, la réparation des tissus, et la réponse immunitaire, pour n’en citer que 
quelques-uns. Par exemple, lorsque les cellules reçoivent et répondent à des signaux moléculaires 
complexes, elles migrent des couches épithéliales aux emplacements cibles, où elles se différencient 
afin de former des cellules spécialisées qui constituent divers organes et tissus. Cependant, une 
adhésion et une migration cellulaire incorrecte ont été impliquées dans des états de maladie tels que 
l’invasion de tumeur et les métastases de cellules cancéreuses.  
 Au cours des dernières années, plusieurs surfaces confectionnées dans le but d’imiter les 
interactions cellule-ECM ont été développées, incluant des bio dispositifs basés sur des protéines et 
des chaines peptidiques courtes, sur l’ADN, l’ARN, et sur des lipides. 
 Parmi les différents nanomatériaux employés dans de telles études, ceux résultants de 
monocouches auto-assemblées (SAMs) d’alcanethiols sur l’or (Au) représentent probablement les 
systèmes modèles les plus utiles et flexibles d’ingénierie de surface pour des évaluations biologiques 
cellulaires. Ces plateformes sont prometteuses pour moduler des propriétés de surface ou pour 
introduire de nouvelles biofonctionnalités via des réactions de couplage avec divers groupements 
alcanethiols qui peuvent être exposés à la phase liquide.  
 Fortement impliqué dans ce domaine de recherche, l’objectif de ce travail de doctorat était 
d’acquérir une compréhension basique et de développer des stratégies chimiques à l’égard de la 
migration cellulaire multidirectionnelle contrôlée (i.e. bidirectionnelle) sur des surfaces d’Au 
fonctionnalisées. Comme cela a déjà été décrit, plusieurs substrats artificiels ont été préparés au cours 
des dernières années afin de mieux comprendre les réponses cellulaires à différentes propriétés 
mécaniques et biochimiques de surface. Cependant, jusqu’à présent, aucun rapport sur le mouvement 
bidirectionnel de cellules le long d’un substrat défini n’a été publié. La migration multidirectionnelle 
contrôlée offre plusieurs avantages par rapport à l’approche monodirectionnelle, puisque les fonctions 
cellulaires peuvent être obtenues et, en principe, recyclées avec un contrôle spatio-temporel. En fait, 
une fois que les cellules atteignent la position cible le long de la surface et réalisent des fonctions 
cellulaires biochimiques ou physiologiques spécifiques (réparation, croissance, mouvement, immunité, 
communication, et phago/endocytose), le mouvement réversible pourrait permettre de les rappeler à la 
position de départ. De cette façon, des études d’interactions cellule-cellule dynamiques peuvent 
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également être exploitées, menant à une connaissance plus approfondie des fondamentaux de la 
biologie et biochimie des cellules. 
 La migration multidirectionnelle peut être établie par la production de gradients dynamiques 
chimiques haptotactiques le long de surfaces d’Au. Plus précisément, l’idée à long terme de ce projet 
est d’utiliser des SAMs de chaînes d’ADN thiolées (ADN-SH) adsorbées sur des surfaces d’Au 
comme modèles pour l’hybridation avec des brins d’acides nucléiques peptidiques (ANP) 
complémentaires, fonctionnalisés avec des motifs peptidiques capables de stimuler la motilité 
cellulaire. De cette façon, les  gradients chimiques supramoléculaires de motifs motogéniques peuvent 
être liés d’une manière directionnelle sur des surfaces d’Au et peuvent dicter une migration cellulaire 
bidirectionnelle dynamique.  
 Cette thèse de doctorat, incluse dans un tel projet de recherche, s’est concentrée sur la production 
d’un gradient statique, directionnel et motogénique le long de surfaces d’Au, afin de prouver 
l’efficacité d’un motif peptidique spécifique, et de générer des brins d’ANP modifiés nécessaires à la 
production des gradients dynamiques correspondant. 
 Le Chapitre 1 donne une description minutieuse des mécanismes biochimiques impliqués dans le 
procédé de migration cellulaire, se concentrant sur les phénomènes de chimitaxie et haptotaxie.   
A travers une vue d’ensemble complète sur l’état de l’art des approches biomimétiques pour l’étude de 
la migration cellulaire, les stratégies principales menant à l’ingénierie de différentes surfaces, ont été 
revues en détails à l’aide d’exemples clés reportés dans la littérature. 
 Le Chapitre 2 est centré sur les résultats obtenus par la formation et l’utilisation du peptide thiolé 
isoleucine-glycine-aspartic acid-glutammine-lysine-1-thiol decanoic acid (IGDQK-SH) en tant que 
motif motogénique pour les cellules à la fois trouvées dans un environnement physiologique 
(fibroblastes) et dans des conditions pathologiques (cellules cancéreuses MDA-MB-231). Après avoir 
synthétisé IGDQK-SH (1), une approche systématique pour la génération du gradient chimique 
motogénique le long de surfaces d’Au a été développée. Des preuves du succès de la préparation de 
tels gradients chimiques statiques ont été obtenus par des méthodologies de caractérisation 
spécifiques, telles que des analyses d’angle de contact (WCA), par microscopie à force atomique 
(AFM) et par spectrométrie photoélectronique X (XPS), accompagné d’analyses informatiques des 
conformations du peptide une fois lié aux différentes surfaces d’Au. Ceci a permis de déterminer les 
propriétés biophysiques, la morphologie, la composition chimique et la structure possible des surfaces 
d’Au résultantes, respectivement. Le gradient chimique de IGDQK-SH a pu induire et contrôler la 
migration cellulaire de deux différentes lignes cellulaires montrant des différences intéressantes liées 
aux propriétés de surface et aux conformations du peptide après la formation des SAMs en présence de 
molécules de remplissage présentant différentes hydrophobicités. En particulier, les résultats 
expérimentaux ont suggéré une attitude de migration prononcée des cellules cancéreuses, après leur 
exposition aux surfaces portant l’IGDQK-SH, comparé aux fibroblastes. Ce résultat peut suggérer un 
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rôle du motif IGD dans la stimulation des cellules cancéreuses à l’égard de leur mobilité accrue et 
progression métastatique in vivo, et est actuellement analysé. 
 Une fois que l’efficacité du peptide motogénique fut prouvée, nous nous sommes penchés sur 
l’objectif final du projet, en synthétisant deux dodécamères d’ANPs simples brins fonctionnalisés  
30 et 31, portant la Rhodamine B et le tétrapeptide IGDQ pour caractériser le gradient chimique par 
des analyses de microscopie et pour stimuler la motilité de la cellule, respectivement. En effet, le 
Chapitre 3 donne une vue d’ensemble sur les différentes méthodologies disponibles pour la SPPS 
décrivant les essais synthétiques afin de synthétiser les ANPs désirés. L’attention sera concentrée sur 
la stratégie impliquant les groupements protecteurs Fmoc/Cbz, qui nous a permis d’isoler les 
oligomères d’ANP cibles. 
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1. Introduction 
 
The cellular microenvironment regulates the behaviour of cells, and is comprised of biochemical, 
biomechanical and bioelectrical signals derived from surrounding cells, extracellular matrix (ECM), 
and soluble factors.[1, 2] These components work in synergistic and antagonistic manners to regulate 
cellular behaviour. The ability to control the cellular microenvironment, such as cell-substrate and 
cell-cell interactions at the micro-and nanoscale, is important for advances in biomaterials[3] and tissue 
engineering,[4] medicine,[5] cell biology[6] and immunology.[7] In order to perform fundamental 
biological processes, most mammalian cells must adhere to the underlying ECM.[8] For example, upon 
receiving and responding to complex molecular signals, cells migrate from the epithelial layers to 
target locations, where they differentiate to form specialised cells that make up various organs and 
tissues.[9] As a result, cell adhesion and migration are critical to processes such as embryogenesis,[10] 
tissue repair,[11] the immune response,[12] wound healing,[13] and angiogenesis.[14] Moreover, improper 
cell adhesion and migration have been implicated in disease states such as tumour invasion[15] and 
cancer cell metastasis.[15] Therefore, understanding the mechanisms of cell adhesion and migration will 
impact a broad range of research communities including nanomedicine,[16] biotechnologies,[17] 
biochemistry[18] and materials research.[19] 
 In the past few years, several tailored surfaces that aim to mimic cell-ECM interactions have been 
developed, including biodevices based on proteins[20] and shorter peptide chains,[21] DNA,[22] RNA,[23] 
and lipids.[24] Among the different nanomaterials employed in such studies, those resulting from self-
assembled monolayers[25] (SAMs) of alkanethiols on gold (Au) probably represent the most useful and 
flexible model systems of surface engineering for cell biology evaluations.[26, 27] These platforms are 
promising for tuning surface properties[28] introducing novel biofunctionalities via coupling reactions 
with various alkanethiol tail groups that can be exposed to the solution phase[29] (Section 1.2).  
 Deeply involved in this research field, the primary aim of this doctoral work was to explore the 
cellular migration on tailored Au surfaces utilising chemical strategies to produce suitable surface 
modifications. Therefore, this introductive chapter is divided into three main parts: i) section 1.1 deals 
with a careful description of the biochemical mechanisms involved in the cellular migration process, 
focusing on the chemotaxis and haptotaxis phenomena; ii) section 1.2 provides a comprehensive 
overview on the state of the art concerning the biomimetic approaches for studying the cellular 
migration by means of key examples reported in the literature; iii) section 1.3 leads to the final part in 
which the objectives of the work described in this doctoral dissertation are presented. 
 
1.1 Cellular migration: a multistep and tuneable mechanism driven by    
assembly and disassembly of molecular processes 
  
 The different kinds of cell behaviours and movements in biological systems have always drawn 
great attention from the scientific community. Cellular motility is nowadays well recognised as a key 
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process involved in both physiological and pathological aspects. Embryonic morphogenesis relies on 
migratory events during gastrulation and neural crest development.[10, 30, 31] In the immune system, an 
elaborate network of signalling directs leukocytes from the circulation into the surrounding tissue to 
destroy invading microorganisms and infected cells.[12, 32] In vertebrate adults, cell motility is a critical 
part of wound healing and tissue repair.[11, 13] Finally, collective motility of epithelial cells constantly 
renews skin and intestinal tissues.[33] Cell migration is also critical in disease states where the failure of 
migratory processes results in disastrous consequences, such as chronic inflammatory,[34] vascular 
diseases,[35] multiple sclerosis,[36] and even mental retardation.[37, 38] Furthermore, aberrant cell 
migration in tumour invasion[39] and metastasis,[40] is the leading cause of cancer-related deaths.[15, 41]  
All nucleated cell types at a given time of their development execute the migration process. For 
most cells, including epithelial, stromal and neuronal cells, migration phases are confined to 
morphogenesis and cease with terminal differentiation towards intact tissue to become reactivated only 
for tissue regeneration[42] or neoplastic processes.[43] For other cell types, such as leukocytes, migration 
is integral to their function and maintained throughout their life span. The motility mechanism is 
ancient, with key molecular components functionally conserved.[44] Crawling migration involves a 
cycle of biophysical processes that are exquisitely spatio-temporally controlled[2, 45] and initiated by a 
cell polarisation.[46] To migrate efficiently, cells must have an asymmetric morphology with defined 
leading and trailing edges (Fig. 1.1). Polarisation is intrinsic to a migrating cell and influences each step 
of the cell motility. The polarity signalling machinery consists of the partitioning defective complex 
(Par),[47] composed by PAR3, PAR6 and atypical protein kinase C (aPKC), which polarises a broad 
range of cellular processes including Rho guanosine triphosphate hydrolase (GTPase) signalling,[48] 
centrosome reorientation, and microtubule stabilisation. A master regulator of cell polarity in 
eukaryotic organisms, ranging from yeast to humans, is the RhoGTPase member Cdc42.[49]  
 
 
Figure 1.1 Schematic model for cell polarity. As a result of extracellular stimuli (yellow spheres), the number of activated 
receptors (red spheres) increases at the cell surface nearest the extracellular guidance cues, generating an asymmetric cellular 
morphology with defined leading and trailing edges. Adapted with permission from reference 46. 
 
It affects cell polarity by restricting where lamellipodia form, and localising the microtubule-
organizing centre (MTOC) and Golgi apparatus in front of the nucleus which is oriented toward the 
leading edge.[50]  
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As displayed in Fig. 1.2, the first step involves the cell formation and extension of protrusions, which 
can be lamellipodia or filopodia (Fig. 1.2a) Central regulators of protrusions are small RhoGTPase 
family proteins such as Rac, Cdc42, and RhoG, which are regulated by the binding of GTP and 
guanosine diphosphate (GDP) molecules.[51] When bound to GTP, they are active and interact with 
their downstream target proteins, which include protein kinases, lipid-modifying enzymes, and 
activators of the Arp2/3 complex. Moreover, they are activated by guanine nucleotide exchange 
factors (GEFs) and inactivated by GTPase activating 
proteins (GAPs). Specifically, they mediate actin 
polymerisation and cell adhesion organisation by 
targeting the wiskott-aldrich syndrome protein 
(WASP)[52, 53] and the WASP family veprolin 
homologous protein (WAVE)[54] which are components 
of the Arp2/3 complex activators. Specifically, Rac 
activates the WAVE proteins which maintain the 
protrusions, and promote lamellipodial extension. 
Whereas Cdc42 stimulates the Arp2/3 complex to 
induce dendritic actin polymerisation[55] through the 
binding to WASP proteins. Once the protrusions are 
formed, they are stabilised by the formation of adhesion 
plaques with the surroundings (Fig. 1.2b), mainly 
mediated by two receptor families: integrins[56] which 
support cell adhesion to the ECM, and cadherins[57] 
which promote cell-cell adhesion during collective 
cellular migration. By connecting the ECM to the 
intracellular cytoskeleton, integrins serve as both traction sites over which the cell moves and as 
mechanosensors, transmitting information about the physical state of the ECM into the cell altering its 
cytoskeletal dynamics.[58] Upon the formation of the adhesive complexes, active GTPases initiate a 
cascade of events, and myosin II generates forces by pulling on the actin microfilament network to 
translocate the polarised cell body[59, 60] (Fig. 1.2c). In addition, myosin II activity is regulated by 
myosin light-chain (MLC) phosphorylation,[61] which is either directly positively regulated by MLC 
kinase (MLCK)[62] or Rho kinase (ROCK)[57], or negatively regulated by MLC phosphatase,[63] which 
is itself phosphorylated and inhibited by ROCK. While MLCK is regulated by intracellular calcium 
concentration as well as by phosphorylation, ROCK is regulated by binding of Rho-GTP. Finally, the 
carefully regulated activation of this signalling network, also leads to the disassembly of adhesion 
plaques at the trailing edge of the cell to form new protrusions, and a net contractile force at the 
leading edge, which allows the cell to migrate (Fig. 1.2d). 
Figure 1.2 Schematic representation of the 
different steps involving in the cell motility cycle. 
Adapted with permission from reference 44.  
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Depending on the cell type, the orchestration of these processes can vary widely. Thus, although 
the same basic cycle of processes is executed, each cell type exerts migration in different contexts 
using distinct molecular repertoires and extracellular guidance cues.[64]  
 
 1.1.1 Cellular migration modes 
 
 1.1.1.1 Classification according to cell morphology and pattern 
 
 Originally, the mode of cell migration was classified on the basis of the morphology of migration 
patterns.[65] As a consequence of this, two main categories were established: cells move either 
individually[66] (amoeboid or mesenchymal) or collectively[67] (the migration of cohesive multicellular 
units). The main characteristics of the different migration modes, such as cell morphology, ECM and 
cell determinants, are described in Table 1.1.  
 Specifically, amoeboid migration commonly refers to the movement of rounded or ellipsoid cells 
that lack mature focal adhesion plaques and stress fibres.[68, 69] Two subtypes of amoeboid movement 
have been described: the first is the rounded, blebby migration of cells[70] that do not adhere or pull on 
substrate but rather use a propulsive, pushing migration mode (Table 1.1a); the second occurs in 
slightly more elongated amoeboid cells that generate actin-rich filopodia at the leading edge,[71, 72] 
which engage in poorly defined, weak adhesive interaction with the substrate (Table 1.1b). In a 
particular case of amoeboid movement, terminally matured nonadhesive, dendritic cells produce 
dynamic actin-rich dendrites at their leading edge (instead of blebs), that cause such cells to become 
entangled with the ECM substrate during migration.[73] 
 Individual cells with high levels of attachment and cytoskeletal contractility develop 
mesenchymal migration,[74] which involves focalised cell-matrix interactions and movement in a 
fibroblast-like manner[75] (Table 1.1c). On the other hand, the migration of individual cells that 
transiently form and resolve cell-cell contacts while moving along a common track is termed chain 
migration or cell streaming[76, 77] (Table 1.1d). 
 Finally, the maintenance of stringent cell-cell adhesion plaques can lead to partial or complete 
silencing of migration activity in cells inside a group yet supports cytoskeletal activity at outward 
edges or at basal cell-substrate contacts. The resulting collective migration[78] (Table 1.1e) occurs in 
the form of multicellular tubes, strands, irregularly shaped masses, or sheets.[76] 
 In different cell types, these modes of migration are associated with different efficiencies yielding 
varying migration speeds, such as the fast migratory scanning of single leukocytes,[68] the relatively 
slow invasive migration of fibroblasts into wound matrix,[75] or at the slowest end, the collective 
migration during organ formation.[79] 
Single-cell and collective migration modes serve mutually exclusive purposes during 
morphogenesis,[80] tissue regeneration,[81] and in pathological conditions.[40] Collective cell migration is 
essential in building, shaping, and remodelling complex tissues and tissue compartments,[82] such as 
epithelia, ducts, glands, and vessels, but also contributes to cancer progression by local invasion.[83]  
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In contrast, single-cell migration allows cells either to cover local distances and integrate into tissues, 
such as neural crest cell migration,[84] or to move from one location in the body to another and fulfil 
effector functions, such as immune cell trafficking.[85] 
 
Table 1.1 Principal features of the various migration modes: (a) amoeboid blebby,[70] (b) amoeboid pseudopodal,[72] 
(c) mesenchymal,[67, 74] (d) chain migration or cell streaming,[86] and (d) collective.[78] Adapted with permission from 
reference 65. 
 
 
 
 1.1.1.2 Classification according to external cues 
  
 Cellular migration modes can be further classified taking into account the ability of cells to 
respond to directional cues with oriented movement. Indeed, if the motogenic stimulus is presented as 
an external gradient, cells respond to the asymmetric environmental factor and undergo directed 
migration.  
 The nature of the asymmetric cue defines the type of directed migration. In response to chemical 
gradients, cells undergo chemotaxis[87, 88] or haptotaxis[89-91], which involve the oriented movement 
towards increasing concentrations of soluble factors and insoluble adhesive matrix components, 
respectively. Whereas in response to physical gradients, cells move through electrotaxis[92] and 
durotaxis,[93] mechanisms. The former concerns the movement of cells as a consequence of stimulation 
by electrical fields, while the latter refers to the cellular migration in response to mechanical forces of 
the ECM such as fluidic shear stress and substrate stiffness gradients. The ability of cells to migrate 
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towards gradients of different nature will be carefully discussed in the next section with particular 
attention for the cellular movement induced by surface-bound chemical gradients. 
 
 1.1.2 Chemotaxis vs Haptotaxis: two sides of the same coin 
 
 It is generally accepted that eukaryotic cells move as a consequence of the spatio-temporal 
integration of both physical and chemical stimuli, which determine the activation of complex 
intracellular signalling pathways for generating a discrete cellular response. Physical cues such as 
matrix pore size and stiffness, as well as chemical cues such as the concentration of signalling 
molecules are the main guiding stimuli for cell migration in vivo, inducing cell polarity and thus 
controlling the migration rate and direction.[94] Furthermore, chemical gradients naturally present in 
the living body, induce two different directional migration modes known as chemotaxis, and 
haptotaxis. While the former describes the unidirectional cellular movement towards increasing 
concentrations of soluble biomolecules (chemoattractants), the latter determines the unidirectional 
movement of the cells following increasing concentration of matrix-integrated biomolecules 
(haptoattractants). These biomolecules are present in the ECM including chemokines,[95] hormones,[96] 
proteins, such as fibronectin (Fn),[97] vitronectin,[98] laminin[99] and collagen,[100] and growth factors, 
such as the epidermal growth factor (EGF),[101] basic fibroblast growth factor (bFGF)[102] and vascular 
epidermal growth factor (VEGF).[103] Their concentrations can initiate multiple intracellular signalling 
pathways through binding to receptors on the cell surface, 
resulting in the cell polarisation and migration. As 
anticipated, these mechanisms are involved in both 
physiological and pathological processes. Indeed, they are 
crucial for axonal projections to find their way in the 
developing nervous system,[104, 105] cells in the innate 
immune system,[106] such as neutrophils, to find and kill 
invading pathogens, as well as cancer cells to invade tissues 
and generate secondary tumours[46] (Fig. 1.3).  
 In contrast to the significant knowledge on the 
mechanism by which bacteria interpret and respond to 
attractant gradients, scientists have just begun to understand 
the inner workings of the eukaryotic migration. It is 
commonly accepted that chemotactic and haptotatic 
migration occurs through the continuous cycle of individual 
steps previously described, with slight differences which are 
not fully understood.[107] As described in Fig. 1.4, upon 
binding the attractant, the cell receptors transmit the signal to the cell interior in order to sense 
appropriately the chemical gradients.[108] After that, cell manipulates and integrates this information to 
Figure 1.3 Examples of directed cell polarity 
in response to gradient of chemoattractant. 
Polarisation of neutrophil (a-d), axons (e), 
Saccharomyces cerevisiae (f), and 
dictyostelium (g). Adapted with permission 
from reference 46. 
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determine which region of its surface is exposed to maximal concentration of the attractant, and 
transmit the signal to the final effectors responsible for spatial regulation of actin rearrangements and 
cell motility. Recent advances in this field highlighted the key role of phosphoinositide 3-kinases 
(PI3Ks) and the phosphatase (PTEN) in transmitting information from cell receptors to the effectors of 
cell polarity.[2, 45, 46] They act as gradient amplifiers enhancing the small difference in signalling 
between the front and the rear of the cell into steeper intracellular signalling gradients able to generate 
a cellular response. PI3Ks and PTEN act as positive and negative regulators,[109] respectively. Indeed, 
cells with altered PI3K or PTEN activity can usually migrate but exhibit a significantly reduced ability 
to move directionally up a chemical gradient.[110]  
 
 
Figure 1.4 Mechanisms required for eukaryotic cell polarisation towards a chemical gradient. Adapted with permission from 
reference 64. 
 
 1.1.3 Chemoattractant molecules 
 
 In order to undergo fundamental biological processes such as adhesion,[111] polarisation,[112, 113] 
and migration,[114] cells adhere to and spread on the ECM.[115, 116] This matrix is mainly comprised of 
proteins[117, 118] (fibrinogen, vitronectin, collagen, Fn) and growth factors[119] (EGF, bFGF, VEGF) as 
well as other large biomolecules, such as glycosaminoglycans.[44] The ECM acts as a scaffold 
facilitating transfer of signals to adhering cells via specific proteins which are recognised by integrins. 
 
 1.1.3.1 Fibronectin (Fn): a fundamental protein in cell adhesion and migration 
processes 
 
 Among the ECM proteins, Fn have been largely used for patterning surfaces that mimic the ECM 
environment for understanding cell behaviour.[97, 120] 
 Fn is a glycoprotein of vertebrates’ ECM, present both as soluble plasma Fn and insoluble 
cellular Fn, which are the components of blood plasma and ECM, respectively.[121] ECM Fn is one of 
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the most involved proteins in cell adhesion,[122] growth,[123] migration,[124] and differentiation 
processes.[123] It exists as a protein dimer, consisting of two nearly identical polypeptide chains linked 
by a pair of C-terminal disulfide bonds.[125] Each fibronectin monomer has a molecular weight of 230–
250 kDa and contains three types of modules[125]: type I, II, and III (Fig 1.5a). All three modules are 
composed of two anti-parallel β-sheets (Fig 1.5b); however, type I and type II are stabilised by intra-
chain disulfide bonds, while type III modules do not contain any disulfide bonds. 
 
Figure 1.5 (a) Modular structure of Fn showing the linear sequence of functional domains and their structural modules; (b) 
3D structure of Fn (PDB 1e88). 
 
Three regions of alternative splicing[126] occur along the length of the Fn structural unit (promoter): the 
"extra" type III modules (EDA and EDB), and a "variable" V-region existing between III14–15 (the 14th 
and 15th type III module). The modules are arranged into several functional and protein-binding 
domains.[127-129] There are four Fn-binding domains allowing Fn to associate with other molecules.[130] 
One of these domains, I1–5, is referred to as the "assembly domain", and it is required for the initiation 
of Fn matrix assembly.[131] Modules III9–10 correspond to the "cell-binding domain" of Fn.[132]  
The Arg-Gly-Asp (RGD) sequence is located in III10 and is the site of cell attachment via α5β1 and 
αVβ3 integrins on the cell surface.[133] The "synergy site" is in III9 and has a role in modulating Fn 
association with α5β1 integrins.[134] There are also domains for fibrin-binding[135] (I1–5, I10–12), 
collagen-binding[136] (I6–9), fibulin-1-binding[137] (III13–14), heparin-binding,[138] and syndecan-
binding[138, 139] (III12–14). 
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 1.1.3.2 Arginine-Glycine-Aspartic acid (RGD): a cell adhesion motif 
  
 The finding by Pierschbacher and Ruoslahti[140, 141] for which a key interaction in the cells 
adhesion on the Fn matrix involved binding of cellular integrins to RGD recognition sequence, located 
in the major loop of the III10 module[142, 143] (Fig. 1.6), made possible the design and production of a 
variety of simpler substrates for studying cell adhesion,[21] proliferation[144] and migration.[145]  
 
Figure 1.6 3D structure of the tenth Fn type III module containing RGD motif (PDB 1ttg). 
 
Because of its small structure, the RGD site can be easily reproduced with peptides. It has been 
demonstrated that the smallest active unit in the peptides is the RGD itself. However while such an 
amino acid (AA) sequence had to remain invariant to preserve the cell attachment activity, the AA 
following this sequence could vary.[146] Additionally, it was found that the AA conformations as well 
as their sequence are two important parameters for the RGD activity. Indeed, peptides in which the 
aspartic acid is in the D-form are inactive, unlike RGD peptides in which the arginine residue is in the 
D-form are active.[147] Moreover changes as small as the replacement of the aspartic acid with a 
glutamic acid, or of the glycine with an alanine, reduce the activity of the peptide in cell attachment 
assays by 100-fold or more.[148] 
 Short peptides containing the RGD sequence can mimic cell adhesion proteins in two ways: when 
bound to a surface, they promote cell attachment,[149] whereas when presented in solution, they prevent 
attachment that would otherwise occur.[150] Both modes of using the adhesive peptides have found 
several applications. In particular, surface-coated RGD peptides are being investigated for 
understanding important mechanisms involved in cell adhesion and migration processes,[151] and for 
the improvement of tissue compatibility of various implanted devices;[152] while soluble peptides 
targeted for individual integrins showed promise as potential drugs for the treatment of a number of 
diseases.[153] 
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  1.1.3.3 Isoleucine-Glycine-Aspartic acid (IGD): a cell motogenic motif 
  
 Interesting and crucial studies reported by Schor et al. on the Fn gelating-binding domain (GBD) 
provided a starting point for the development of a novel family of chemotactic peptides.[154, 155] Upon 
demonstrating that low concentrations of GBD stimulate the migration of human dermal fibroblasts 
into 3D-gels of native type I collagen fibers, they attributed this biological activity to the highly 
conserved isoleucine-glycine-aspartic acid (IGD) motif of Fn.[156, 157] Indeed as displayed in Fig. 1.7, 
the GBD contains two IGD motifs, isoleucine-glycine-aspartic acid-glutamine (IGDQ)[158] and 
isoleucine-glycine-aspartic acid-serine (IGDS), located within the I7 and I9 modules, respectively. 
Fibroblast migration was evaluated in the collagen gel migration assay by using IGD-containing 
synthetic peptides. Cell motogenic response revealed that fibroblasts migration is characterised by two 
distinct phases: an initial substratum-independent phase of cell activation, and a subsequent 
substratum-dependent manifestation of enhanced migratory activity. Moreover, it was established that 
IGD peptides stimulated fibroblast migration in the following order of activity: IGDS > IGDQ > IGD. 
Finally, the expression of motogenic activity by soluble IGD synthetic peptides clearly distinguishes 
them from their RGD counterparts, which do not stimulate chemotactic migration when presented to 
cells in soluble form, allowing novel studies for selectively inducing chemotactic migration. 
 
 
Figure 1.7 (a) 3D structure of the sixth and seventh Fn type I modules containing IGDQ motif (PDB 3mql); (b) 3D structure 
of the eight and ninth Fn domain pair type I module containing IGDS motif (PDB 3gxe). 
 
 To shed further light, they extended these studies and confirmed their initial hypothesis by using 
the Migration Stimulating Factor[159] (MSF). MSF is a genetically truncated isoform of Fn which 
contains four IGD motifs,[160] located in I3, I5, I7, and I9 modules within the GBD and heparin binding 
(Hep1) domain (Fig. 1.8).  
 10 
  Chapter I   
 
 
Figure 1.8 Modular structures of Fn and MSF showing the four IGD motifs within the GBD and Hep1 domains of MSF. 
  
 When it is present in its full length form stimulates cellular migration.[161] Whereas, when it is 
divided into smaller subunits, only the GBD is able to stimulate cell migration.[154] MSF motogenic 
activity was studied performing 3D collagen migration and transmembrane assays. The results 
reported in Fig. 1.9 indicate that in both experiments MSF and GBD stimulate migration in a 
chemotactic manner, whereas Hep 1 is devoid of motogenic activity. This last conclusion suggests that 
MSF activity within Hep1 is critical despite the presence of two IGD motifs, but further studies 
demonstrated that it can be improved and modulated in the presence of serum and vitronectin.[162] 
 
Figure 1.9 Fibroblasts migration in response to full length MSF and its constituent parts, GBD and Hep1, by using collagen 
gel migratory (a) and transmembrane (b) assays. Adapted with permission from reference 159. 
 
 
 1.2 The biomimetic approach for investigating cellular migration 
 
 Since cell migration in vivo occurs by chemotaxis or haptotaxis, chemical gradients able to mimic 
the natural 3D environment and guide cell migration in vitro are essentially based on immobilised or  
soluble factor gradients.[163] Unlike exposure to soluble factors cues, the presentation of ECM ligands 
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to cells has been difficult to control. In the past few years, several strategies to engineer substrates 
with defined surface chemistry in order to control the interface between cells and a solid support have 
been developed.[164-166] Therefore, tailored surfaces that aim to mimic the ECM and induce cellular 
migration have been generated by using different materials.[166-168] Among them, SAMs of alkanethiols 
on Au remain the ideal model platform for studying cell behaviour.[169] This is mainly due to the 
organic coupling strategies amenable to thiol chemistry, which allows a variety of biomolecules to be 
tethered onto the surface,[170] as well as to be confined to selective regions,[171] so that a specific 
biointeraction can be observed. 
 
 1.2.1 Mixed SAMs for studying cell adhesion and migration 
 
 One of the potential advantages of using SAMs is the possibility of constructing mixed SAMs that 
consist of distinct mixtures of molecular adsorbents. Mixed SAMs are useful in presenting ligands to 
immobilise cells via specific interactions[169] utilising a molecule for cell adhesion[172] (usually at a 
0.01–1% substrate density) and bioinert molecules that can resist adsorption of proteins and cells.[173] 
Mixed SAMs can also be used to form gradients that are especially useful for cell-migration 
studies.[94, 174]  
 On the basis of these observations, Burton et al.[175] patterned chemical gradients of bioinertness 
on Au surfaces able to differently influence the mammalian cell adhesion and the bacterial biofilm 
formation.  
As schematically presented in Fig. 1.10a, surface gradients were fabricated by using mixed SAMs of 
oligo(ethylene glycol)-terminated alkanethiol (C17H35O4-SH) which is well known to exhibit strong 
resistance to protein adsorption, with either methyl- or hydroxyl-terminated alkanethiols (C12H25-SH 
or C11H23O-SH) presenting different degrees of affinity for cells. They compared the response of 
mammalian and bacterial cells to these surface gradients observing a drastic difference. Indeed 
mammalian cell adhesion was strongly influenced and regulated by the density of adhesive (methyl- or 
hydroxyl-terminated alkanethiols) and resistant groups (oligo(ethylene glycol)-terminated alkanethiol) 
present on the surfaces. As described in Fig.1.10b, the number of mammalian cells adhering onto the 
Au surface increases towards the region presenting lower surface density of C17H35O4-SH. This latter 
was covered with a nearly confluent layer of mammalian cells 116 h after the seeding. A critical 
density of adhesion ligands was determined (specific distance between the binding sites of the ligands 
of ca. 57-70 nm), below which the cell resistance is linearly dependent on the surface density of 
tris(ethylene glycol)-terminated alkanethiol, and above which cell adhesion readily occurs and is 
insensitive to the amount of tri(ethylene glycol) on the surface. In contrast to mammalian cells, the 
formation of bacteria biofilms on chemical gradients increased linearly with an increase in the surface 
adhesiveness. These results were consistent with the anchorage dependence mechanism for 
mammalian cell adhesion and the non-specific immobilisation process for bacteria biofilm formation. 
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Figure 1.10 (a) Schematic representation of bioinertness chemical gradients along a Au surface; (b) Micrographs of cultured 
mammalian cells at different times on a gradient SAM of C11H23O-SH. From left to right, the pictures show a number 
increase in adhered cells on the highest to lowest surface density of C17H35O4-SH along the chemical gradient. Images in (a) 
and (b) adapted with permission from reference 175. 
 
 1.2.1.1 Mixed dynamic SAMs  
 
 Cells can adhere to mixed SAMs through several mechanisms.[176] They can be immobilised either 
through preadsorption of ECM proteins,[170, 177] glycans[178] and other biomolecules[179, 180] onto the 
SAMs, or via non-specific interactions[181] such as hydrophobic interactions between the cell 
membrane and the SAMs.[182] However, one of the most often used approach involves cell 
immobilisation by covalently binding chemotactic molecules to SAMs.[169] Furthermore, introducing 
dynamic properties, i.e. the ability to modify the surface with an external stimulus, opens up many 
further opportunities for designing functional surfaces for cell culture and reversible control over 
surface properties.[164, 183] 
 Developing dynamic SAM substrates starts with the design of a strategy to ‘‘switch’’[184] the 
composition of cell-binding ligands on a substrate, between an active and an inactive state.[185, 186] The 
switching could involve isomerisation of an immobilised ligand,[187] or a substrate can be ‘turned on’ 
by binding a ligand, while it is ‘turned off’ by releasing a ligand from the substrate.[188] Dynamic 
control over cell adhesiveness has been achieved exploiting electro-,[189] photo-,[190] or chemical[191] 
stimuli, at the cell-surface interface. Non-invasive methods, such as photochemical[192] or 
electrochemical[193] stimuli, are potentially interesting since the nature of the surface properties can be 
rapidly switched. 
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 Several examples reported the use of Fn in combination with mixed SAMs of alkanethiols to 
promote the biospecific attachment of cell through integrin-dependent recognition.[97, 120] 
 Yousaf et al. recently patterned SAMs on Au surfaces via microfluidic lithography by using Fn as 
a chemotactic moiety for inducing cellular migration.[194] As represented in Fig. 1.11a, they generated 
a polydimethylsiloxane (PDMS) microfluidic cassette with a spiral pattern which was reversibly 
sealed onto a bare Au surface. A solution of hexadecanethiol (HDT) was then flowed through the 
microfluidic chip, followed by the backfilling of the remaining bare Au substrate with tetra(ethylene 
glycol)-terminated undecanethiol (TEG). Finally for cell attachment, Fn was adsorbed only to the 
hydrophobic HDT pattern resulting in an adhesive SAM gradient. Upon removal of the PDMS mask, 
cells revealed the Fn adhesive regions, and due to the inert TEG regions migrated towards the spiral 
pattern following the Fn distribution (Fig 1.11b).  
 Another interesting example, reported by Liu et al., involved the production of Fn gradients by 
using an electrochemical approach.[195] As illustrated in Fig. 1.11c, the gradients were generated by 
forming a C11H23O-SH-containing SAM on Au, which was subsequently desorbed by application of a 
local potential. Once a gradient of one thiol component was established, a second thiol C16H31O2-SH 
was used to backfill the Au substrate resulting in a counter-propagating two-component SAM 
gradient. To create protein gradients on surfaces, Fn was covalently attached to the carboxyl terminus 
of C16H31O2-SH, previously activated by using a mixture of 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) and N-hydroxysuccinimide (NHS) producing a gradient across the surface. In 
addition, by using the same approach surface gradients of the growth factor VGEF[196] were also 
prepared in order to compare cell responses to different chemical gradients of ECM components. 
 
Figure 1.11 (a) Schematic depiction of the microfluidic technique to produce Fn gradient along a Au surface; (b) Directed 
cellular migration towards the spiral pattern following the adhesive regions where Fn is adsorbed; (c) Schematic 
representation of the electrochemical approach for producing protein immobilised gradients along a Au surface. E1 and E2 
represent the electrodes to which was applied a potential window of 1400 to 400 mV or 900 to 800 mV. Images an (a), (b) 
and (c) adapted with permission from references 194 and 195, respectively. 
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 An alternate method is to prepare SAMs of integrin binding peptide sequences,[197] among which 
the RGD peptide domain is the most often used.[198] In this approach cells are immobilised onto SAMs 
by targeting integrins with a binding ligand presented onto surface,[199] since this ensures the viability 
of the cells growing on the surface. 
 Following this approach, Mrksich et al. used mixed SAMs of two types of molecule to control 
surface densities of cell, anchoring different peptides and study their effect on the cell adhesion 
properties.[200] They created binary SAMs consisting of one adsorbate which possesses terminal 
hydroquinone groups, and tri(ethylene glycol) alkanethiols which prevent nonspecific adsorption of 
proteins[201, 202] (Fig. 1.12a). This property is particularly important as it ensures the attachment of the 
cells only through the membrane receptors. After reversible oxidation of the hydroquinone groups to 
quinones, they coupled two peptides (the linear RGDL-CP and the cyclic RGDC-CP) both featuring 
recognition moiety RGD, and a cyclopentadiene group (CP) for the cycloaddition reaction. In 
particular, SAMs presenting either a low-affinity ligand RGDL-CP, or a high-affinity ligand RGDC-CP 
were designed in order to compare and quantify several aspects of cell adhesion. After oxidation of the 
hydroquinone moieties, the two RGD-modified peptides were immobilised via a quantitative Diels-
Alder-type reaction, the latter ensuring an uniform coverage of the peptides across the substrate  
(Fig. 1.12b).  
 
Figure 1.12 Synthetic pathway for the production of mixed SAMs: (a) oxidation of monolayers presenting a mixture of 
hydroquinone and tri(ethylene glycol) groups to monolayers presenting the corresponding quinone groups; (b) production of 
monolayers presenting either the linear RGDL-CP or the cyclic RGDC-CP peptides via a Diels-Alder-type reaction. Images in 
(a) and (b) adapted with permission from reference 200. 
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When cells were seeded on these dynamic SAMs, they interacted specifically via cell-surface integrins 
to both peptides, showing higher affinity for the cyclic RGD ligand. In addition, inhibition assays and 
quantification of focal adhesions (FAs) revealed that cells on cyclic RGD had twice the average 
number of Fas. These aspects together demonstrated that, the affinity between the integrins and 
ligands influences the assembly, nucleation and growth of FAs, providing a new approach to explore 
one of the fundamental mechanism utilised by cells to perceive environmental changes. 
 Following these results, Yousaf et al. proposed a combined electroactive and photochemical 
method to selectively immobilise ligands onto Au surfaces.[203] They used microcontact printing (µCP) 
to pattern Au with mixed SAMs presenting nitro-veratryloxycarbonyl protected hydroquinone 
(NVOC-H2Q), tetra(ethylene glycol) alkanethiols, and HDT. In Fig. 1.13, the strategy for the spatial 
and temporal control of the dynamic SAMs is described. In order to generate a hydrophobic pattern, 
hexadecanethiols were adsorbed onto Au surfaces, followed by the backfilling of the empty regions 
with a mixed monolayer of NVOC-H2Q and tetra(ethylene glycol) groups (Figs. 1.13a-b). Upon UV 
illumination, deprotection of the NVOC 
groups causes the exposition of the 
hydroquinone moieties in select regions 
of the monolayer. As a consequence 
fibroblasts exclusively adhere to the 
hydrophobic patterns (Figs. 1.13c-d). 
Furthermore, cells migrated and 
proliferated until they became contact 
inhibited, remaining confined within the 
patterns. The next step was the 
application of a mild oxidative potential 
(ca. 50 mV) to convert the unreactive 
hydroquinone monolayer to the 
corresponding reactive quinone, which 
was coupled to a soluble peptide RGD-
oxyamine (Figs. 1.13e-f). Modulating the 
surface property from inert to active for 
cell adhesion, fibroblasts were now able 
to sense the new adhesive regions and 
direct their migration towards the 
revealed patterned RGD peptides (Fig. 
1.13g). Following this principle, Yousaf et al. extended their studies combining a photodeprotection 
strategy and dip pen nanolithography (DPN) to reveal functionalised SAMs in a gradient.[204] 
Specifically, symmetric (as a control surface) and asymmetric nanoarrays were produced via DPN 
Figure 1.13 Different steps involved for controlling the cellular 
migration on dynamic patterned Au surfaces. Adapted with 
permission from reference 203. 
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deposition of hydroquinone terminated alkanethiols on a Au surface which was subsequently 
backfilled with tetra(ethylene glycol) alkanethiols (Fig. 1.14a). The hydroquinone presenting 
nanoarrays were converted to the corresponding quinone through electrochemical oxidation, and an 
oxyamine terminated linear RGD peptide was then immobilised onto the surface (Fig. 1.14b). 
 
 
 
 
Figure 1.14 (a) Photochemical deprotection and subsequent oxidation of mixed monolayers presenting NVOC protected 
hydroquinone and tetra(ethyleneglycol) groups to chemoselectively immobilise aminooxy terminated ligands; (b) Schematic 
representation of DPN method for patterning Au surfaces and generating RGD gradients. Images in (a) and (b) adapted with 
permission from reference 204. 
 
 In order to evaluate the effect on the polarisation of adherent fibroblasts onto the symmetric and 
asymmetric peptide nanoarrays, three fluorescent dyes targeting the nucleus, Golgi apparatus and actin 
cytoskeleton were used to label the cells. After fluorescently labelling, on symmetric nanoarray cells 
were observed having a diffusive nucleus-centrosome-Golgi vector that indicates the absence of a 
preferential migratory direction (Fig. 1.15a). Whereas on asymmetric nanoarray, cell polarity vectors 
orient towards higher RGD density as indicated by the reorganisation of the actin cytoskeleton and 
positioning of the Golgi in front of the nucleus (Fig. 1.15b). This result clearly shows that in the 
absence of cell-cell interactions, a cell can be directly influenced by its nanoadhesive environment to 
polarise toward the higher density of chemotactic peptides.  
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Figure 1.15 Lateral force microscopy images of the symmetric (a) and asymmetric (b) arrays with related fluorescent images 
of fibroblast adhered onto the patterned surfaces. (c) Polarity vector defining the distance between nucleus, centrosome and 
Golgi centre. (d) Vector defining the internal polarity on symmetric and asymmetric peptide nanoarrays (d). Images in (a), 
(b), (c) and (d) adapted with permission from reference 204. 
 
  
 In addition to electrochemical activation of cell adhesiveness of SAM-presenting substrates, 
Kessler et al.[190] reported the use of a polymer system that incorporates an azobenzene moiety for 
switching between an adhesive and non-adhesive state of the polymer (Fig. 1.16). Their system was 
based on SAMs featuring RGD peptides in which a photoswitchable azobenzene derivative is 
incorporated to control the exposition of the RGD peptidic ligand on the polymethyl methacrylate 
(PMMA) surfaces. Cell adhesion on different surfaces is affected by the spacer length between the 
peptide ligand and the surface. 4-[(4-Aminophenyl)azo] benzoic acid[205] was employed as a light 
controlled switch, as it retains its photochemical activity and stability when immobilised in the 
polymer.[206] A key feature of azobenzene derivatives is that, upon switching, the length of the 
azobenzene moiety is varied. The E-isomer is ca. 3 Å longer than the Z-isomer.[207] The azobenzene 
can be switched to the Z-isomer by irradiation at 360 nm, however, at the photostationary state (PSS) 
only between 70 and 90% of the unstable Z-isomer is obtained.[208] All of the photoswitchable RGD 
peptide-presenting units (Fig. 1.16) provided enhanced cell adhesion on PMMA disks in the E-isomer 
state. Irradiation reduced the proximity of the RGD ligands to the surface via E/Z isomerisation, 
resulting in a minor reduction in cell adhesion in the Z-configuration. Moreover, on acryloyl-Gly-  
[4-(4-aminophenyl)azo] benzocarbonyl-c(-RGDfK-) units 5, cell adsorption in the Z-isomer could be 
reduced to the level of uncoated PMMA disks, while in the E-isomer state adsorption was enhanced by 
17% , demonstrating the photochemical control of cell adhesion properties. 
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Figure 1.16 Molecular structures of cyclic RGD peptides containing a photoswitchable 4-[(4-
aminophenyl)azo]benzocarbonyl unit, where c-(RDfK) is a cyclic pentapeptide composed by arginine-glycine-aspartic-acid-
D-phenylalanine-lysisne. Adapted with permission from reference 190. 
 
1.3 “Pna-Assisted Cellular Migration Along eNgineered surfaces” 
(PACMAN) Project 
 
 As already described, several artificial substrates were prepared in the last years to better 
understand the cellular responses to different mechanical and biochemical surface properties. 
However, to date no reports regarding the bidirectional movement of the cells along a defined 
substrate have been published.  
 Therefore, the aim of the PACMAN project was to gain a basic understanding and develop 
protocols for the controlled reversible cellular migration on tailored Au surfaces utilising chemical 
strategies to produce suitable surface modifications (Fig. 1.17). The idea was to generate a 
bidirectional supramolecular gradient of DNA/Peptidic Nucleic Acid (PNA) duplexes onto Au 
surfaces, exploiting the unique, selective, and specific recognition properties of single-stranded 
PNAs (ssPNAs).   
 The controlled bidirectional migration offers several advantages respect to the monodirectional 
approach, since the cellular functions can be obtained and, in principle, recycled with spatio-temporal 
control. Moreover, once the cells reach the target position along the surface, the reversible movement 
allows to exploit specific chemical and physiological cellular functions (repair, growth, movement, 
immunity, communication, and digestion), and recall back the cells to the starting position that can act 
as a reservoir.   
By this way, studies of cell-cell interactions can also be exploited allowing for a deeper knowledge 
about the fundamentals of the cell biology and biochemistry.          
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Figure 1.17 Schematic representation of the PACMAN project principle. 
 
  
The bidirectional migration can be determined through the production of haptotactic chemical 
gradients along the substrate. This objective can be achieved by using and characterising two thiolated 
single-stranded DNAs (ssDNA-SH) adsorbed onto the Au through the hybridisation with 
complementary motogenic-bearing ssPNAs. As schematically shown in Fig. 1.18, the bidirectional 
gradient can be produced by using two ssDNA-SH (DNA1-SH and DNA2-SH), different regarding 
their sequence, which can be deposited at the initial step onto the surface. Specifically, DNA1-SH can 
be adsorbed onto the Au by gradually immersing it into a diluted DNA1-SH solution. Since the 
exposition time of Au substrate portions to the DNA1-SH solution is different, a gradient of  
DNA1-SH concentration along the surface can be generated (Fig. 1.18a). By using the same approach, 
the DNA2-SH can be after backfilled onto the Au, allowing a bidirectional gradient of DNA molecules 
along the surface (Fig. 1.18b). These ssDNA-SH can subsequently interact, at different times, with the 
two complementary ssPNAs (PNA1 and PNA2) functionalised with a suitable motogenic promoting 
molecule at their extremities. After the hybridisation between DNA1-SH and PNA1, the deposition of 
the cells at the origin of the DNA1-SH gradient can be performed, and their motion towards the 
maximum concentration of the motogenic molecule can be monitored through optical microscopy 
imaging (Fig. 1.18c). When cells will reach the target position, unwinding of DNA1-SH/PNA1 
duplexes can be carried out by an enzymatic approach or through a light-induced external stimulus  
(Fig. 1.18d). After the unwinding step, the hybridisation between DNA2-SH and PNA2 can be 
performed, and since PNA2 is also functionalised at its extremity with a motogenic molecule, reverse 
cellular migration along the DNA2-SH gradient can be achieved (Fig. 1.18e). When the cells will 
come back to the starting position, unwinding of DNA2-SH/PNA2 duplexes can be once more carried 
out to restore the starting system (Fig. 1.18f). 
 
 20 
  Chapter I   
 
 
 
Figure 1.18 Schematic overview of the PACMAN project. (a) Chemical gradient generation of DNA1-SH; (b) chemical 
gradient generation of DNA2-SH; (c) hybridisation between DNA1-SH and PNA1 to induce the monodirectional cellular 
migration; (d) unwinding of DNA1-SH/PNA1 duplexes; (e) hybridisation between DNA2-SH and PNA2 to induce the 
reversible cellular migration; (f) unwinding of DNA2-SH/PNA2 duplexes to obtain the starting system. 
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2. Cellular migration on patterned Au surfaces induced by  
a novel IGD-containing synthetic peptide 
  
 This chapter describes the synthesis of a novel IGD-containing peptide to produce a haptotactic-
like chemical gradient along Au surfaces able to modulate cellular migration. This molecule was 
designed with the aim of evaluating if a surface-bound chemical gradient of a motogenic peptide can 
be generated onto Au surfaces to induce monodirectional cellular migration.  
 The chapter is divided into six main parts: i) section 2.1 provides an overview of the use of 
organic thin film substrates for cell adhesion, focusing on SAMs of alkanethiols on Au as one of the 
most synthetically versatile class of monolayers for such purposes; ii) section 2.2 presents the recent 
developments in the fabrication of surface-bound gradients, highlighting the role of the gradient 
biomaterials in controlling the cell behaviour, especially cell migration; iii) section 2.3 describes one 
of the main objectives discussed in this doctoral dissertation, such as the selection of a motogenic 
motif and the synthetic approach for its production; iv) section 2.4 deals with the choice of the suitable 
Au surfaces for producing and inducing the chemical gradients and the cell migration, respectively; v) 
section 2.5 reports on the preparation and characterisation of the haptotactic chemical gradients onto 
Au surfaces; vi) section 2.6 gathers the results obtained when the haptotactic gradient was employed to 
induce and direct the cell migration. 
 
2.1 Organic thin films: molecular self-organised nanostructures 
 
 Structurally-ordered nano- and microsized architectures based on the controlled 
assembly/organisation of fundamental molecular modules [1-6] can act as seeds for the growth of novel 
structured materials, in which the molecular properties result largely modified or completely different 
from those of the constituting molecular modules.[7-10] Perceiving the value of structural- and order-
dependent properties emerging from such architectures, chemists have then focused their attention on 
the construction of novel materials trying to gain fundamental understanding on the assembly process 
and on its repercussions on the features of the final architecture. 
 In this way, one growing aspect regards the preparation of organic thin films features a controlled 
organisation of atoms or molecules in a two- or three-dimensional space.[11, 12] 
 The self-assembly ability of biomolecules, such as lipids, to spontaneously organise into 
nanostructures mimicking the living cell membranes, represents one approach for the preparation of 
organic thin films. Indeed, Lagmuir films are formed by spreading amphiphilic molecules at the 
liquid/air interface of common liquids such as water (Fig. 2.1a).[13, 14] On solid substrates, when the 
surface pressure is sufficiently high to ensure lateral cohesion in the interfacial film, Langmuir films 
can be transferred from the water surface onto a solid substrate through the so called Langmuir-
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Blodgett (L-B) technique, which involves the vertical movement of a solid substrate through the 
monolayer/air interface (Fig. 2.1b).[15, 16] 
 Another approach for the production of organic thin films is Organic Molecular Beam Deposition 
(OMBD),[17] an evaporation technique similar to Molecular Beam Epitaxy (MBE) that involves the 
thermal evaporation of ultra-pure elements under Ultra High Vacuum (UHV) conditions to grow 
pure, fine structure, and crystalline materials. Once the evaporation has taken place, the vapours 
from the elements condense on the substrate where they may react with each other (Fig. 2.1c). 
However, L-B films are known to possess poor chemical and mechanical stabilities due to the Van der 
Waals forces that hold together the resultant films,[18, 19] while OMBD films requiring UHV and 
specialised equipment are not of easy preparation. Among these methodologies, organic thin films of 
SAMs grown from solution or from gas phase, offer unique opportunities to increase the fundamental 
understanding of the self-organisation mechanism with dedicated particular properties, due to the 
ability to tailor both the head and tail groups (Fig. 2.1d).  
 
Figure 2.1 Schematic overview of the different approaches involving the preparation of crystalline organic thin films: (a) 
Langmuir films; (b) L-B films; (c) OMBD films; (d) SAMs. 
 
 A large number of recent reviews summarising the research on SAMs focus their attention on the 
structural properties and applications of the resulting architectures.[20-22] In this section, a general 
overview on the methodologies to prepare and characterise SAMs will be presented. Specifically, the 
attention will be focused on the preparation, formation and structural properties of SAMs formed by 
alkanethiols on Au for cell biology studies and applications. 
 
 2.1.1 Self-assembly vs. self-organisation: two sides of the same medal  
 
  In order to obtain predefined engineering of structured functional materials, it is pivotal the 
understanding and control of both the self-assembly and self-organisation mechanisms, which can give 
rise to a collective molecular-scale order via weak non-covalent interactions. Despite the intrinsic 
differences between the two mechanisms,[23, 24] these terms are often used with little care in the 
contemporary chemical literature, leading to perplexity and imprecise meanings.[25] Although both 
these phenomena occur through non-covalent interactions (e.g., hydrogen bonds, halogen bonding, 
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ionic interactions, metal chelation, dipolar and van der Waals interactions, etc.), they are profoundly 
different on the thermodynamic basis. Indeed, whilst self-assembly implies spontaneous processes 
tending towards equilibrium products, self-organisation is intended for non-equilibrium processes. As 
clearly observed in biology, the self-organisation of an undefined number of molecular components is 
the result of a set of dynamic dissipative non-linear non-equilibrium processes, which ultimately lead 
to a structural order at the nano and microscopic levels, driven by a delicate interplay between internal 
(coordination interaction, hydrogen bonds and dipole-dipole to name a few) and external 
(concentration, temperature, stoichiometries, solvent and time) factors. With respect to self-assembled 
systems, the self-organisation process can lead to non-thermodynamically stable products, each one 
favoured by a combination of the above-mentioned external and internal factors, and thus displaying 
peculiar assembly-related properties (both morphological and electronic). Exploiting this dependence, 
more complex hierarchised self-organised structures could be envisaged through a sequential stepwise 
building-up approach.  
 In contrast, the self-assembly process depends on equilibrium conditions and the fundamental 
molecular modules specifically interact among themselves through molecular interactions encoded 
within the module structure, leading to the controlled formation of a pre-defined architecture. Thus, an 
important difference between self-assembly and self-organisation lies in the initial structural encoding 
of the molecular components, which is not required for the latter. If generalised, it is clear that due to 
the general reversible nature of the noncovalent interactions between the self-assembling components, 
any self-assembled system has the intrinsic capability for self-correcting. Indeed self-assembled 
architectures reflect those encoded in the molecule, determining the structural and functional 
properties of the final material at the equilibrium (i.e., the most thermodynamically favourable 
structure).  
 The fine control and prediction of such an ensemble of dissipative and non-dissipative, 
equilibrium and non-equilibrium processes constitute the major challenges towards the design and 
engineering of superior and reproducible complex matters displaying exploitable properties for 
applications in material sciences.[26] A predictive molecular programming of the self-assembling and 
self-organising molecular modules strictly depends on the driving structural and electronic information 
as encoded in the fundamental molecular components and how these parameters are responding and 
sensitive towards the internal and external factors.[27] 
 
 2.1.2 From molecular to macroscopic Self-Assembly: a strategy applicable 
at all scales 
 Is anything not Self-Assembly? This was the famous question of G. M. Whitesides and  
B. Grzybowsky in 2002 that led to define self-assembly as the autonomous organisation of components 
into patterns or structures without human intervention.[28] Later, in 2006 the group of B. Grzybowsky 
extended this definition to the spontaneous formation of organised structures from many discrete 
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components that interact with each other, directly and/or indirectly through their environment.[29, 30] 
The term ‘‘organised’’ refers to some form of spatial and/or temporal ordering (e.g., an ionic crystal) 
and distinguishes self-assembly proper from less ordered aggregation processes such as 
precipitation[31] and ballistic deposition.[32] Within the class of phenomena that we call self-assembly it 
is important to distinguish two main classes: static self-assembly and dynamic self-assembly by 
considering the thermodynamic description of the resulting assemblies (Fig. 2.2).[26] 
 
 
Figure 2.2 Schematic representations of the different thermodynamic processes between static and dynamic self-assemblies. 
For equilibrium self-assembly, particles form a static structure closed to energy exchange with environment. For non-
equilibrium self-assembly, the flux of energy through the system (later dissipated as heat), maintains an organised structure in 
one of several metastable states. For different rates of energy input (dE1 vs. dE2), different structures may form under 
dynamic self-assembly. Adapted with permission from reference 26. 
 
 2.1.2.1 Static self-assembly 
 
 Static self-assembly refers to stable equilibrium structures characterised by a maximum (local or 
global) in the system’s entropy and no systematic energy flows. Examples include organic[33, 34] and 
inorganic crystals,[35, 36] block copolymer assemblies,[37, 38] supramolecular structures,[39, 40] and 
capillary self-assembly.[41, 42] Most interesting, self-assembled structures rely on specific recognition 
events between different types of components. Mirkin et al.[43] developed a complex nanoscopic 
system composed by nanoparticles covered with short DNA strands. During self-assembly, only the 
complementary strands recognise one another, and the NPs form crystals of desired lattice types (Fig. 
2.3a). Specifically, DNA first binds to complementary strands tethered onto the NP surfaces, thereby 
exposing a short “linker” sequence to other, similarly functionalised AuNPs. These linkers then bind 
the particles together into an ordered structure via complementary base-pair interactions. The strength 
of these base-pair interactions can be modulated by changing the temperature of the system: above the 
melting temperature (Tm) particles are free in solution, below the Tm they organise into an ordered 
close-packed lattice. Following this principle, more complex structures can be created by the 
introduction of two types of NPs, each functionalised with a different “linker” sequence that bind 
specifically to one another. In this case, introduction of an additional interaction leads to a different 
ordered structure (Fig. 2.3b). 
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Figure 2.3 Schematic representation of Au NPs that can self-assemble by addition of one (a) or two (b) DNA strands bearing 
specific sequence “linkers”. Adapted with permission from reference 43. 
 
 Another example of static self-assembly has been reported by Stupp et al.[44, 45] who described the 
assembly process of nanofibers made of amphiphilic molecules comprising hydrophobic “tails” and 
appropriately crafted peptide “heads” (Fig. 2.4). Similar to traditional surfactants, these molecules 
assemble in water so as to bury the tails and expose the heads. Instead of forming spherical micelles, 
the peptides prefer to hydrogen-bond into planar β-sheets, and the amphiphiles organise into micron-
long cylinders.[46]  
In other words, the local directionality of hydrogen-bonding between neighbouring molecules 
translates into large-scale directionality of the self-assembled structures. The regularity and robustness 
of the fibers are quite remarkable and have provided a basis for their application in promoting growth 
of blood vessels[47] and nerve regeneration.[48] 
 
Figure 2.4 Primary (a) and tertiary (b) structures of Stupp’s peptide amphiphiles that self-assemble into long fibers (c). 
Adapted with permission from reference 44. 
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 2.1.2.2 Dynamic self-assembly 
 
 Despite of the possibility of forming complex architectures, the structures self-assembled under 
thermodynamic equilibrium are limited by their static nature. This is in contrast to biology, where 
many of the self-assembled systems can adapt their mode of organisation and function in response to 
external stimuli. To do this, biological systems escape thermodynamic equilibrium and self-assemble 
in metastable states dependent on external conditions.[49, 50] Indeed dynamic self-assembly refers to 
ordered non-equilibrium structures, which are maintained far from equilibrium by a supply and 
subsequent dissipation (e.g., into heat) of useful energy. Free from the constraints of entropy 
maximization, these systems can ‘‘reside’’ in low entropy states often characterised by complex 
spatial or coherent spatio-temporal organisation.[51, 52] Furthermore, the variety of dissipative 
interactions and the dependence of dynamic self-assembly on an external energy supply provide a 
basis for the systematic design and control of synthetic dynamic self-assembly systems.[53, 54] 
 Usually, biological dynamic self-assembly involves synchronous action of multiple 
agents/interactions of which some are designed to bring components together and some to separate 
them. Biological dynamic self-assembly occurs from the molecular to the organismal scales.  
 At the molecular level, the genetic code of life persistent over aeons through replication of DNA, 
transcription to RNA, and translation into functional proteins represents a finely tuned symphony of 
dynamic self-assembly processes. For example, the replication of DNA is energetically driven by the 
hydrolysis of deoxyribonucleotide triphosphate precursors[55] and entails self-assembly of proteins 
called helicase, DNA polymerase, and primase. Helicase physically separates the antiparallel strands 
at the origin of replication,[56] DNA polymerase powered by nucleoside triphosphates synthesises new 
Watson–Crick base pairs,[56, 57] and ligase seals the new strands together[58] before returning the system 
to the final equilibrium state.  
 On the cellular scale, dynamic self-assembly underlies the functioning of the maze of cytoskeletal 
fibers (microtubules and actin filaments), which are responsible for the cell’s structural integrity, 
mechanical resilience, and ability to move.[59, 60] The unique features of these self-assembling polymers 
are that they are maintained in a state of non-equilibrium balance between assembly at one end and 
disassembly on the other, and that the assembly steps require a constant supply of chemical energy (in 
the form of GTP or adenosine triphosphate, ATP) to prevent the fibers from so-called ‘‘catastrophing’’ 
and ultimately shrinking.[61] 
 Finally, on the scale of cellular or bacterial populations, dynamic self-assembly mediates 
collective behaviours including the formation of spatial patterns as wells as swarming.[62] For instance, 
in bacterial colonies, communication mediated by chemicals each member secretes into the 
surrounding medium allows the group to adjust to changing nutrient conditions. When nutrients are 
abundant, bacteria form circular aggregates; when food is scarce, they organise into fractal or vortex-
like structures to maximize the efficiency of food consumption.[63, 64] The underlying assembly 
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mechanism relies on the coupling of the local reproduction rate to the diffusive delivery and 
consumption of nutrients.[64] 
 In the field of nanoscience and nanotechnology, inspired by the importance of self-assembly in 
nature, scientists have developed a range of methodologies to explore and use self-assembly as a 
synthetic tool for generating highly ordered tailored surfaces able to interact with biological 
components. Among the various patterning methodologies, the use of SAMs is one of the most 
promising techniques for the fabrication of supramolecular structures.[65] In addition, the biomimetic 
and biocompatible nature of SAMs makes them useful in chemical and biological applications.[66] 
Providing examples of different systems, the next section will discuss the nature of SAMs and their 
unique features, thoroughly describing the structures and properties of SAMs from alkanethiols on Au 
as model substrates to obtain the needed design flexibility for investigation of specific interactions at 
interfaces. 
 
 2.1.3 Patterned surfaces: the SAMs approach 
 
 The field of SAMs began in the 18th century when Benjamin Franklin observed the spontaneous 
spreading of oil on the surface of a pond. At the end of the 19th century , the ingenious work of  
Agnes Pockels on the surface tension measurements led to the construction of the first apparatus to 
study films at the air-water interface.[67] Langmuir and Blodgett developed methods to forming SAMs 
on water and transfer them on solid supports,[13-16] and Zisman and co-workers in 1946 published the 
first systematic preparation method of a molecular SAMs from a surfactant onto a clean platinum 
surface.[68] The knowledge obtained through these pioneering investigations led to the definition of 
SAMs as ordered molecular assemblies that are formed spontaneously by the adsorption of molecular 
constituents from solution or the gas phase onto solid supports. The adsorption is driven by the 
specific affinity of the adsorbates chemical function, or “head group”, for a substrate.  
 After the historical predecessors, a strong activity in the area of SAMs and progress in the 
understanding on a microscopic level started, supported by the emergence of new tools for observing 
and manipulating atomic, molecular, and colloidal components, such as scanning probe and electron 
microscopies. As anticipated in the previous section, in contrast to ultrathin films made by LB and 
OMBD techniques, SAMs are highly stable and ordered structures, easy to prepare and manipulate. 
Moreover, they develop on objects of all sizes, providing a convenient, flexible and simple system 
with which to tune the surface properties by choosing the appropriate terminal functional groups. 
Indeed, a SAM-molecule can be defined by three chemical entities, each of which plays an important 
role in the assembly process (Fig. 2.5).  
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Figure 2.5 Schematic view of a classical SAM showing the terminal group, the molecular backbone and the head group of 
the adsorbates. 
 
 The first part is the surface-active head group which renders the adsorption on the substrate, as a 
result of strong substrate-molecular interactions. The second part is the spacer group, normally 
composed by an alkane chain, which facilitates the packing of the molecules in the monolayers and 
serves as a linker between the head and the end groups. The third part is the end (or tail) group which 
is located at the monolayers surface. As mentioned before, the properties of this terminal group define 
the surface properties; in fact, by changing the end functional groups of SAMs, the macroscopic 
properties, such as wettability, biocompatibility and adhesion, can be altered and tuned. A large 
number of different substrates can be employed to produce SAMs, ranging from planar surfaces[21] 
(glass or silicon slabs supporting a thin films of metal, metal foils, single crystals) to highly curved 
nanostructures[21] (colloids, nanorods, nanocrystals). This, in combination with the employed different 
head groups, allows the production of controlled surfaces with specific interactions. For example, 
silanes on hydroxilated surfaces,[69] fatty acids on metal oxide surfaces,[69] phosphonates on 
zirconium,[70] and alkanethiols on metals like Au, Ag, Pt, Pd, Hg and Cu.[21] 
 
 2.1.3.1 Applications, synthesis and properties of alkanethiolate SAMs on Au 
 
 The first work describing the ability of disulphides and thiols molecules to self-assemble on Au 
substrates was published by Nuzzo and Allara in 1983.[71] A series of organic disulfides were used to 
prepare supported and oriented monolayers which were characterised by infrared spectroscopy (IR), 
WCA and ellipsometry techniques. They demonstrated the feasibility of Au surfaces functionalisation 
by disulphide adsorption, and the possibility to apply this methodology to a variety of molecular 
structures with different functional groups located at the ambient interface. Since their discovery, 
SAMs on Au became the most studied model for monolayers.[21, 69] Both thiols and disulphides are 
compatible with most organic functional groups allowing the incorporation of a large variety of 
terminal functionalities in Au-thiol monolayers. They are easy to manipulate, being stable under 
normal laboratory conditions, and their synthetic chemistry is well established. Furthermore, Au 
presents peculiar properties which make it a model substrate for studying SAMs. First, Au is easy to 
obtain as a thin film by physical vapour deposition,[72, 73] sputtering,[74] or electrodeposition,[75] or on 
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supports like silicon, muscovite (mica) or glass slides.[76-78] It is exceptionally easy to pattern by a 
combination of lithographic techniques and chemical etchants. Au is also a reasonably inert metal 
which does not react with O2 and most of the chemicals. These properties make it simple to handle 
and manipulate under atmospheric conditions instead of UHV, allowing the development of many 
experiments in cell biology assessments. Moreover, thin Au films are common substrates used for a 
number of existing spectroscopies and analytical techniques, including surface plasmon resonance 
(SPR) spectroscopy, quartz crystal microbalance (QCM), and ellipsometry.  
 Especially, Au is compatible with cells, meaning that cells can adhere and function on modified 
Au surfaces without evidence of toxicity.[79] Indeed, by using alkanethiols with different terminal 
functionalities it is possible to either resist or promote protein adsorption. For instance, hydrophobic 
SAMs adsorb proteins and can thus promote cell adhesion,[80] while SAMs that terminate in ethylene 
glycol moieties resist protein adsorption and therefore prevent cell adhesion.[81] In addition, SAMs 
formed from thiols on Au are stable for periods of days to weeks when in contact with the complex 
liquid media required for cell studies.[65, 82, 83]  
 
 2.1.3.2 SAMs formation kinetics and mechanism  
 
 As mentioned before, SAMs on Au can be formed from solution or from vapour phase. Since all 
the work described in this dissertation is based on the SAMs production from solution phase, this 
approach will be described in details. The schematic mechanism of the SA process is shown in Fig. 
2.6, and the protocol involves the immersion of a freshly prepared or clean substrate into a dilute 
ethanolic solution of thiols (10-3 M) for 12-18 h at room temperature (r.t.).  
 For most alkanethiols, two distinct adsorption kinetic processes can be observed: a very fast 
initial step, and a slow reorganisation.[69] The first step, which takes a few minutes (min) of immersion 
of the substrate into the corresponding alkanethiol solution, gives the contact angles which are close to 
their limiting values and the thickness about 80-90% of its maximum, and the second step, which lasts 
several hours, allows the thickness and contact angles to reach their final values. 
 
 
Figure 2.6 Schematic representation of the different steps involved in the SAM formation: a) immersion of Au(111) substrate 
into the thiol solution; (b) initial adsorption of the thiol molecules onto the surface; c) lying-down phase formation; d) 
transition from lying-down to standing-up phase; e) formation of a complete and ordered SAM. 
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The initial step was found to strongly depend on thiol concentration. Specifically, at 1 mM 
solution the first step was over after 1 min, while it required over 100 min at 1 µM concentration. The 
second step was described as a surface crystallization process, where alkyl chains get out of the 
disordered state and into unit cells, thus forming a two-dimensional crystal. Therefore, the kinetics of 
the first step is governed by the surface-head group reaction, and the activation energy may depend on 
the electron density of the adsorbing sulfur.  
On the other hand, the kinetics of the second step is related to chain disorder, the different 
components of chain-chain interaction (VDW, dipole-dipole, H-bonding.), and the surface mobility of 
adsorbed molecules. 
Chemisorption of thiols and disulphides on clean Au gives indistinguishable monolayers through the 
formation of Au(I)-thiolate (RS-)species.[21] Moreover, the bonding of the thiolate group to the Au 
surface was found to be a very strong homolytic bond with dissociation energy of strength of 
approximately 40 kcal mol-1. Concerning the alkanethiols, the reaction can be considered an oxidative 
addition of S-H to the Au surface, followed by a reductive elimination of the hydrogen (Eq. 2.1). 
Observing that the monolayers can be formed from gas phase, in the complete absence of O2, and 
according to the results obtaining using different spectroscopic characterisations, it was postulated that 
the proton probably ends as a H2 molecule. However, the possibility of formation of water during the 
process must be also considered. 
 
𝐑𝐒 − 𝐇 + 𝐀𝐮𝐧𝟎  ⇒  𝐑𝐒−𝐀𝐮+ • 𝐀𝐮𝟎 + 𝟏𝟐𝐇𝟐  Eq. (2.1)                
 
 In the case of disulphides species, a simple oxidative addition of the S-S bond to the Au surface is 
considered the possible mechanism for the formation of SAMs (Eq. 2.2). 
 
𝐑𝐒 − 𝐒𝐑 + 𝐀𝐮𝐧𝟎  ⇒  𝐑𝐒−𝐀𝐮+ • 𝐀𝐮𝟎          Eq. (2.2) 
  
The structure of SAMs depends on the morphology of the metal. Au(111) is the lowest energy surface 
orientation, which is thus preferred in the growth of thin films.[84] It is characterised by an atomic 
arrangement of six-fold hexagonal symmetry which corresponds to the most efficient way of packing 
atoms within a single layer ("close-packed"). Due to the strong interaction between thiol molecules 
and Au(111) substrate, the sulfur chemisorbs on specific sites of the surface, forming densely packed 
monolayers, with a chain tilt of ca. 30o respect to the surface normal. This arrangement allows a 
maximum packing driven by the VDW interactions between alkyl chains (Fig. 2.7a), and a structure 
with a (√3×√3)R30° lattice. Helium diffraction and scanning tunneling microscope (STM) studies 
demonstrated the presence of a c(4×2) superlattice of the basic (√3×√3)R30° structure  
(Fig. 2.7b).[85] 
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Figure 2.7 (a) Schematic representation of an alkanethiol molecule adsorbed onto a Au surface. Angles Θ, Ψ and Φ are used 
to describe the molecular orientation and refer to the tilt angle, twist angle and tilt direction, respectively; (b) structural model 
depicting the unit cell of Au(111) surface along with the (√3×√3)R30° hexagonal lattice and the rectangular (3×2√3) surface 
lattice. The darker and lighter molecules represent the c(4×2) superstructure.  
 
 Of particular interest are monolayers comprising a well-defined mixture of molecular structures 
called mixed SAMs. The idea of patterning SAMs with two or more thiols is very useful for studying 
biological and biochemical processes through the anchoring of biomolecules, such as peptides, 
proteins, and oligonucleotides.[86-89] 
 Besides their applications in cellular adhesion[90, 91] and proliferation[92, 93] studies, mixed SAMs 
are particularly useful for producing surface-bound gradients to study and control cell migration.[94, 95]  
Methods for the fabrication of such gradients, their importance in biomedical and biosensors 
applications, will be the subjects of the next paragraph. Specifically, the production of chemical 
gradients to control and direct the cellular migration along defined substrates will be carefully 
evaluated. 
 
2.2 Surface-bound gradients 
  
 2.2.1 General notions 
  
 Surface gradients are surfaces with chemical or physical properties that gradually change over a 
given distance. A gradual change in a physical property, such as the wettability, can be induced by a 
change in surface chemistry, for example by a surface composition gradient.[96] 
 Gradients are ubiquitous in nature and thus biomimetic gradients allow us to gain a deeper insight 
into biological processes. Concentration gradients across membranes are central to energy generation 
in cells,[97, 98] and biomolecule gradients direct the haptotaxis of cells, for example in axonal 
outgrowth.[99]  
In addition, materials featuring gradients can be a valuable materials research tool that allows high-
throughput and cost-effective analysis of the influence of a wide range of parameters in the minimum 
amount of time.[100, 101] In the past few decades, several methodologies for the preparation of surface 
gradients have been developed.[96, 102, 103]A first classification can be obtained on the basis of their key 
features, such as gradient type, dimensionality, directionality, length scale, temporal dependency, and 
functionality (Fig. 2.8).[96] 
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Figure 2.8 Schematic representation of the potential applications of surface gradients. Adapted with permission from 
reference 96. 
 
 2.2.1.1 Gradient directionality 
 
 All gradients are, by definition, directional, meaning that the properties of substrates covered by 
gradients change gradually in a particular direction across the substrate (Fig. 2.8a). The most widely 
used gradient assemblies are those that possess a variation of some physicochemical properties in one 
direction, namely directional or unidirectional.[104] Even for unidirectional gradients, one can fabricate 
substrates on which two gradients of the same type propagate from two opposite directions and may 
eventually collide.[105] An obvious extension of unidirectional gradients involves so-called radial 
gradients[106, 107] in which the gradual variation of physicochemical character occurs radially on the 
substrate, commencing at a central point somewhere on the substrate. Although the gradients 
mentioned above involve the variation of a single property, the same concept can be extended to 
gradients involving a gradual variation of more than one characteristic. For instance, unidirectional 
gradients involving a gradual variation of roughness in one direction and a gradual change in chemical 
composition in the opposite direction are examples of such structures.[108] Among them, a particular 
class of multigradient substrates involves an orthogonal gradient motif, wherein two properties vary 
independently across the specimen in two mutually perpendicular directions.[109] These gradients can 
involve a change in two different chemistries or can be made of two dissimilar characteristics, namely 
chemistry and roughness or chemistry and substrate rigidity. 
 
 2.2.1.2 Gradient temporal dependency 
 
 Most gradient structures can be termed static, meaning that their physicochemical properties have 
been fixed at the time of their creation. However, for some operations it is advantageous to create 
gradients that can change their properties in response to a variation of some external stimulus, such as 
solvent quality,[107] pH,[110, 111] temperature,[112-114] and electric or magnetic field[115, 116] (Fig. 2.8b). 
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 Dynamic gradients of surface-bound polymers, capable of varying their properties as a function 
of solvent quality, pH, or charge have been reported.[107, 117] For instance, substrates can be decorated 
by two chemically distinct polymer brushes (namely brushes A and B) that have dissimilar solubilities 
in various solvents. Upon changing the solvent quality, either brush A or B can swell, or the other one 
can collapse.[118] Moreover, various substrates where the density of weak polycationic and polyanionic 
polymers (i.e., polymers that exhibit positive and negative charges upon altering the pH of the 
solution) changes independently in two opposite directions can be also produced.[119] A gradient of 
positive or negative charge can then be obtained by simply varying the pH of the solution in which the 
substrates are immersed.[118, 120] 
 
 2.2.1.3 Gradient dimensionality 
 
 Gradients on surfaces can exist in various dimensions, and the dimensionality of a gradient 
structure is derived primarily from the dimensionality of the matrix into which the gradients are 
deposited (Fig. 2.8c). Two-dimensional (2D) gradients can be formed by combining different 
preparation techniques and used as suitable platform for producing three-dimensional (3D) gradient 
arrangements. Early work for creating 3D gradients involved the deposition of polymer films using the 
“knife-edge coating” method,[108, 121] which enabled the formation of polymer-based structures with 
gradual variations in composition and thickness.[122, 123] Most recent efforts included the production of 
substrate decorated with polymer brush assemblies comprising a gradual variation of grafting 
density,[124] thickness (i.e., polymer length),[125] and polymer composition.[126, 127] Specifically, Wu et 
al. reported on the fabrication of polymer grafting density gradients on flat silica-based surfaces.[128] In 
their method, a gradient of organosilane-based initiator for atom-transfer radical polymerisation 
(ATRP) was generated by the vapor diffusion method,[129] followed by backfilling the substrate with a 
hydrophobic organosilane SAM.[124] 
  
 2.2.1.4 Gradient functionality 
 
 By their nature, gradients are functional structures. Indeed, chemical gradients transporting 
materials in a directional manner are responsible for driving many important biological[130, 131] and 
physical[132, 133] processes (Fig. 2.8d). For instance, the growth of axons from ganglions to target 
tissues and the directed movement of certain bacteria toward nutrients occur in response to the 
concentration gradients of molecules emanating from an axon target or food source.[134] Concentration 
gradients of molecules in fluids or on surfaces also affect phenomena such as osmotic swelling,[135] 
surface pressure,[136] and surface wettability.[137, 138] The methods of forming gradients on surfaces can 
be also applied to record some important physical phenomena.[107, 139] For instance, by continuously 
immersing a flat substrate into a polymer solution, it is possible to systematically study the adsorption 
of polymers onto that substrate.[140, 141] Another example involves a study of polymerisation kinetics 
where substrates decorated with polymerisation initiators can be slowly dipped into a solution of a 
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monomer (and a catalyst), thus producing a gradient in the chain length of the surface-bound 
polymer.[125] Measuring the chain length of such polymers grown at various points along the gradient 
can reveal information about the kinetics of polymerisation on surfaces in a very systematic and facile 
manner. Finally, gradients are conveniently suited to screen some important physicochemical 
phenomena.[142, 143] One example involves studies of protein adsorption on surfaces where the grafted 
polymer brush density or length (or the combination of both, in case of orthogonal gradients) varies 
continuously and independently across the substrate.[144] 
 
 2.2.1.5 Gradient type 
 
 Gradients can be classified into many categories depending on their physicochemical nature  
(Fig. 2.8e). For this discussion, gradients will be described in terms of either their chemical 
composition (chemical gradients) or their resultant physical properties (physical gradients). 
 Conventional chemical gradients involve the gradual variation of one or more chemical properties 
of a substrate. A variation in the density and/or the chemical nature of the surface-anchored species 
leads to a position-dependent variation in the wettability of the surface.[145, 146] For example, two 
chemically distinct macromolecular brushes may be grafted to a substrate so that the grafting densities 
of each vary in directions that are either opposite or orthogonal to each other.[147] Clearly, having a 
chemical gradient present on a surface may alter many properties of the final material (i.e., surface 
wettability, optical, electrical, and other characteristics that can vary as a function of the position onto 
the substrate). On the other hand, physical gradients are defined as structures that possess a gradual 
variation of some physical property other than wettability.[148, 149] One such property, the substrate 
modulus (i.e., rigidity of the substrate), has in the past been shown to impact cell motility (so-called 
durotaxis).[150] Wang et al. were among the first groups to create such substrates by interdiffusing 
mixtures of acrylamide and bis-acrylamide of different compositions.[142] They later extended the 
method by creating rigidity gradients through the exposition of acrylamide and bis-acrylamide 
solutions (containing a small amount of photoinitiator) to UV light across masks having position-
dependent shading.[151] Another physical property of interest is surface topography/roughness. One of 
the first attempts to create substrates with a gradual variation of surface roughness was reported by 
Einaga et al.[152] who fabricated graded-morphology diamond thin films using a simple technique 
involving chemical vapor deposition (CVD). During the process, the temperature of the substrate was 
gradually changed by heating one end of the substrate while cooling the other. This setup thus 
facilitated control of the size of the grains in the film from submicrometer (lower temperature) to 10 
µm (higher temperature). 
 
 2.2.1.6 Gradient length scale 
 
 Each gradient is characterised by an inherent length scale over which a surface physicochemical 
property changes gradually, thus it can be viewed as having dual character (Fig. 2.8f). First, a gradual 
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variation can be observed on the inherent gradient length scale[153] (i.e., the length scale associated 
with the overall gradual variation of a given property on the substrate). In addition, on length scales 
significantly smaller than the inherent length scale, the structure appears to exhibit a uniform 
property.[154] Therefore, the overall sample can then be considered to be a collection of individual 
homogeneous specimens, each having a discrete property. This dual nature (discrete on 
nano/microscales and continuous on the mesoscale) makes gradients a powerful tool for systematically 
studying and driving various physicochemical phenomena.[154, 155] 
 
 2.2.2 Methods for preparing surface gradients 
 
 On the basis of the preparation method, approaches to create a substrate-bound gradient can be 
broadly classified into two main categories: top-down and bottom up techniques. 
 
 2.2.2.1 Top-down preparation methods 
 
 Top-down techniques involve gradual surface modifications via external, high-energy sources 
such as UV light,[156, 157] plasma,[158, 159] corona discharge,[160, 161] and etching solution,[162, 163] in order to 
introduce active sites on inert surfaces[164-167], such as polyethylene (PE), polypropylene (PP), 
polytetrafluoroethylene and polyesters. Going into details, the plasma modifies a surface by 
bombarding it with electrons, atoms, ions, or radical molecules (Fig. 2.9a).[168] UV irradiation 
generates peroxides on the surfaces through a radical-based photo-oxidation process (Fig. 2.9c),[169] 
while corona discharge produced hydroperoxides that can be further decomposed into polar oxygen-
based functionalities like hydroxyl group, ether, ketone, aldehyde, carboxylic acid and carboxylic ester 
(Fig. 2.9b).[167] Using etching solutions, for example hydrochloric and sulfuric acids, ammonium 
fluoride and sodium hydroxide, different polymers can be degraded by continuous immersion into 
these reactive solutions, and new functional groups can be introduced after the treatment  
(Fig. 2.9d).[163]  
 
 
Figure 2.9 Schematic representation of the top-down technologies for the preparation of surface gradients: (a) apparatus for 
the production of a gradient on PP surfaces by plasma discharge; (b) apparatus for the production of a gradient on PE 
surfaces by corona discharge; (c) photocatalytic oxidation of a thiol SAM by using UV irradiation; (d) hydrolysis of 
poly(vinylene carbonate) film (PVCa) to poly(hydroxymethylene) film (PHM) upon gradual immersion into a NaOH aqueous 
solution. Images in (a), (b), (c) and (d) adapted with permission from references 168, 167, 169 and 163, respectively. 
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The drawbacks of the top-down methods are their limited application to specific types of functional 
substrates, and especially their incompatibility with surfaces presenting biomacromolecules such as 
ECM proteins and grown factors.  
 
 2.2.2.2 Bottom-up preparation methods 
 
 On the other hand, the bottom-up technology is more versatile allowing the production of surfaces 
which can be gradually switched from soft to rigid,[170] from hydrophobic to hydrophilic,[171] and from 
non-adhesive to cell adhesive for modulating cellular responses.[170, 171] Therefore, in relation to the 
work presented in this dissertation, this section is focused on the description of the different bottom-up 
techniques for the generation of surface-chemical gradients based on SAMs,[172, 173] along with their 
applications for understanding fundamental aspects in cell adhesion, proliferation and  
migration.[93, 174-176] 
  
 2.2.3 Surface gradients based on alkanethiols SAMs on Au 
 
 The first technique for generating alkanethiol concentration gradients was developed by Liedberg 
and Tengvall in 1995.[177] As shown in Fig. 2.10a, the idea was to cover a Au substrate with a 
polysaccharide matrix and add different ω- alkanethiol solutions behind glass filters which are fixed at 
the two ends of the surface. The alkanethiols were then allowed to diffuse for several hours into the 
matrix, generating a densely packed monolayer with a gradually changing end-functionality.  
The structure, composition, and lateral dimension of these gradients were characterised by using 
ellipsometry, contact angle measurements, and IR spectroscopy, which demonstrated the formation of 
highly organised and densely packed all-trans gradient assemblies extending over macroscopic 
distances (4-8 mm).  
 Terrill et al. were the first to develop a gradient-preparation technique that used an 
electrochemical potential to induce the desorption of alkanethiols from a fully covered SAMs.  
The width and the slope of the gradients were controlled and modified by changing the potential 
window and the position of the electrodes. [178]  
 Following this approach, a recent work developed by Amirfazli et al. proposed a novel method 
based on direct laser patterning (DLP) to produce surface energy gradient.[179] As shown in Fig. 2.10b, 
the first step involves the formation of a homogeneous and hydrophobic SAM of HDT, which was 
then selectively desorbed using a laser beam. By varying continuously the laser intensity along the 
scan direction, a gradient in desorption was produced. In the last step, the surface was backfilled with 
mercaptohexadecanoic acid in order to obtain a line pattern having a gradient in surface wetting from a 
maximum hydrophobicity at the beginning to a minimum hydrophobicity at the end of the substrate. 
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Figure 2.10 Schematic representation of diffusion (a) and desorption (b) techniques for producing chemical gradient of 
mixed alkanethiols SAMs. Images in (a) and (b) adapted with permission from references 177 and 179, respectively. 
 
However, diffusion- and desorption-based techniques present the common problem to generate 
inhomogeneous surface gradients, therefore new methods have been developed based on microcontact 
printing (µCP)[180, 181] and microfluidic lithography.[182, 183] The former provides structures with high 
contrast and sharp contours, by using elastomeric stamp with well-defined features to transfer an 
‘inked’ material onto a substrate (Fig. 2.11a). Whitesides et al. were the first to apply this technique 
for generating alkanethiols gradients.[184] They exposed the silicone elastomer (PDMS) stamp first to 
the HDT solution, and after inking to a bare Au surface. Although the whole exposed surface of the 
stamp was covered with the ink, only the regions that came into contact with Au were printed with 
hexadecanethiol. Even though µCP was originally used as a method to pattern Au, its value in 
patterning surfaces for other applications quickly became apparent. Since then, µCP has been used by 
researchers in widely differing fields to pattern metals, polymers, DNA, proteins, and cells.[181]  
 Proceeding towards higher degrees of accuracy and stability, microfluidic lithography offers a 
simple and versatile way to produce spatially and temporally constant gradients, mainly based on 
mixed SAMs of alkanethiols with biologically relevant molecules, such as ECM proteins, enzymes, 
and growth factors. By designing the microchannel system, the laminar flow of fluids in small 
capillaries permits multiple streams of solutions containing different concentrations to flow side by 
side through the channels.[182, 183] A broad variety of concentration profiles can be created 
perpendicular to the direction of flow, and their slope and shape can be easily defined by controlling 
the chemical composition of the individual streams (Fig. 2.11b). 
 
Figure 2.11 µCP (a) and microfluidic lithography (b) methods for patterning chemical gradients of alkanethiols SAMs. 
Images in (a) and (b) Adapted with permission from references 180 and 183, respectively. 
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 The main disadvantages of patterning using µCP are that the density of the stamped material is 
not easy to control, and only a limited fraction of materials can be patterned. Demonstrating a higher 
level of complexity and control than the above examples, microfluidic techniques allow to overcome 
these problems. However, some of the PDMS properties may be disadvantageous in certain situations. 
For example, PDMS is incompatible with many organic solvents; it has therefore been applied 
primarily to aqueous solutions. When working with biological samples, nonspecific adsorption may 
occur. The presence of nanoparticles of silica in commercial PDMS causes undesired scattering of 
light. Furthermore, microfluidic methods present some limitations due to the need for specialised and 
expensive equipment, and the complexity to create patterns with features more elaborate than parallel 
stripes, such as arrays, without additional steps. 
 The last method which will be discussed in this section affords a systematic, simple and 
reproducible approach for the preparation of surface-chemical gradients, without the need for 
particular and rigorous conditions. The principle was developed by Spencer et al. by using a two-step 
immersion process.[185, 186] As displayed in Fig 2.12, during the first immersion step, a gradual change 
in surface concentration of one type of alkanethiol is achieved by varying the immersion type of Au 
surface into the alkanethiol-containing solution. The immersion of the substrate occurred along its 
longitudinal axis through the action of a computer-driven linear motor. Because partial monolayers are 
less ordered than full monolayers, in order to obtain a complete monolayer two approaches can be 
employed: the full immersion and the head-to-tail methods. Following the initial step, the former 
involves the full immersion of the surface into the complementary alkanethiol solution for a given 
time. On the other hand, the head-to-tail approach involves the gradually immersion of the sample in 
the same way as in the first step allowing the end of the substrate that was least exposed to the first 
component to be initially immersed in the complementary solution. Since this technique will be 
employed for producing chemical gradients in order to induce cellular migration, the method will be 
carefully reviewed and discussed in the next section. 
 
 
Figure 2.12 Schematic representation of the two-step immersion principle by using either the full immersion or the head-to 
tail approach in order to backfill the Au surfaces. 
 
 The two alkanethiols employed in this study were dodecanethiol (C11H25-SH) and  
11-mercapto-1-undecanol (C11H23O-SH) which showed different hydrophobicity gradients along the 
Au surfaces. Specifically, the full-immersion method by using the methyl-terminated alkanethiol in the 
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first step to produce the chemical gradient, and the hydroxyl-terminated alkanethiol in the second step 
to backfill the substrate, gave the best results in terms of monolayer completion, stability and 
reproducibility. In Fig. 2.13a the advancing and receding WCA measurements obtained by this method 
are shown. This plot and the WCA values, as results of five different gradient films, demonstrated the 
production of a linear and reproducible (± 5°) hydrophobicity gradient over a significant distance  
(35 mm). A more direct illustration of such gradient is provided by the photograph in Fig. 2.13b which 
shows the increase in hydrophobicity of water droplets deposited on a Au surface along the direction 
of the chemical gradient. By choosing an appropriate 
combination of the adsorbing solutions and the velocity 
program of the linear motor, which determines the im 
mersion speed of the sample into a dilute thiol-
containing solution, they tailored the slopes and the 
lengths of various chemical gradients. Furthermore, 
they provided a feasible approach to generate gradients 
of a variety of chemical and biological functionalities 
on the millimeter-centimeter scale. To analyse the 
effects of two surface properties simultaneously, they 
extended this methodology to fabricate orthogonal 
surface-chemical gradients of thiols introducing a 
further immersion step in the perpendicular direction 
before backfilling with the third component.[109] 
Surfaces wetting behaviour was determined by 
measuring the water and hexadecane contact angles, 
respectively. The first showed a gradient along both 
immersion axes, whereas the hexadecane contact angle 
varied only along one of the axes. Therefore, they 
demonstrated that, by simply changing the order in which the immersions are carried out, it is possible 
to modulate and switch the wetting behaviour of Au surfaces. The method provides a systematic 
approach to produce and study three-component mixed SAMs which can be applied to thiols bearing 
different functional groups, especially biologically active moieties. 
 
2.3 Choice of the motogenic molecule: small peptides containing the IGD 
motif 
As described in section 1.1, the recent finding of the cells migratory response to IGD-containing 
peptides provided a rational platform for the development of a novel family of therapeutic compounds 
designed to stimulate or inhibit cell migration in relevant clinical situations, such as tumour invasion 
and cancer cell metastasis, which are characterised by progressive modifications in the chemical 
composition and/or physical organisation of the ECM.[187, 188] Despite the fact that the biochemical 
Figure 2.13 Dynamic contact angles (a) and 
water droplets (b) along a hydrophobicity 
gradient of C11H25-SH using the full immersion 
preparation method. Adapted with permission 
from reference 185. 
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pathways mediating cell activation by IGD motif are still unclear and not well understood, further 
studies revealed that longer IGD-containing peptides present higher motogenic activity than peptides 
including only the smallest active unit IGD.[187] It is important to point out that these preliminary 
results demonstrated the biological activity of IGD-containing peptides in collagen gel migration and 
transmembrane assays. Indeed, to date no examples regarding the cell migratory response to surface 
immobilised IGD modified peptides have been reported. Taking into considerations these aspects, our 
idea was to synthesise a thiolated peptide containing the IGD motif for producing the haptotactic 
chemical gradient along the Au surfaces able to promote the cell migration. Since the IGD motif 
presents specific motogenic properties, it should activate and stimulate cellular migration more than 
the RGD units that are well-known to have as feature only cell-adhesion properties. The most active 
AA sequence for stimulating the migratory cell response has been demonstrated to be isoleucine, 
glycine, aspartic acid and serine (IGDS). However, from a synthetic point of view, in addition to the 
fluorenylmethyloxycarbonyl (Fmoc) protection of the AA amino groups, its chemical synthesis 
required also the protection of all the others AA reactive groups. In particular the hydroxyl group on 
the side chain of the serine has to be protected, since as primary alcohol is very reactive towards 
acylation reactions that give undesired side products. Therefore as represented in Fig 2.14, we have 
decided to synthesise the thiolated pentapeptide composed by L(+)-isoleucine, glycine, L(-)-aspartic 
acid, L(-)-glutamine, L(-)-lysine and 1-thiol decanoic acid (IGDQK-SH). In addition to similar 
motogenic properties, IGDQK-SH peptide is easier to synthesise due to the presence of glutamine 
which does not require any additional protective groups. While the IGDQ motif recognises and binds 
to the integrins of the cells stimulating their migration, the lysine moiety acts as a linker between the 
motogenic portion of the molecule and the thiolated spacer which allows the Au surface 
functionalisation. This peptide was designed first to prove its motogenic activity, and after to produce 
ssPNAs functionalised with the motogenic sequence IGDQ at their extremity  in order to produce a 
supramolecular chemical gradient of haptotactic molecules. 
 
 
Figure 2.14 Molecular structure of the target peptide IGDQK-SH. 
 
2.3.1 Synthetic approach towards the production of IGDQK-SH peptide 
 
 In order to obtain the target peptide IGDQK-SH, the synthesis of the protected spacer  
1-thioacetate decanoic acid was required. The synthetic pathway to produce molecule 3 is reported in 
Scheme 2.1. It involves the nucleophilic substitution of potassium thioacetate on 1-bromide decanoic 
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acid (2) in dimethylformamide (DMF), giving the desired molecule 3 in 94% yield, without further 
purification step.  
 
Scheme 2.1 Synthetic pathway for the production of 1-thioacetate decanoic acid.  
 
 For the synthesis of IGDQK-SH, Fmoc based solid phase peptide synthesis (SPPS) was 
employed. The synthetic approach involved a sequence of reactions in order to selectively remove the 
different protecting groups (Scheme 2.2). A tert-butyl ester (OtBu) and a tert-butyloxycarbonyl (Boc) 
were suggested to protect the carboxylic and the amino moieties of aspartic acid and isoleucine, 
respectively.  
 
 
Scheme 2.2 Semi-automated Fmoc-based SPPS of IGDQK-SH. Conditions: (a) piperidine/DMF (1:4), 6 × 4 min; (b) Fmoc-
Lys(Alloc)-OH (0.2 M), O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU, 0.4 M) 
and N,N-diisopropylethylamine (DIEA, 2 M), N-methyl-2-pyrrolidone (NMP), r.t., 25 min; (c) piperidine/DMF (1:4),  
6 × 4 min; (d) 1- thioacetate decanoic acid (0.2 M), HATU (0.4 M) and DIEA (2 M), NMP, r.t., 6 h; (e) phenylsilane, 
[Pd(PPh3)]4, CH2Cl2, r.t., 30 min; (f) I, G, D or Q (0.2 M), HATU (0.4 M) and DIEA (2 M), NMP, r.t., 25 min; (g) pyrrolidine 
(2 M), DMF, r.t, 18 h; (h) TFA, triisopropylsilane (TIS), 1,2-ethanedithiol (EDT), water, (95: 2.5: 2.5: 2.5) r.t., 90 min. 
 
 The SPPS was performed on an automated peptide synthesiser in semi-automated mode, by using 
Rink-amide 4-methylbenzhydryl amine resin (Rink-amide MBHA resin) as the solid support.  
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The resin (4) was loaded by adding the first AA of the sequence (Fmoc-Lys(Alloc)-OH, K) which was 
after coupled with 1-thioacetate decanoic acid, affording the Alloc-protected compound 6.  
Pd(0)-catalyzed removal of the Lys Alloc protecting group was then followed by the assembly of the 
remaining AA building blocks (I, G, D, Q), which was performed by using the Fmoc-based strategy in 
a fully automated mode. The deprotection of thioester-protected IGDQK (8) was achieved by using 
pyrrolidine,[189] followed by the resin cleavage with trifluoroacetic acid (TFA) to obtain desired 
deprotected peptide IGDQK-SH (1) which was used for the chemical gradient generation onto the Au 
surfaces.  
 The critical step was the deprotection of the thioester moiety before performing the resin 
cleavage. In order to maintain the selective removal of the protecting groups, different strategies were 
attempted including enzymatic reactions in the presence of lipases. It is important to point out that the 
deprotection, namely the cleavage of the thioester group, was optimised using a model compound, and 
after successfully applied to the IGDQK-SH synthesis as a last step of the SPPS. As displayed in 
Scheme 2.3, the model system was built loading the Rink amide-MBHA resin only with the Fmoc-
glycine that was subsequently coupled to 1-thioacetate decanoic acid affording thioester derivative 10. 
Before the resin cleavage step, the conversion of the thioester group into the corresponding thiol was 
performed using pyrrolidine[189] following the conditions reported in Table 2.1. 
 
 
Scheme 2.3 Semi-automated Fmoc-based SPPS of the thiolated derivative 11. Conditions: (a) piperidine/DMF (1:4), 6 × 4 
min; (b) Fmoc-Gly-OH (0.2 M), HATU (0.4 M) and DIEA (2 M), NMP, r.t., 25 min; (c) piperidine/DMF (1:4), 6 × 4 min; (d) 
1- thioacetate decanoic acid (0.2 M), HATU (0.4 M) and DIEA (2 M), NMP, r.t., 6 h; (e) thioester deprotection according to 
the condition shown in Table 2.1; (f) TFA : TIS : H2O : EDT (92.5 : 2.5 : 2.5 : 2.5), r.t., 90 min. 
According to the results obtained for compound 11, desired therminated free-thiol peptide 1 was 
obtained by using a large excess of pyrrolidine (see entry 4, Table 2.1) for a long reaction time (see 
entry 4, Table 2.1). 
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Table 2.1 Experimental conditions used for the deprotection of the thioester group. 
Pyrrolidine Solvent Time (h) Product 
15 equivalents DMF 1.5 
40% thioester derivative 10 
60% thiol derivative 11 
30 equivalents DMF 3 
25% thioester derivative 10 
75% thiol derivative 11 
30 equivalents DMF 6 
25% thioester derivative 10 
75% thiol derivative 11 
50 equivalents DMF 16 
quantitative conversion  
into thiol derivative 11 
  
The crude product was purified by reverse-phase HPLC (RP-HPC), and analysed by MALDI-TOF 
spectrometry that confirmed the successful synthesis (Fig. 2.15).  
 
 
Figure 2.15 MALDI-TOF analysis (a) and HPLC chromatogram (b) of purified IGDQK-SH 1. HPLC conditions: Agilent 
Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The 
eluents were monitored at 260 nm. 
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Indeed as shown in Fig. 2.15a, the mass peaks centred at m/z 745.4198, m/z 767.4086, and m/z 
783.3839 correspond to [C33H61N8O9S], [C33H60N8O9NaS], and [C33H60N8O9KS] mass ions, 
respectively (calculated theoretical masses of m/z 745.4204, m/z 767.4102, and m/z 783.3841). 
 
2.4 Au surfaces: ideal substrates for SAMs and cellular migration studies 
 
 In order to engineer suitable substrates for promoting cell migration, Au surfaces were chosen as 
model platforms to follow the movement of the cells. Among their peculiar properties, they were 
selected for the following reasons: i) Au substrates can be easily functionalised with molecules bearing 
thiol groups, allowing the formation of suitable SAMs; ii) thin Au substrates (10-50 nm) allow optical 
microscopy imaging of living cells; iii) several reports dealt with surface functionalisation of Au to 
promote directional migration of cells. 
 Since the cells are sensitive to changes in substrate stiffness and topological features, the as-
received Au surfaces were treated to be flattened, with respect to the height profiles, and 
homogeneous, in terms of absence of surface-adhered organic contaminants.  
 To do this, the Au substrates were first heated at 450 °C for 30 min, and after incubated in the 
UV/Ozone cleaning system at r.t. for 10 min prior to SAMs formation. We have employed Au 
substrates from different commercial sources, and therefore by applying this treatment various Au 
substrates, different from shape, dimensions, thickness, and adhesion layer were obtained.  
The resulting surfaces were analysed by using atomic force microscopy (AFM) and WCA techniques, 
in order to select which commercial source best fitted our requirements. AFM allows for roughness 
analysis evaluation of the produced surfaces through the root mean square deviation (RMSD) that 
represents the geometric average height of roughness irregularities over the sampling length. 
Therefore, it provides insight into Au surfaces a measure of their homogeneity over long distances 
(10×10 μm were analysed in different spots of each surfaces). In parallel, WCA assessment can clearly 
assess if the cleaning procedure is efficient in the removal of the organic pollutants, since a decrease of 
surface WCA values is connected to that; in fact, Au surfaces presenting organic contaminants are 
characterised by moderately to relatively high WCA values (> 25°) , while cleaned and pure Au 
substrates show low WCA values (< 10°).  
 According to the results obtained in terms of low surface RMS roughness and WCA values  
(RMS = 1.26 nm over 10 μm, WCA< 6°), round coverslips (15 mm in diameter, thickness 0.13 mm) 
bearing a titanium adhesive layer (2 nm) and coated with Au (13 mm diameter, 10 nm thickness) were 
chosen for our experiments (Fig. 2.16a-b). Moreover, in order to be able to monitor and direct the 
cellular migration, Au surfaces were patterned with a self-adhesive polymeric PVC mask[190].  
The designed mask presents three parallel channels, each of them composed by a circular area  
(2 mm in diameter) in which the cells were deposited and let them adhere, and a rectangular path (1 
mm in width and ca. 8-9 mm in length) towards which the cells should migrate under appropriate 
conditions (Fig. 2.16c). 
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Figure 2.16 (a) WCA measurements before and after heating and UV/Ozone treatment. The decrease of WCA values (from 
ca. 40°C to < 6°) is associated with the production of a pure Au surface without organic contaminations. (b) AFM 
topography (above) and cross-section profile (below) of a Au surface after heating and UV/Ozone treatment showing a flat 
surface with smooth edges, as indicated by homogeneous and low height profiles values over 10 μm. (c) Au surface pattering 
with a self-adhesive PVC mask. 
 
 2.4.1 Labelling nomenclature of SAMs 
 
 For the sake of clarity, the different methodologies and systems employed for the Au surface 
functionalisation and chemical gradient production will be defined using the following nomenclature: 
 
- IGDQK-S∙Au : IGDQK-SH SAMs; 
- C8H17-S∙Au : 1-octanethiol SAMs; 
- MT(PEG)4-S∙Au : α-methoxy-ω-thiol tetraethylene glycol SAMs; 
- IGDQK-S∙Au / C8H17-S∙Au : mixed IGDQK-SH and 1-octanethiol SAMs; 
- IGDQK-S∙Au / MT(PEG)4-S∙Au: mixed IGDQK-SH and α-methoxy-ω-thiol tetraethylene 
glycol SAMs; 
- ∂ IGDQK-S∙Au : chemical gradient of IGDQK-SH SAMs; 
- ∂ IGDQK-S∙Au / C8H17-S∙Au : mixed chemical gradient of IGDQK-SH and 1-octanethiol 
SAMs produced by using the full immersion approach; 
- ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au : mixed chemical gradient of IGDQK-SH and α-methoxy-
ω-thiol tetraethylene glycol SAMs produced by using the full immersion approach; 
- ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au : mixed chemical gradient of IGDQK-SH and 1-octanethiol 
SAMs produced by using the double gradient approach; 
- ∂ IGDQK-S∙Au / ∂ MT(PEG)4-S∙Au : mixed chemical gradient of IGDQK-SH and  
α-methoxy-ω-thiol tetraethylene glycol SAMs produced by using the double gradient 
approach. 
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2.5 Chemical gradient production of IGDQK-SH SAMs 
 As carefully described in section 2.2, a variety of methods for producing surface-bound gradients 
of SAMs onto Au substrates have been reported. Among these, SAMs of two thiols with different 
gradient density were prepared according to the method described by Spencer et al.,[109, 185] introducing 
significant differences in the type of employed n-alkanethiols and method to promote the formation of 
the ordered SAMs. The principle is to generate the ∂ IGDQK-S∙Au by gradually immersing the Au 
substrates into a dilute IGDQK-SH-containing solution, through the action of a linear-motion actuator 
with a speed established at 14 µm s-1 (15 min in time to achieve the complete immersion of the Au 
surface). WCA measurements and tapping mode atomic force microscopy (TM-AFM) analyses were 
performed in order to evaluate the surface organisation and properties. Whereas the former showed 
WCA variation (ΔWCA) along the Au substrate, indicating a gradual change in surface wettability 
from hydrophobic to hydrophilic (WCA from ca. 40° to 35°, Table A2, Appendix), the latter suggested 
a poor surface organisation of IGDQK-SH resulting in large peptide aggregates (height profiles:  
60-100 nm) along the gradient direction (Fig. 2.17). 
 
Figure 2.17 TM-AFM images (a) with their relative cross-section profiles (b) towards the ∂ IGDQK-S∙Au. 
 
 This was probably due to both the strong interactions between the charged AA groups and the Au 
surface, and the intermolecular interactions between IGDQK-SH molecules, which forced the peptide 
to assume a flat orientation when adsorbed on Au. In fact, as reported in the literature for 
biomolecules,[191-193] such as thiolated peptides and oligonucleotides immobilised onto Au surfaces, the 
introduction of alkanethiols into such SAMs allows the control of the surface properties through the 
formation of ordered mixed SAMs. It has been well demonstrated that the alkanethiols act as spacers 
that finely modulate the surface density of biomolecules preventing their intermolecular interactions. 
Moreover, the presence of alkanethiols within the SAMs also prevents nonspecific interactions 
between peptides and oligonucleotides with the Au. 
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 Taking into consideration these aspects, the idea was to produce mixed ∂ IGDQK-S∙Au in the 
presence of n-alkanethiols. Specifically, in order to switch the IGDQK-SH orientation from a state 
where the molecules were most probably lying flat onto the surface (Computational section 2.5.1.4) to 
an upright orientation, two different approaches were employed: i) once the ∂ IGDQK-S∙Au was 
established, the Au surface was completely backfilled with a second n-alkanethiol component, by fully 
immersing it into a dilute thiol solution (full immersion method, Fig. 2.18a); ii) following the initial 
∂ IGDQK-S∙Au, a second chemical gradient was produced in the same direction as the first one with 
different immersion speed, by gradually immersing the Au substrates into a complementary  
n-alkanethiol solution (double gradient method, Fig. 2.18b).  
 Concerning the n-alkanethiols used for producing mixed gradients of SAMs, α-methoxy-ω-thiol 
tetraethylene glycol [MT(PEG)4-SH], and 1-octanethiol (C8H17-SH) were selected for their different 
affinity and interaction with cells (Fig. 2.19). Indeed, it is known that poly-ethylene glycol  
(PEG)-modified surfaces are able to resist the non-specific adsorption of biomolecules and 
cells,[194, 195] while more hydrophobic surfaces (C8H17-S∙Au) are useful tools for cell migration, 
adhesion and proliferation studies.[196]  
 
 
Figure 2.18 Pictures showing the different steps of the ∂ IGDQK-S∙Au production by using the full immersion (a), and the 
double gradient (b) approaches. 
 
 
 
 
Figure 2.19 Molecular structures of C8H17-SH (a) and MT(PEG)4-SH (b). 
  
  
 
   54 
Chapter II 
 
2.5.1 Characterisation of the chemical gradient 
  
 2.5.1.1 Water contact angle (WCA) investigation 
   
 To analyse the surface functionalisation due to the peptide adsorption, and demonstrate the 
production ∂ IGDQK-S∙Au, WCA measurements were performed. Table 2.2 shows the static WCA (°) 
values as a function of position along the 
longitudinal axis of the sample, by using the 
full immersion and the double gradient 
methods, respectively. In all cases, WCA 
variations (ΔWCA) between the initial point 
(1 mm) and the final point (9 mm) of the Au 
surfaces were observed, indicating a gradual 
change in surface wettability from hydrophobic to hydrophilic or vice versa, depending from the 
complementary n-alkanethiol and the gradient preparation method employed to backfill the Au 
surfaces. 
 
Table 2.2 Static WCA(°) along the ∂ IGDQK-S∙Au, measured at r.t. using the full immersion and the double gradient 
methods as the preparation techniques.* 
*Each value is the average of three measurements on the sample. 
[a] WCA(°) difference between the initial point (1mm) and the final point (9 mm) of the Au surfaces.  
[b] ∂ IGDQK-S∙Au with immersion speed established at 14 µm s-1. 
[c] ∂ C8H17-S∙Au with immersion speed established at 62 µm s-1. 
[d] ∂ MT(PEG)4-S∙Au with immersion speed established at 62 µm s-1. 
  
 
 The differences observed in surface wettability could be attributed to the different interactions 
between IGDQK-SH and the alkanethiols that could determine different IGDQK-SH orientations and 
conformations. To further confirm and investigate these assumptions we performed computational 
analyses that are described in section 2.5.1.4. Moreover, ΔWCA obtained performing the full 
immersion method were enhanced and more significant providing the best conditions to produce ∂ 
IGDQK-S∙Au for the cell migration. As control surfaces, WCA measurements were also carried out on 
IGDQK-S∙Au, C8H17-S∙Au, and MT(PEG)4-S∙Au. After 24 h of immersion, they reached the expected 
saturated values without showing ΔWCA along the Au surface position (Table A2, Appendix).  
SAMPLE 1 mm 5 mm 9 mm Δ[a] 
∂ IGDQK-S∙Au[b] / C8H17-S∙Au 48.7 ± 1.0 59.3 ± 0.7 71.2 ± 0.7 22.5 
∂ IGDQK-S∙Au / MT(PEG)4-S∙Au 37.9 ± 0.3 40.6 ± 1.1 45.0 ± 1.4 7.1 
∂ IGDQK-S∙Au / ∂ C8H17-S∙Au[c] 34.8 ± 0.1 30.1 ± 0.2 28.6 ± 1.2 -6.2 
∂ IGDQK-S∙Au / ∂ MT(PEG)4-S∙Au[d] 35.0 ± 2.5 37.2 ± 0.3 40.5 ± 0.7 5.5 
Figure 2.20 Water droplets along ∂ IGDQK-S∙Au / C8H17-S∙Au.  
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 2.5.1.2 Atomic Force Microscopy (AFM) analysis 
 
 
  To extend the characterisation of ∂ IGDQK-S∙Au and 
examine in details the surfaces organisation and properties, TM-
AFM analyses were also performed. Figs. 2.22 and 2.23 display 
the results obtained performing the full immersion and the double 
gradient approaches in the presence of C8H17-S∙Au, and 
MT(PEG)4-S∙Au, respectively. AFM images recorded from 
different areas of the sample show bright spots intermitted by 
clean Au regions (dark orange portions) indicating that IGDQK-
SH adsorbed onto the Au surfaces, and this latter were not entirely 
covered by peptide molecules. In all cases, an increased number of 
molecules adsorbed onto the Au surface towards the direction of the chemical gradient was observed. 
This observation indicated the successful production of ∂ IGDQK-S∙Au along the Au surfaces and 
confirmed the results obtained by WCA measurements. Topographical analyses of the surfaces show 
substantial differences in terms of surface organisation between the methods employed for the gradient 
generation and the thiols involved in the backfilling step. As displayed in Figs. 2.22a and 2.23a, better 
results in terms of SAMs organisation were obtained generating the ∂ IGDQK-S∙Au with the full 
immersion technique in the presence of both C8H17-S∙Au and MT(PEG)4-S∙Au. Indeed, the most 
frequent height class of the bright protrusions in the images is approximately 4 nm, which closely 
correspond to the most developed conformation of peptide IGDQK-SH (ca. 3.4 nm according to 
modelled structure in Fig. 2.29b). The generation of ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au and ∂ IGDQK-
S∙Au / ∂ MT(PEG)4-S∙Au resulted in large peptide aggregates (height profiles: 40-150 nm, Figs. 2.22b 
and 2.23b) which increase in number and dimension towards the chemical gradient direction. 
Furthermore by using C8H17-S∙Au to backfill the Au surfaces, a dramatically increase in WCA values 
(entry 1, Table 2.2) and number of molecules adsorbed onto the Au surface towards the ∂ IGDQK-
S∙Au was observed together with a high surface organisation, providing the best platform for inducing 
the cell migration. 
   
 
 
 
 
Figure 2.21 Schematic representation  
of the AFM technique. 
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Figure 2.22 TM-AFM images (above) with their relative cross-section profiles (below) towards the ∂ IGDQK-S∙Au / C8H17-
S∙Au (a) and ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au (b). 
 
 
 
Figure 2.23 TM-AFM images (above) with their relative cross-section profiles (below) ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au 
(a) and ∂ IGDQK-S∙Au / ∂ MT(PEG)4-S∙Au (b). 
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 2.5.1.3 X-ray photoelectron spectroscopy (XPS) analysis 
 
In order to determine their chemical composition,  
∂ IGDQK-S∙Au were also characterised by XPS analysis.  
As expected, IGDQK-S∙Au displayed a constant C (1s), S 
(2p) and N (1s) atomic percentages (At%) across the whole 
surface (Fig. 2.25a), as well as C8H17-S∙Au (Fig. 2.25b), 
and MT(PEG)4-S∙Au (Fig. 2.25c), characterised by constant 
C (1s) and S (2p) At%. 
  
 
 
 
Figure 2.25 XPS profiles of IGDQK-S∙Au (a), C8H17-S∙Au (b), and MT(PEG)4-S∙Au (c). 
 
It should be pointed out that XPS analysis cannot provide as precise compositional values as those 
obtainable by elemental analysis. However, as can be seen from the data reported in Table 2.3, very 
similar values between experimental At% and theoretical ones were found.    
 
 
 
 
Figure 2.24 Schematic representation of the 
XPS technique. 
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 Table 2.3 Theoretical and experimental At% of C, S, and N for IGDQK-S∙Au, C8H17-S∙Au, and MT(PEG)4-S∙Au. 
  
Another consideration that we have to take into account is that XPS allows scanning of few 
nanometers inside the substrates (about 3-10 nm) and not all the produced surfaces resulted in 
monolayers (roughness ca. 4 nm) along Au surfaces. As afore discussed, the AFM results indicated 
that ∂ IGDQK-S∙Au / C8H17-S∙Au and ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au, being the product of a 
longer period backfilling procedure with the complementary fillers, resulted more organised and 
monolayer-like surfaces, while ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au and ∂ IGDQK-S∙Au / ∂ MT(PEG)4-
S∙Au showed aggregates along the Au surfaces. As a consequence of this, it was not possible to use 
Au normalisation (variation of N At%/Au At%, supposed to increase as a function of the distance 
along every ∂ IGDQK-S∙Au) to assess the gradual increase of IGDQK-SH density. In the presence of  
∂ IGDQK-S∙Au and filler, we can expect a gradual change in the ratio between the two species along 
the surface, in terms of relative surface occupation. Therefore, at the beginning of the chemical 
gradient N At% is low, due to both small surface occupancy by adsorbed IGDQK-SH and presence of 
the N-lacking fillers. On the other hand, at the end of ∂ IGDQK-S∙Au there is the maximum surface 
occupancy by adsorbed IGDQK-SH and a small presence of the filler. Taking into account these 
considerations, XPS profiles of all the surfaces having ∂ IGDQK-S∙Au plus a filler show an almost 
linear increase of N At%, a similar trend for S At%, and a constant reduction of C At% (Fig. 2.26), the 
latter being well related to what found in a reference study.[185] From all of these data and observations, 
a general trend only (N and S At% increase and overall C At% decrease along the chemical gradient) 
can be extrapolated by the XPS data, and not absolute values of elemental composition. However, the 
directional N At% increase, together with WCA and AFM results, definitively confirmed the 
production of reproducible ∂ IGDQK-S∙Au along the Au surfaces.  
In the presence of a similar surface occupancy by IGDQK-SH and the fillers, one could expect to 
see a constant S At% togethr with increasing N At% along the Au surfaces, for ∂ IGDQK-S∙Au / 
C8H17-S∙Au and ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au, or a more pronounced increased of S At% 
compared to N At% in the case of ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au and ∂ IGDQK-S∙Au / ∂ MT(PEG)4-
S∙Au. However, in the plots reported in Fig. 2.26 this seems not to be the case. By plotting N to S At% 
ratio as a function of position along the Au surface, very interesting information emerged. The fact 
that in any situation that ratio is almost constant (Fig. 2.27) means that S At% increases as similarly as 
Sample At% C t At% Cexp At% S t At% Sexp At% N t At% Nexp 
IGDQK-S∙Au 78.57% 76.02% 2.39% 19.04 19.05% 5.02% 
C8H17-S∙Au 88.88% 83.66% 11.11% 16.33% - - 
MT(PEG)4-S∙Au 90% 87.83% 10% 12.17% - - 
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for N At%. This may suggest that most of the surface occupancy is due to IGDQK-SH adsorbed onto 
Au, being IGDQK-SH the first molecule to be interfaced with the nacked Au surfaces in any kind of 
substrate.  
 
 
Figure 2.26 XPS profiles of ∂ IGDQK-S∙Au / C8H17-S∙Au (a), ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au (b), ∂ IGDQK-S∙Au / 
MT(PEG)4-S∙Au (c), and ∂ IGDQK-S∙Au / ∂ MT(PEG)4-S∙Au (d). 
  
 
 
Figure 2.27 N/S At% plots calculated for IGDQK-S∙Au (a), ∂ IGDQK-S∙Au / C8H17-S∙Au (b), ∂ IGDQK-S∙Au / ∂ C8H17-
S∙Au (c), ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au (d), and ∂ IGDQK-S∙Au / ∂ MT(PEG)4-S∙Au (e). 
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  2.5.1.4 Computational studies onto IGDQK-SH model systems 
 
 In order to rationalise the results regarding the physicochemical properties of the functionalised 
surfaces, and evaluate the IGDQK-SH behaviour once immobilised onto the Au substrates, classical 
molecular dynamics (MD) simulations have been performed. Therefore, the aim was to characterise 
the conformational and dynamical properties of our peptide in the presence and in the absence of 
C8H17-S∙Au and MT(PEG)4-S∙Au. 
 In these preliminary computational studies, short MD simulations (10 ns) of model systems were 
run in explicit MeOH to evaluate the peptide conformations according to mimic the conditions in 
which SAMs are formed. In order to compare such results with the conditions in which IGDQK-SH 
SAMs are exposed to the cells, we are currently performing MD simulation of the optimised 
geometries (as found in MeOH) in water. According to the experimental conditions used to generate 
the chemical gradients, ten different systems were identified for systematically modelling the behavior 
of IGDQK-SH: 
 
- IGDQK-SH in MeOH : a single molecule of peptide in MeOH represented the starting model 
system that can give us an idea on the behaviour of the free peptide molecule in a solution. 
The solvated system in a buffer of MeOH counts 3627 atoms. 
- IGDQK-S∙Au : a single molecule of chemisorbed peptide through the thiol moiety on a slab 
of Au was used as a reference system to simulate the conformational properties at the surface-
interface in the presence or absence of the two fillers. The solvated system in a buffer of 
MeOH counts 15272 atoms. 
- IGDQK-S∙Au / C8H17-S∙Au and IGDQK-S∙Au / MT(PEG)4-S∙Au : a single molecule of 
chemisorbed peptide onto a slab of Au was simulated surrounded by either C8H17-S∙Au or 
MT(PEG)4-S∙Au. These solvated systems in a buffer of MeOH counts 13172 and 12515 atoms 
in the presence of C8H17-S∙Au and MT(PEG)4-S∙Au, respectively. 
- 2 IGDQK-S∙Au: two molecules of chemisorbed peptide simulated through the thiol moiety on 
a slab of Au were used as a reference system to simulate  the conformational properties at the 
surface-interface in the presence or absence of the two fillers. The solvated system in a buffer 
of MeOH counts 13708 atoms. 
- 2 IGDQK-S∙Au / C8H17-S∙Au and 2 IGDQK-S∙Au / MT(PEG)4-S∙Au: two molecules of 
chemisorbed peptide onto a slab of Au were simulated surrounded by either C8H17-S∙Au or 
MT(PEG)4-S∙Au. The second thiolated peptide is placed close to the first, spaced out by a 
molecule of C8H17-S∙Au or MT(PEG)4-S∙Au. These solvated systems in a buffer of MeOH 
counts 13208 and 14806 atoms in the presence of C8H17-S∙Au and MT(PEG)4-S∙Au, 
respectively. 
- n IGDQK-S∙Au: an increasing number of chemisorbed peptide molecules through the thiol 
moiety on a slab of Au was used as a reference system to simulate the conformational changes 
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of the increasing concentration of chemisorbed thiolated peptides onto the surface in the 
presence or absence of the two fillers. The solvated system in a buffer of MeOH counts 15830 
atoms. 
- n IGDQK-S∙Au / C8H17-S∙Au and 2 IGDQK-S∙Au / MT(PEG)4-S∙Au: an increasing 
number of chemisorbed peptide molecules onto a slab of Au was simulated having each 
peptide line spaced out by a line of either C8H17-S∙Au or MT(PEG)4-S∙Au. This system was 
designed with the aim of simulating the ∂ IGDQK-S∙Au along the Au surfaces in the presence 
or absence of the two fillers. Indeed in the C8H17-S∙Au or MT(PEG)4-S∙Au, an increasing 
number of filler molecules was replaced by peptide molecules. This situation allowed 
generating a single peptide placement on one side, followed by an increased concentration 
which reached the full Au surface coverage on the opposite side. These solvated systems in a 
buffer of MeOH counts 16762 and 15132 atoms in the presence of C8H17-S∙Au and 
MT(PEG)4-S∙Au, respectively. 
 
All the aforementioned MD simulations are summarised in Table 2.4. 
 
Table 2.4 MD simulations performed onto the selected model systems. 
 
 
 
  
 
 
 
 
 
 
 
 
 The simulated one-slab Au(111) surface counted 480 atoms on which the thiolates species were 
all modelled accordingly to the generally-accepted high-coverage thiol arrangement on Au(111), 
namely on a (√3x√3)R30° overlayer.[84] Such one-slab Au surface designed for our simulations can fit 
130 thiol molecules.  
 In order to evaluate the IGDQK-SH structural changes, the  RMSD of the Cα, N and C atoms of 
the peptide backbone, and the radius of gyration (Rg) were calculated (the H-bonds were not detected 
along the simulation having an occupancy ≥ 4%). While the former gives an indication of the different 
peptide conformations, the latter is a measure of the SAM compactness.  
SAMs Time (ns) # of atoms 
IGDQK-SH in MeOH 10 3627 
IGDQK-S∙Au  10 15272 
2  IGDQK-S∙Au 10 13708 
n  IGDQK-S∙Au 10 15830 
IGDQK-S∙Au / C8H17-S∙Au 10 13172 
2  IGDQK-S∙Au / C8H17-S∙Au 10 13208 
n  IGDQK-S∙Au / C8H17-S∙Au 10 16762 
IGDQK-S∙Au / MT(PEG)4-S∙Au 10 12515 
2  IGDQK-S∙Au / MT(PEG)4-S∙Au 10 14806 
n  IGDQK-S∙Au / MT(PEG)4-S∙Au 10 15123 
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 Starting from the system that simulates the behaviour of the peptide in solution (IGDQK-SH in 
MeOH), the RMSD and Rg plots are represented in Fig. 2.28. As a result of the degrees of freedom 
associated to a free IGDQK-SH molecule in MeOH, the RMSD plot presents large fluctuations which 
are related to significant peptide conformational changes in solution (Fig. 2.28a). Moreover 
performing a cluster analysis along the IGDQK-SH in MeOH trajectory, such variations resulted in 
two main populated conformations which are displayed in Fig. 2.29. In fact these data suggest us that 
IGDQK-SH can interchanges between a folded and extended conformation with occupancy of the 
35.72 % and 64.28 %, respectively. 
 The oscillation between these two conformations is also confirmed by the calculation of the Rg 
peptide backbone as a function of time (Fig. 2.28b). Sspecifically, this parameter represents a measure 
of mass-weighted spatial distribution of the atoms in each peptide conformations, therefore it is higher 
when the molecule is unfolded giving an estimation on the deviation of the peptide structure from its 
mass centre. The obtained plot shows that the Rg of IGDQK-SH initially decreases when the peptide 
adopts more compact (folded) conformation, whereas it increases when the molecule switches to the 
extended structure, showing Rg values oscillating between the two conformations as a function of 
time. 
 
Figure 2.28 RMSD (a) and Rg (b) plots calculated along the 10 ns trajectory of IGDQK-SH in MeOH. 
 
Figure 2.29 Folded (a) and extended (b) conformations adopted by IGDQK-SH during the MD simulation in MeOH. 
  
 Following these preliminary results, the next MD simulations were performed in order to simulate 
the peptide behaviour once immobilised onto a Au surface. Indeed the systems composed by one 
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IGDQK-S∙Au in the presence or absence of either C8H17-S∙Au or MT(PEG)4-S∙Au were simulated. As 
described for the peptide in solution, the RMSD fluctuations and the Rg values in addition to the 
solvent accessible surface area (SASA) were calculated for the aforementioned systems and their 
relative plots are reported in Fig. 2.30. The SASA gives an idea of the degree of exposed surface 
within a molecule as a function of its conformational changes. When comparing the different Figs, 
significant differences emerged. Specifically, the RMSD of the peptide Cα, N and C atoms revealed 
large fluctuations (black profile in Fig. 2.30a) which can be compared to those observed for IGDQK-
SH in solution, demonstrating that structural changes persisted even if the peptide was chemisorbed 
onto a Au surface. On the contrary, when IGDQK-SH was surrounded by either C8H17-S∙Au or 
MT(PEG)4-S∙Au such fluctuations drastically decreased due to the formation of well-ordered and 
stable mixed SAMs (red and blue profiles in Fig. 2.30a). Moreover between the two alkanethiols, 
C8H17-S∙Au resulted slightly more stable than the corresponding MT(PEG)4-S∙Au, probably due to a 
better adaptation of the IGDQK-SH structure within the octanethiol layer. 
 Peptide tendency to fold onto the surface (IGDQK-S∙Au) or within mixed IGDQK-S∙Au/C8H17-
S∙Au and IGDQK-S∙Au / MT(PEG)4-S∙Au was also appreciable calculating the Rg values. The plot 
displayed in Fig. 2.30b showed that in all the cases Rg decreased along the 10 ns trajectories, reaching 
stable values which indicate a transition of the peptide structure from a lying flat to an upright 
orientation. Notably, this trend resulted more discontinuous for a single peptide molecule immobilised 
onto the Au surface, due to the high molecular movement that characterised the chemisorbed IGDQK-
S∙Au molecule in the absence of any filler. Interestingly, the SASA profile in the three simulations 
nicely reflects the tendency of IGDQK-SH to adopt a particular conformation in which the exposed 
surface tends to decrease along the simulated time (Fig. 2.30c).  
 
 
Figure 2.30 RMSD (a), Rg (b) and SASA (c) plots calculated along the 10 ns trajectory of IGDQK-S∙Au (black profile), 
IGDQK-S∙Au / C8H17-S∙Au (red profile), and IGDQK-S∙Au / MT(PEG)4-S∙Au  (blue profile). 
  
 Among the three model systems, it is appreciable that the lower SASA values in the IGDQK-
S∙Au / MT(PEG)4-S∙Au simulation indicate the adoption of the folded conformation (Fig. 2.29a). In 
addition to this, a significant Rg decrease was also observed in the presence of C8H17-S∙Au which can 
be associated to a particular insertion of the glutamine residue within the octanethiol layer. The last 
observation was confirmed by the IGDQK-SH molecular conformations evaluated in the MD 
simulations. As highlighted by the calculated electrostatic surface potential[197] displayed in  
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Fig. 2.31a, the single Au-peptide immobilised tends to lay down pointing the hydrophobic residues 
Isoleucine (ILE) and Glycine (GLY) towards the surface, while exposing the hydrophilic AA 
Glutamine (GLN) to the solvent bulk. These data were in agreement with what we observed by AFM 
analysis of the Au surfaces functionalised with ∂ IGDQK-S∙Au.  In fact, on such substrates AFM 
topography showed the presence of large peptide aggregates which increased along the chemical 
gradient direction (Fig. 2.17).   
 
Figure 2.31 Front (left) and top (right) views of the IGDQK-SH conformations and orientations once chemisorbed onto a 
one-slab Au surface in the IGDQK-S∙Au (a), IGDQK-S∙Au / C8H17-S∙Au (b), and IGDQK-S∙Au / MT(PEG)4-S∙Au (c) MD 
simulations. The AA residues within the peptide structure are labelled with their symbol name, namely Isoleucine (ILE), 
Glycine (GLY), Aspartic acid (ASP), Glutamine (GLN) and Lysine (LYS). 
 
 On the other hand in the presence of the two alkanethiols, IGDQK-SH exposed mostly the 
hydrophobic AA residues. As shown in Figs. 2.31b-c, the peptide adopts different arrangements in the 
presence of the two filler SAMs. Despite in both of the situations it shows a folded conformation 
within each corresponding layer of the filler, when surrounded by C8H17-S∙Au, IGDQK-S∙Au 
conformation is more extended and the AA sequence results more exposed to the solvent interface 
(Fig. 2.31b). This aspect can be explained considering the H-bond detected along the simulation 
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between the LYS residue of the peptide and the terminal oxygen of the PEG molecule that further 
anchors IGDQK-S∙Au onto the MT(PEG)4-S∙Au (Fig. 2.31c). 
 Going further into the investigations, we moved next to the simulation of two peptide molecules 
adsorbed onto a Au surface (2 IGDQK-S∙Au) surrounded by either  C8H17-S∙Au or MT(PEG)4-S∙Au. 
 Similarly to what observed when one IGDQK-SH molecule was interfaced with the two fillers, 
the RMSD plots showed a more discontinuous trend of fluctuations for 2 IGDQK-S∙Au due to the 
higher degree of movement of the two molecules alone onto the surface, while a more stable trend is 
observed in the presence of a molecule filler. Notably, more stable values are observed during the 
simulations in the presence of MT(PEG)4-S∙Au (Fig. 2.32a). This confirmed that some intermolecular 
interactions occurred and forced the peptide structure to be more folded when surrounded by PEG 
molecules. Indeed by monitoring the involved H-bond interactions during the simulation of 2 IGDQK-
S∙Au / MT(PEG)4-S∙Au, a 48% of occupancy was detected for the intermolecular interaction between 
the ASP and ILE, along with the previous observed H-bond between the LYS and the terminal oxygen 
of the PEG (24 % occupancy). On the other hand, only a 12% of occupancy was observed for the 
ASP-ILE H-bond during IGDQK-S∙Au / C8H17-S∙Au trajectory, confirming the relative major 
oscillations shown by RMSD values. The main H-bonds involved in the different MD simulations are 
summarised in Table 2.5. This behaviour was confirmed by the Rg calculations shown in Fig. 2.32b. 
Indeed, if in both of the cases a decrease of Rg along the 10 ns trajectories was detected, a more 
homogeneous trend was observed in the presence of MT(PEG)4-S∙Au that perfectly reflected the 
situation aforementioned for which the peptide is more folded due to the stronger H-bonding  
interactions with the PEG molecules. On the other hand, the simulation of the two peptides onto the 
Au surface (2 IGDQK-S∙Au) further confirms the significant conformational changes reflected by the 
Rg plot where an intermittent decrease and increase occurs.  
 The whole picture described so far is well confirmed by the SASA plot where an instable trend is 
observed for 2 IGDQK-SH∙Au (black profile in Fig. 2.32c) compared the more homogeneous decrease 
of the exposed surface due to the conformations adopted. It is worth to note that the 2 IGDQK-S∙Au / 
C8H17-S∙Au (red profile in Fig. 2.32c) exhibits a major exposition of the peptide surface to the solvent 
compared to 2 IGDQK-S∙Au / MT(PEG)4-S∙Au (blue profile in Fig. 2.32c). 
 
 
 
Figure 2.32 RMSD (a), Rg (b) and SASA (c) plots calculated along the 10 ns trajectory of 2 IGDQK-S∙Au (black profile), 2 
IGDQK-S∙Au / C8H17-S∙Au (red profile), and 2 IGDQK-S∙Au / MT(PEG)4-S∙Au (blue profile). 
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Table 2.5 H-bond interactions detected during the different MD simulations. 
H-bonds 
SAMs Residues Occupancy  
(%) 
2  IGDQK-S∙Au / C8H17-S∙Au ASP-ILE 12 
n  IGDQK-S∙Au / C8H17-S∙Au ASP-GLY 32 32.03.03 
ASP-ILE 22.66 
GLN-ILE 18.73 
LYS-GLY 10.12 
GLY-GLN 8.80 
LYS-GLN 8.58 
ASP-ASP 7.07 
 ASP-GLN 6.38 
IGDQK-S∙Au / MT(PEG)4-S∙Au LYS-PEG 4 
2 IGDQK-S∙Au / MT(PEG)4-S∙Au ASP-ILE 48 
 LYS-PEG 24 
 ASP-ILE 17.69 
n IGDQK-S∙Au / MT(PEG)4-S∙Au ASP-GLY 13.39 
 LYS-GLY 10.12 
 LYS-GLN 7.18 
 ASP-ASP 6.21 
 ASP-GLN 5.66 
 Concerning the visual inspection of the different conformations and orientations assumed by  
2 IGDQK-S∙Au in the presence of either C8H17-S∙Au or MT(PEG)4-S∙Au, the situation is even more 
interesting and clear compared to what was previously observed. As represented in Fig. 2.33a, the two 
isolated IGDQK-S∙Au molecules result to lay onto the surface showing the tendency to interact 
through their alkyl chains with the surface moving away from each other. At the same time, the 
intricate interactions between the peptide and PEG resulted in an folded arrangement of the two 
IGDQK-S∙Au molecules, both laying down onto the MT(PEG)4 SAMs (Fig. 2.33c).  
 Conversely in the presence of C8H17-S∙Au, it was clear that one of the two IGDQK-S∙Au 
molecules was held erect by the interaction with the neighbouring that cause the ILE residue to point 
towards the ASP allowing the formation of the H-bond (Fig. 2.33b).  
 These results definitively confirmed what we observed by WCA and AFM measurements. In fact 
the PEG-functionalised surfaces, as a consequence of the folded IGDQK-SH conformation which 
allows the exposition of the hydrophilic AA to the solvent phase, resulted in less organised (AFM 
topographies showed the presence of peptide aggregates, Fig. 2.23) and more hydrophilic (low WCA° 
values, Table 2.2), compared to the corresponding octanethiol-functionalised surfaces (Fig. 2.22). All 
these evidences are in perfect agreement with the experimental results underlying the better orientation 
of IGDQK-S∙Au when surrounded by C8H17-S∙Au. 
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Figure 2.33 Front (left) and top (right) views of the IGDQK-SH conformations and orientations once chemisorbed onto a 
one-slab Au surface in the 2 IGDQK-S∙Au (a), 2 IGDQK-S∙Au / C8H17-S∙Au (b), and 2 IGDQK-S∙Au / MT(PEG)4-S∙Au (c) 
MD simulations. The AA residues within the peptide structure are labelled with their symbol name, namely Isoleucine (ILE), 
Glycine (GLY), Aspartic acid (ASP), Glutamine (GLN) and Lysine (LYS).  
  
 To further rationalise these data and evaluate whether this behaviour can be also observed in the 
presence of higher concentration of IGDQK-SH, 10 ns of classical MD simulations were also 
performed for n IGDQK-S∙Au, n IGDQK-S∙Au / C8H17-S∙Au, and n IGDQK-S∙Au / MT(PEG)4-S∙Au 
systems, simulating the experimental conditions in which a ∂ IGDQK-S∙Au was produced along the 
Au surfaces. Considering the RMSD plot reported in Fig. 2.34a, the same trend showing stable 
fluctuations in the three situations with more stable values during the simulations in the presence of 
MT(PEG)4-S∙Au was obtained, as discussed for the simulations involving two peptide molecules.  
A net distinction between the two alkanethiols clearly emerged in this case, highlighting the stronger 
intermolecular interactions that stabilised the peptide in a folded conformation when interfaced with 
PEG molecules (lower RMSD values, blue profile in Fig. 2.34a). Whereas higher degrees of 
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movement were detected for the n IGDQK-S∙Au / C8H17-S∙Au (higher RMSD values, red profile in 
Fig. 2.34a). Therefore, a significant number of H-bonds was revealed in both the cases, as a 
confirmation of the intricate network composed by the intermolecular interactions between IGDQK-
S∙Au and the alkanethiols molecules (Table 2.5). 
 
 
Figure 2.34 RMSD (a), Rg (b) and SASA (c) plots calculated along the 10 ns trajectory of n IGDQK-S∙Au (black profile) n 
IGDQK-S∙Au / C8H17-S∙Au (red profile), and n IGDQK-S∙Au / MT(PEG)4-S∙Au (blue profile). 
 
 Surprisingly, in these cases the Rg plot gave additional information (Fig. 2.34b). Indeed, if in the 
previous simulations the Rg values decreased reflecting the peptide tendency to assume a folded 
conformation, in these latter situations the Rg first decreased, and after directly increased towards 
stable values. This can suggested that, starting from the fully extended conformation, IGDQK-SH 
tends to relax for a short time assuming the folded orientation, to sharply re-stretch towards the 
extended conformation held on and stabilised by the intermolecular interactions. Additionally, even if 
the trend was the same for the two fillers, in the presence of C8H17-S∙Au the Rg values presented 
bigger increments (red profile in Fig. 2.34b), which definitively demonstrate that the peptide is more 
elongated and the IGDQK sequence is more exposed when it is inserted into the octanethiol SAMs. 
Furthermore, it is worth to note that the n IGDQK-S∙Au exhibit a more relaxed and folded 
conformation (black profile Fig. 2.34b) compared to n IGDQK-S∙Au / C8H17-S∙Au (red profile in  
Fig. 2.34b), confirming the crucial role of the octanethiol SAMs. The considerable difference between 
the two different fillers is also clearly visible when the SASA was calculated (Fig. 2.34c), displaying a 
major and increasing exposed surface when IGDQK-S∙Au is surrounded by the octanethiol SAM  
(red profile in Fig. 2.34c). Moreover as previously observed, the visual inspection of the different 
peptide conformations confirmed that the hydrophobic AA residues are more exposed to the solvent 
when a ∂ IGDQK-S∙Au was simulating in the presence of C8H17-S∙Au (Fig. 2.35b). Interestingly in 
the absence of the filler SAMs, n IGDQK-S∙Au exhibits a more flat and disordered organisation of its 
simulated chemical gradient (Fig. 2.35a). These results definitively confirm the importance of the 
fillers to generate ordered mixed SAMs, and their influence on the IGDQK-SH conformations once 
immobilised onto the Au surfaces. 
   69 
Chapter II 
 
 
 
Figure 2.35 Front (left) and top (right) views of the IGDQK-SH conformations and orientations once chemisorbed onto a 
one-slab Au surface in the n IGDQK-S∙Au (a), n IGDQK-S∙Au / C8H17-S∙Au (b), and n IGDQK-S∙Au / MT(PEG)4-S∙Au (c) 
MD simulations. 
  
2.6 Cellular behaviour on IGDQK-SH chemical gradients 
 
  The cellular behaviour onto the Au surfaces functionalised with ∂ IGDQK-S∙Au was assessed by 
employing two cell lines for which migration processes are known to occurr in pathological and 
physiological conditions. To this aim, MDA-MB-231 cells (a model of human breast cancer, 
ATCC® HTB-26™) and human dermal fibroblasts isolated from fetal skin (AG04431 skin HDFs, 
Corriel Institute For Medical Research, USA) were selected, respectively (Fig. 2.36). 
 As a first preliminary study, we wanted to observe the cells onto the Au surfaces through 
microscopy imaging techniques. Therefore after depositing such cell lines onto a model surface 
functionalised by C8H17-S∙Au, we monitored them by using an optical microscope over the desired 
time lapse, that for general SAMs stability reasons was selected as five days.[198] In addition to this 
aspect, our idea was also to explore the ability of cells to maintain or recover their viability properties. 
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In order to achieve that, we performed confocal laser scanning microscopy (CLSM) after staining both 
cell lines against nucleus and cytoskeleton (actin filaments), which represent two intracellular 
microstructures whose integrity assessment is of paramount importance to understand the retention of 
the proper cellular features. 
 
 
Figure 2.36 Optical microscopy images of MDA-MB-231 cells (a) and fibroblasts (b) cells grown on T25 flask (left) and 
onto untreated Au-coated coverslips (right). 
 
 As displayed in Fig 2.37, the huge size difference between the fibroblasts and MDA-MB-231 
cells is at first highlighted. The former cell type shows a more elongated shape, while the latter being 
polygonal-like and characterised by a big nucleus. Both nucleus and cytoskeleton (actin filaments) 
turned out to be intact under the chosen experimental conditions. The most important aspect was that 
the morphology observed for both cell lines was associated to healthy cells which after five days 
preserved the integrity of their membranes, and continued to proliferate and accomplish their cellular 
functions. 
 
 
 
 
Figure 2.37 CLSM images of MDA-MB-231 cells (a) and fibroblasts (b) after five days deposition onto C8H17-S∙Au 
functionalised surfaces. Two fluorescent dyes, namely 4’,6-diamidino-2-phenylindole (DAPI) and Rhodamine-Phalloidin 
were used to label the cells, targeting the nucleus and the actin cytoskeleton, respectively, 
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 Subsequently, these two cell lines were interfaced with IGDQK-S∙Au (Fig. 2.38), C8H17-S∙Au  
(Figs. 2.39a-b), and MT(PEG)4-S∙Au (Fig. 2.39c), by letting them adhere in the deposition spot 
delimited by the PVC mask, which is located at about 2 mm from the beginning of the chemical 
gradient. After medium addition, the resulting surfaces were imaged by optical microscope on a time 
lapse of 5 days (at t = 0, 48 h, 96 h and 120 h) and edited with appropriate software to enhance the 
position of all the cells along the Au substrates. As displayed in the following Figs, the two cell lines, 
which as expected replicate with very different rates (high for the cancer MDA-MB-231 cells, low for 
the fibroblasts) did not significantly advance toward the channel delimited by the PVC mask, as a 
main consequence of the lack of any directional chemical distribution of the chemotactic or the fillers 
along the surfaces.  
It is important to note that adhesion and replication properties of the two cell lines are oppositely 
influenced by the surface wettability. Indeed, MDA-MB-231 cells preferred to adhere and replicate 
onto hydrophilic surfaces functionalised with IGDQK-S∙Au and MT(PEG)4-S∙Au (Figs, 2.38a-2.39c). 
On the contrary, fibroblasts in the optimised conditions which allow cells to adsorb onto the Au 
surfaces did not adhere on MT(PEG)4-S∙Au, and they were washed away from the surfaces during the 
medium addition step. Therefore, fibroblasts showed enhanced adhesion and replication onto 
hydrophobic surfaces composed by C8H17-S∙Au (Fig. 2.39b). 
 
 
 
Figure 2.38 Software edited optical microscopy images of MDA-MB-231 cells (a) and fibroblasts (b) onto IGDQK-S∙Au 
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Figure 2.39 Software edited optical microscopy images of MDA-MB-231 cells (a) and fibroblasts (b) onto C8H17-S∙Au, and 
MDA-MB-231 cells (c) onto MT(PEG)4-S∙Au. 
 
 Preliminary experiments onto ∂ IGDQK-S∙Au, without any alkanethiol as filler, did not show 
good degrees of cell adhesion nor directed migration along the surfaces, for both the cell lines. This 
could be related to the poor surface organisation of ∂ IGDQK-S∙Au (Fig. 2.17), as revealed by AFM 
analysis showing large peptide aggregates along the gradient direction, Additionally, computational 
analyses aimed to simulate a ∂ IGDQK-S∙Au confirmed us that, in the absence of filler SAMs, ∂ 
IGDQK-S∙Au exhibit a more flat and disordered organisation (Fig. 2.35a), which seemed to be 
incompatible proper binding with cellular receptors mediating adhesion and migration.  
 Following these preliminary results, cells were then interfaced with ∂ IGDQK-S∙Au / C8H17-S∙Au 
Au-functionalised surfaces that were characterised by a higher surface organisation together with the 
most significant ∆WCA (AFM images in Fig. 2.22a, WCA values in Table 2.2). As shown in  
Fig. 2.40, a moderate degree of average displacement of both cell lines was observed. MDA-MB-231 
cells replicated with higher rate, rapidly reaching confluence at the boundary between the deposition 
spot and the channel (Fig. 2. 40a). 
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Figure 2.40 Software edited optical microscopy images of MDA-MB-231 cells (a) and fibroblasts (b) onto ∂ IGDQK-S∙Au / 
C8H17-S∙Au.  
 
This could be the reason why the majority of the cells did not reach the final point of the surface. 
Nonetheless, a minor fraction of the cells (those located “at the frontier” of the deposition spot) was 
able to move along the chemical gradient. This resulted in a broadened localisation of the migrating 
cells where some of which reached the remarkable distance of about 8 mm from the deposition area. 
 On the other hand, fibroblasts with their elongated shape and reduced migration performance 
(compared to the highly metastatic behaviour of MDA-MB-231 cells) were found to slowly replicate 
on the time lapse of five days and migrated towards the increase of IGDQK-SH concentration, 
reaching approximately one-third of the overall distance available on the functional surface  
(Fig. 2.40b). 
In order to evaluate how the surface organisation and properties could influence the cellular 
behaviour, cells were deposited onto the Au-functionalised substrates with ∂ IGDQK-S∙Au / ∂ C8H17-
S∙Au. AFM analyses onto such surfaces showed a lower degree of surface organisation (Fig. 2.22b), 
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compared to the Au substrates functionalised with ∂ IGDQK-S∙Au / C8H17-S∙Au (Fig. 2.22a). 
Moreover, they are made by two components that could induce cellular migration, namely an increase 
in chemotactic peptide and an augmentation in surface hydrophobicity (the latter being known to play 
roles in modulating cell migration) along the same direction. Therefore, a blank experiment was 
required prior the execution of the aforementioned test. By depositing cells onto a surface prepared by 
applying only the second step of the double gradient method, consisting of the gradually immersion of 
the Au sample into the HS(CH2)7-CH3 solution, no cellular migration of both cell lines was observed 
(Fig. A11, Appendix). This observation suggested that the hydrophobicity increase along the surface 
by itself (ΔWCA of ca. 13°, Table A2, Appendix) was not responsible for the induction of appreciable 
cellular migration.  
 Taking into consideration this important result, the cells were tested onto ∂ IGDQK-S∙Au / ∂ 
C8H17-S∙Au (Fig. 2.41). In these conditions, the results with the two cell lines were different of what 
was obtained with ∂ IGDQK-S∙Au / C8H17-S∙Au (Fig. 2.40). For MDA-MB-231 cells, a clear 
migration occurred along the surface with a moderate fraction of cells that was able to reach the end of 
the channel. However, the movement of the cells was less pronounced if compared with the migration 
observed by employing the ∂ IGDQK-S∙Au / C8H17-S∙Au. In fact due to the hydrophilicity increase 
across the surface (entry 2, Table 2.2), many cells were spread along the channel since the beginning 
of the experiment during the deposition step (Fig. 2.41a). 
 Fibroblasts instead remained for the majority inside the deposition spot, with an overall average 
displacement lower that in the previous experiment. On the other hand, few fibroblasts that started the 
migration were able to reach the end of the channel, a situation which was not observed in the other 
experiment conditions (Fig. 2.41b).  
 Taking into consideration these data, when comparing the effect of the technique applied for 
generating ∂ IGDQK-S∙Au in the presence of the same filler, it was clearly observed that, in both 
cases, for the two cell lines a migration along the Au surfaces occurred with remarkable differences. 
Moreover as previously shown, a gradient of hydrophobicity alone along the samples was not able to 
induce cellular migration. Therefore from all of these observations, it turns out that the cell migration 
was induced and directed by surface-bound ∂ IGDQK-S∙Au. In addition, the surfaces organisation and 
wettability properties were responsible for the differences in the migration behaviour of MDA-MB-
231 cells and fibroblasts, modulating the cell adhesion, proliferation and migration rate. 
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Figure 2.41 Software edited optical microscopy images of MDA-MB-231 cells (a) and fibroblasts (b) onto ∂ IGDQK-S∙Au / 
∂ C8H17-S∙Au  
  
 Considering that the generation of ∂ IGDQK-S∙Au using C8H17-S∙Au was the most efficient 
system for inducing and directing the migration of the two cell lines, further biological experiments 
were carried out keeping constant the gradient generation method (full immersion) and changing the 
filler. Indeed, cells were interfaced with ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au (Fig. 2.42). In these case, 
fibroblasts did not adhere being washed away from the deposition spot, in analogy of what observed 
onto surfaces functionalised with MT(PEG)4-S∙Au. On the contrary, MDA-MB-231 cells showed 
mostly replication behaviour, reaching confluence inside the deposition spot, while a very minor 
fraction of individual cells that migrated toward the increasing concentration of IGDQK-SH compared 
with the previous results (Fig. 2.42a). Furthermore, when comparing the effect of the fillers applying 
the same gradient generation method, the resulting surfaces possess similar roughness and XPS N At% 
levels along the ∂ IGDQK-S∙Au, with the only difference being the ΔWCA (higher ΔWCA for  
∂ IGDQK-S∙Au / C8H17-S∙Au, Table 2.2). 
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Figure 2.42 Software edited optical microscopy images of MDA-MB-231 cells onto ∂ IGDQK-S∙Au / MT(PEG)4-S∙Au (a) 
and ∂ IGDQK-S∙Au / C8H17-S∙Au (b). 
 
 Therefore in addition to the surface organisation and wettability properties, the different peptide 
conformations and orientations in the presence of the two fillers, strongly influence and modulate the 
cellular behaviour and migration. All these evidences were in perfect agreement with the 
computational results that underlined the most organised and elongated orientation of IGDQK-S∙Au 
(Fig. 2.29b) when surrounded by C8H17-S∙Au (Fig. 2.33b). As a consequence of this extended 
conformation, the AA sequence IGDQ resulted well exposed to the solvent interface, allowing the 
cells to recognise such motogenic portion in the right way of reading, and thus migrate towards the  
∂ IGDQK-S∙Au (Fig. 2.40). On the other hand, the presence of stronger H-bonding interactions 
between IGDQK-S∙Au and MT(PEG)4-S∙Au molecules, causes a distortion in the peptide’s structure 
that forces IGDQK-S∙Au to assume a more folded conformation (Fig. 2.29a).  
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Due to this particular peptide’s conformation, the motogenic AA sequence is not well accessible to the 
cells (Fig. 2.33c), therefore it could be the reason why onto PEG-functionalised surfaces cells, being 
unable to correctly detect the IGDQ sequence, in some cases did not adhere nor migrate (Fig. 2.42a). 
 
 2.6.1 Cell viability under IGDQK-SH stimulation 
 
 Since the most significant differences in terms of cell adhesion and replication properties were 
observed for MDA-MB-231 cells onto Au-functionalised surfaces with ∂ IGDQK-S∙Au compared to 
the reference substrates (Figs. 2.38a, 2.39a-c), the idea was to investigated the effect of our IGDQ-
containing peptide onto such cells, by exposing them to IGDQK-SH solutions.  
 The experimental conditions were selected on the basis of some previous studies regarding the 
biochemical effects of IGD-containing peptides added in solution to fibroblasts, which did not provoke 
an increase in cell proliferation during the migration assays.[187, 188] Therefore, the cell viability on a 
time lapse of 72 h was assessed by a classical evaluation of formazan conversion through the MTS 
assay using IGDQK-SH concentrations of 0.1 µM and 1 µM. This test is a colorimetric method for 
determining the number of viable cells in proliferation or during cytotoxicity assays, which is based on 
the use of a tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS, Fig. 2.43) and an electron coupling reagent phenazine 
methosulfate. The MTS compound is bioreduced by cells into a colored formazan product that is 
soluble in tissue culture medium (Fig. 2.43).  
 
 
 
 
Figure 2.43 Structural representation of the tetreazolium compound used in the cell proliferation assay (MTS) and resulting 
bioreduced compound measured during the assay (Formazan). 
 
The quantity of formazan product as measured by the amount of 490 nm absorbance is directly 
proportional to the number of living cells in culture. As clearly shown in the resulting cell viability 
plot (Fig. 2.44), the addition of IGDQK-SH in solution did not cause any evident increase or decrease 
in cell viability after 24, 48 or 72 h. Indeed, the cell viability values fluctuated around the control 
value (100% of viability without IGDQK-SH stimulation), with experimental errors that did not allow 
to draw significant statistical differences within the sampled conditions. Taking into consideration 
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these results, the enhanced replication observed in the IGDQ-containing surfaces cannot be ascribed to 
a specific induction mediated by the IGDQK moiety, rather it could be connected to increased 
adhesion of the individual cells onto such functional surfaces compared to the reference substrates. 
 
 
 
 
Figure 2.44 MTS assay showing the MDA-MB-231 cell viability as a function of time onto cells without IGDQK-SH 
stimulation (ctrl) and in the presence of IGDQK-SH 0.1µM and 1µM. 
 
 Interestingly, compairing the two cell lines, MDA-MB-231 cells showed an enhanced and more 
significant migratory activity suggesting a selective stimulation of IGDQK-SH towards the cancer 
cells. This result might suggest a role of the IGD motif in the stimulation of the cancer cells towards 
their enhanced motility and metastatic progression in vivo.  
 To further rationalise these data, we are currently performing phosphorylation studies of the 
protein FAK125, main responsible for cell motility machinery activation, through Western Blotting 
investigations onto both cell lines under IGDQK-SH stimulation. 
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 3. Peptidic Nucleic Acids (PNAs) 
  
 This chapter describes the synthetic steps taken towards the preparation of native and modified 
PNA oligomers able to recognise surface-bound complementary ssDNA-SH, towards the production 
of supramolecular PNA/DNA gradients along Au surfaces.  
 The chapter is divided into four sections: i) section 3.1 provides a comprehensive description of 
PNA physicochemical properties and applications, leading to the objective in which PNA target 
oligomers are described; ii) section 3.2 includes a description of the retrosynthesis and existing solid 
phase synthesis (SPPS) strategies to prepare PNA oligomers, followed by a discussion of the 
orthogonal protecting group strategy adopted, to finally describe PNA monomers synthesis; iii) section 
3.3 deals with the synthesis and functionalisation of ssPNA oligomers by both manual and semi-
automated SPPS; iv) section 3.4 discusses the preliminary results about ssDNA-SH and ssPNAs 
hybridisation properties in solution. 
 
3.1 PNA towards the supramolecular approach 
 
 PNA was first introduced by Nielsen et al. in 1991.[1] It is a DNA analogue in which the 
phosphate backbone is replaced by N-(2-aminoethyl)glycine (AEG) units. The structure of PNA in 
comparison to that of DNA and the interaction properties with complementary ssDNA are shown in 
Fig. 3.1. As reported by Hyrup and Nielsen,[2, 3] PNA presents several differences and advantages over 
DNA: (i) PNA oligomers can be easily synthesised using established techniques from peptide 
chemistry i.e. SPPS; (ii) organic moieties can be covalently attached to both oligomer’s C-terminal 
carboxylic acid or N-terminal amino groups, or on nucleobases and introduced lateral chains; 
(iii) PNA is achiral, so all enantiomeric purity problems are avoided; (iv) PNA peptidic backbone is 
neutral compared with DNA’s negatively charged sugar-phosphate backbone, therefore no 
electrostatic repulsion exists when PNA hybridises with another PNA or DNA oligomer; (v) as a 
consequence of this lack of electrostatic repulsion PNA/PNA duplexes have a higher thermal stability 
relative to DNA/PNA and DNA/DNA duplexes, reflecting in higher melting temperatures; and (vi) the 
possibility to easily control the helix handedness upon introduction of opportunely-modified 
enantiomerically pure AA.[4] Furthermore, PNAs have a high biostability, since they are not degraded 
by nucleases nor proteases.[5] They are also chemically resistant to strong acids and weak bases.[6] 
 These properties make them an appealing candidate for a wide number of applications in 
biochemistry and material science.[7]  
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Figure 3.1 Schematic representation of DNA and PNA molecules (a), and DNA/PNA duplex (b). B represents the 
nucleobases (adenine, thymine, cytosine and guanine). 
 
 3.1.1 PNA applications 
    
 3.1.1.1 PNA as a versatile tool in biology applications 
 
 PNAs can be used in many of the biotechnological applications as synthetic DNA, but with the 
additional benefits gained from tighter binding and greater selectivity. They represent powerful tools 
for biological applications, such as diagnostics, detection and pharmaceuticals.[2, 5, 6, 8] For instance, 
PNA probes for in situ hybridisation yield higher signals and better specificity. Thus PNA-
fluorescence in situ hybridization (FISH) techniques have been developed for quantitative telomere 
analyses, chromosome painting, viral and bacterial diagnostics in both medical and environmental 
samples.[9-11] PNAs present also strand invasion properties[12] and capability to form triple-helices[13] 
with dsDNA. Because of such features and being chemically and biologically stable, they can be used 
to design gene therapeutic drugs.[14] There are basically two strategies involved in using PNAs as 
therapeutic drugs, namely antigene and antisense methods.[15, 16] In antigene strategy PNA oligomers 
are designed to recognise and hybridise to complementary sequences in a particular gene.[17] They are 
capable of arresting transcriptional processes by virtue of their ability to form stable triplex structures, 
strand invasions or strand displacement complexes with DNA.[18-20] Alternatively, in the case of 
antisense strategy PNAs can be designed to recognise and hybridise to complementary sequences in 
messenger RNA (mRNA) and thereby inhibit its translation.[21, 22] Normally, the antisense effect is 
based on the steric blocking of either RNA processing, transport into cytoplasm, or translation. 
Although the results with PNAs in cell-free systems were encouraging, their poor cellular uptake is the 
main obstacle for their effective therapeutic use.[23] In order to improve the efficiency of PNA 
delivery, many strategies have been explored. Since a positive charge will enhance the attraction of 
molecules to the cell membrane, some studies have attempted to incorporate positively 
charged residues such as lysine and arginine, or ligands into PNA molecules, to increase its cellular 
uptake.[24, 25] Moreover, PNAs have been also conjugated with short peptide sequences, antibodies, or 
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steroids.[26, 27] Further in vitro molecular biology and genetic applications include the use of PNA 
oligomers as molecular tools in PCR clamping,[28, 29] modulation of enzymatic cleavage,[30, 31] and 
sequence-specific purification of nucleic acids.[32, 33]  
 
 3.1.1.2 PNA-containing SAMs on solid surfaces 
 
 Apart from the biological applications, PNA have been recently introduced in the fields of 
supramolecular and materials chemistry.[34] In particular, surface functionalisation with functional 
PNA strands, through the exploitation of SAMs, is currently of substantial interest.[7] In fact, the 
possibility of transferring the unique PNA recognition properties to bulk or nanostructured materials 
by surface coating/functionalisation results in novel functional nanomaterials (vide infra).  
 PNA-based SAMs have mainly been prepared by covalent attachment of modified PNA 
oligomers bearing terminal anchoring groups to various surfaces (e.g. gold, pyrite, glass) with the 
intention of preparing microarray biosensors.[35-38] 
 In a very recent example, Calabretta et al.[39] reported the patterning of PNA on glass surfaces 
using reactive µCP. Glass surfaces were modified with aldehyde functional groups, and the PNA 
oligomers were functionalised with an amino group attached via a short aminoethyl ethoxy linker. To 
pattern the surfaces, a freshly oxidized PDMS stamp was “inked” with a 20 μM solution of PNA in 
acetonitrile for 5 min, dried with N2 and then brought into contact with the aldehyde modified glass 
surface for 15 min. This allowed the amino groups to react with the aldehyde functional groups 
forming an imine linkage between the PNA and the glass substrate. The imine bonds were then 
reduced to the corresponding amines in the presence of NaBH4. This process is summarised in 
Fig. 3.2. Fluorescence microscopy of a glass surface printed with a fluorescein-bearing PNA oligomer 
confirmed the micropattern of covalently-bounded PNA on the glass surface (Fig. 3.2b). The patterned 
surfaces were then hybridised with complementary and single-base mismatched dye-labeled DNA 
oligomers to test their ability to recognise complementary DNA sequences. It was shown that both 
sequences successfully hybridised to PNA, however the mismatched sequence’s PNA/DNA duplex 
displayed a lower melting temperature of approximately 5 °C compared with the fully complementary 
sequence, therefore confirming that the microarray biosensor could be used to selectively detect 
sequence mismatches and point mutations in DNA. 
 
Figure 3.2 (a) Schematic representation of the patterning of amino-capped PNA oligomers onto aldehyde-functionalised 
glass slides via reactive contact printing. (b) Fluorescence microscope image (scale bar: 200 μm) of a glass surface following 
µCP with fluorescein-labeled PNA. Adapted with permission from reference 39. 
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 In a parallel work, Messere et al. reported on the functionalisation of PNA-based magnetic 
conjugates using an alternative strategy, in which dextran-coated magnetic nanoparticles have 
opportunely been modified introducing reversible bonds for the immobilisation of unmodified 
oligonucleotides.[40] When complementary ssPNA and ssDNA nanohybrids were mixed, the base 
pairing led to an extended nanoparticle-based assembly (Fig. 3.3).  
 
 
Figure 3.3 TEM images of the ssPNA/ssDNA hybridisation inducing nanoparticle aggregation. Adapted with permission 
from reference 40. 
  
 Upon magnetic field application, the ssPNA/ssDNA particle assembly shows higher responses 
rate to the external field, thus supporting the hypothesis of the formation of the assembly and its 
enhanced activities in the presence of the magnetic field which allows for the control of nanoparticle’s 
aggregation state and organisation. These materials are on the way to be tested for the local and 
thermal-induced release of DNA strands for in vivo applications.[40] 
 In one of the first reports, thiol-derivatised ssPNAs bearing a terminal cysteine group have been 
self-assembled on Au using a classical wet technique, by soaking a Au surface in a PNA-containing 
μM solution.[37, 41] By means of Fourier transform reflection absorption infrared spectroscopy  
(FT-RAIRS), AFM and XPS, it has been shown that the molecular orientation of the adsorbed ssPNAs 
(sequence: Cys-O-O-AATCCCCGCAT, where O = –NHCOCH2OCH2CH2OCH2CH2–) strongly 
depends on the surface coverage. Specifically, at high coverage, the ssPNAs molecular axe assumes a 
normal position and forms SAMs without the need for co-adsorbing adjuvant molecules for filling the 
undergrowth space. As expected, at low coverage, the ssPNAs lie flat on the surface, thus confirming a 
concentration-dependent structural transition. Knowing the structural properties for the ssPNAs-based 
SAMs is essential for engineering efficient biosensors for the characterisation of target DNA 
molecules in solutions.[42, 43]  
 Following a similar approach, Willner et al. self-assembled a cysteine-modified ssPNA  
(NH2-Cys-ACGACGGCCAGT-H) on a Au-coated AFM tip for probing and detecting the 
hybridisation interaction with a ssDNA[44] (Fig. 3.4). Exploiting a chemical force microscopy (CFM), 
the adhesion force between a ssPNA-modified tip or a DNA/PNA-modified tip with an hydrophobic 
Au surfaces coated with undecanethiol could be measured in a TRIS-HCl buffer solution (5 mM at pH 
= 7.4). 
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Figure 3.4 Schematic representation of the CFM-based diagnostic nanotool for detecting DNA sequences through a 
measurement of the adhesion forces generated between the PNA-modified tip (a) and the PNA/DNA-functionalised tip (b). 
Adapted with permission from reference 44. 
 
 A substantial decrease in the resulting adhesion force has been observed for the double stranded 
DNA/PNA-modified tip (Fig. 3.4b, F = 1.13 nN) compared with ssPNA-modified tip (Fig. 3.4a, F = 
4.35 nN) as a consequence of the increased hydrophilic character of the tip upon hybridisation with the 
complementary ssDNA (5'-ACT-GGC-CGT-CGT-3'). Interestingly, soaking the ssPNA-modified tip 
into a solution of a DNA mutant displaying only one single base mismatch as compared with the fully 
complementary strand, led to an adhesion force that is identical to the non-hybridised ssPNA-modified 
tip at a concentration of 5 × 10-10 M.  
 Similar ssPNAs containing SAMs for DNA detection have also been reported by Burgener et al. 
following a pre-modification of a Au surface with a dextran layer, which is then functionalised by an 
organic monolayer bearing terminal thiol functionalities that undergo a covalent bond-forming 
reaction with a ssPNA bearing a terminal reactive maleimide group.[45] Surface plasmon resonance 
imaging (SPRI) has recently emerged as an extremely versatile method for detecting interactions of 
biomolecules in a micro-array format, through the spatial monitoring of local differences in the 
reflectivity of incident light from an array of biomolecules linked to a chemically-modified Au 
surface. SPRI of PNA-modified Au surfaces has recently been reported for ultrasensitive, 
nanoparticle-enhanced detection of DNA sequences down to 1 fM (SPRI usually detected as bright and 
dark spots in the SPR image).[46] In this device configuration, gold nanoparticles (AuNPs) were 
functionalised with DNA, and dithiobis(N-succinimidyl propionate) (DTPS) was used for linking PNA 
to the gold surface of sensor microchannels. Following a sandwich-like strategy, a solution of a full 
matching DNA sequence was then injected into a microchannel containing immobilised PNA together 
with AuNPs bearing a DNA dodecamer (12-mer), both complementary for the terminal tracts of the 
targeting DNA strands. The specificity of the full matched DNA strands has been checked by 
comparing the AuNPs-enhanced SPRI signals with those obtained when singly mismatched DNA 
sequences were allowed to interact with the surface-immobilised ssPNA. From the Δ%Rb/Δ%R ratio 
between AuNPs-enhanced responses (SPRI kinetic data were obtained by plotting the difference in 
percent reflectivity Δ%R), an average value of 7.4 was calculated for 1 fM concentration. This increase 
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is attributed to the high dissociation constants of the mismatched sequences, the response of which 
dropped to the background level below 1 pM, thus dramatically increasing the mismatch recognition in 
connection with the decreased detection limits. 
 
 3.1.2 Design of the target recognition PNA-based scaffolds for the 
supramolecular assemblies 
 
 The first intention of the project involved the production and characterisation of the bidirectional 
reversible gradient of DNA/PNA duplexes along the Au surfaces. The idea was to synthesise two 
ssPNA oligomers, and functionalise them with different chromophores in order to distinguish both 
chemical gradients through confocal microscopy imaging. To confirm the presence of the bidirectional 
gradient, Rhodamine B (Rho B) and 3-Carboxycoumarin (CC) were chosen as fluorescent probes, 
allowing a selective gradients characterisation. The choice of the PNA sequences and number of 
monomers was fundamental. Indeed, two ssPNA 12-mers with different base sequences were selected, 
in order to ensure the hybridisation with complementary ssDNA-SH and avoid the self-recognition 
between PNA molecules, respectively (Fig. 3.5). Since we have demonstrated the motogenic 
efficiency of the IGDQK-SH peptide, after the production and characterisation of the bidirectional 
gradient, the two chromophores can be replaced by the IGDQ peptide in order to obtain two 
motogenic-bearing PNA 12-mers able to control the cellular movement (Fig. 3.6). 
 
 
Figure 3.5 Molecular structures of the PNA 12-mers functionalised with Rho B (a), and CC (b). The PNAs sequences from N 
to C terminal group are: Rho-TATTAAATATTT-Lys (a), and CC-ATTTAATATTAA-Lys (b). 
 
 
Figure 3.6 Molecular structures of the motogenic-bearing PNA 12-mers. The PNAs sequences from N to C terminal group 
are: IGDQ-TATTAAATATTT-Lys (a), and IGDQ-ATTTAATATTAA-Lys (b). 
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3.2 Synthetic strategies for preparing PNA 
 
 In order to successfully synthesise the desired PNA oligomers, a review of the existing methods 
to prepare the monomer and oligomer was required.  
 The core of the monomeric unit is the AEG moiety protected at the terminal amino group. Three 
main retrosynthetic routes (A-C) have been described for this unit[6] (Scheme 3.1). Route A, which is 
one of the most convenient and inexpensive methods, involves an SN2 reaction between a mono-
protected ethylenediamine species and an α-halogenated acetic acid or its esters.[47-49] Routes B and C 
both involve reductive amination reactions.[50, 51] Whereas in route B the reaction is performed between 
the mono-protected ethylenediamine and a glyoxalic ester, in route C protected glycinal and glycine 
synthons are used. The completion of the PNA monomers is then performed by coupling the modified 
nucleobases bearing a carboxymethyl moiety with the secondary amine of the AEG 
unit in the presence of coupling reagents (e.g. N,N’-dicyclohexylcarbodiimide [DCC], O-
(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate [HBTU], etc.). Due to this 
coupling reaction, the carboxylic group of the AEG is normally protected as an ester which is then 
selectively deprotected to produce the monomer bearing the carboxylic group required for the PNA 
oligomerisation. The choice of the protecting groups on the AEG amino group and on the nucleobases 
depends on the strategy used for the oligomer synthesis.  
 
Scheme 3.1 Retrosynthetic pathway towards the production of PNA monomers showing routes A-C to obtain the AEG unit. 
 
 The carboxymethyl nucleobases required for coupling to the AEG unit are shown in Fig. 3.7. 
Carboxymethylthymine is synthesised by N1 alkylation of thymine with α-bromoacetic acid and is 
generally used in its non-protected form. The carboxymethyl adenine and cytosine derivatives are 
generally prepared in two steps by protecting the exocyclic amino group first, followed by alkylation 
with the opportune bromoacetic acid derivatives.  
 
 
Figure 3.7 Nucleobase derivatives used for PNA synthesis. From left to right, thymine, cytosine, adenine and guanine 
derivatives are shown. 
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 Among the different nucleobases guanine is certainly the most difficult to be modified due to its 
lack of solubility. Generally the synthesis involves the use of 2-amino-6-chloropurine as a starting 
material, where N9 alkylation at the position is performed with α-bromoacetic ester followed by 
protection of the exocyclic amino group. Saponification in situ and hydrolysis of the protected 
nucleobases give the desired guanine derivative.[49] 
 PNA monomers feature a protected N-terminus and a free carboxylic group are comparable to the 
AA used to prepare peptides, therefore PNA oligomerisation can be performed with the same synthetic 
procedures commonly used for peptides i.e. solid phase synthesis. A general strategy for the synthesis 
of PNA oligomers on solid phase resins is shown in Scheme 3.2.[6]  
 
 
Scheme 3.2 General representation for the synthesis of PNA oligomers on solid-phase resins. Adapted with permission from 
reference 6. 
  
 In the first step, a monomer is loaded onto the free amino groups of the resin. Subsequently, the 
elongation takes place by repeated cycles of N-terminal deprotection of the anchored monomer and 
coupling between this latter and the following N-protected monomer. The coupling reactions are 
carried out in the presence of coupling reagents which are expected to give yields above 99%. As 
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aforementioned, the exocyclic amino groups present on cytosine, adenine and guanine are protected to 
prevent side reactions during the oligomerisation synthesis. At the desired length of oligomer, the final 
cleavage can be carried out to release the synthesised molecule from the resin yielding the crude 
product.  
 The most common strategies used in PNA synthesis involve the N-terminal Boc [1, 6, 52-54]and the 
Fmoc[49, 55-57] protecting groups. The Boc strategy was the first to be used for synthesising PNA 
oligomers.[1, 54] Homothymine sequences were synthesised first, and later the strategy was optimised 
for mixed sequences.[58] The chosen solid phase resin is MBHA derivatised PS resin to which the first 
PNA monomer is linked by an amide bond. The amino groups on the nucleobases are orthogonally 
protected with benzyloxycarbonyl derivatives (Cbz), and this protecting group combination is usually 
referred to as the Boc/Cbz strategy. The Boc group was deprotected with TFA during the oligomer 
elongation, whereas the final cleavage of PNA from the resin, together with the simultaneous 
deprotection of the exocyclic amino groups of the nucleobases, is carried out using HF or a mixture of 
TFA and trifluoromethanesulfonic (TFMSA) acids. Such drastic cleavage conditions limited the range 
of PNA oligomers synthesised according to the Boc protocol. A search for milder conditions led to the 
development of the Fmoc strategy where the N-terminal Fmoc protecting group is cleaved under mild 
basic conditions using piperidine. As displayed in Table 3.1, this makes the Fmoc strategy compatible 
with a wider variety of resin linkers which can be cleaved under less acidic conditions (e.g. TFA). 
 
 
Table 3.1 Linkers used to attach growing PNA oligomers to resin support polymers:  
(a),[52] (b),[55] (c),[49] (d),[59] (e),[60] (f),[61] (g),[62] (h).[63] 
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 3.2.1 Protecting group strategy and orthogonality 
 
 In order to successfully synthesise the desired PNA oligomer, both the monomer and the 
oligomer synthesis required protecting groups that could be orthogonally deprotected when required. 
Furthermore, the linker between the solid phase resin and growing PNA oligomer had also to be 
orthogonal to the protecting groups. After reviewing all these conditions, the following strategy has 
been proposed. The monomers would be synthesised using the Fmoc/Cbz strategy by using Fmoc 
protection on the N-terminal of the AEG moiety and Cbz protection on the exocylic amino groups of 
the nucleobases.[49] The Cbz group is stable to both basic and acidic conditions, up to pH 1.[64] It is 
generally deprotected by hydrogenation in the presence of palladium on activated carbon, strong acids 
(e.g. TFMSA), or nucleophilic substitution with silyl derivatives. Since the Cbz group is stable to 
TFA, a tert-butyl ester was proposed as the protecting group for the carboxylic moiety of the AEG 
unit. The Fmoc/Cbz protected monomers were then used to prepare PNA oligomers using the 
commercially available Rink-amide MBHA resin. Since this resin is stable to basic conditions, the 
oligomer elongation using Fmoc chemistry is compatible, and the oligomers can be cleaved from this 
resin under acidic conditions using TFA[65]. With the nucleobase protection, the oligomer can be used 
for further reactions in solution, and when required the Cbz deprotection can be achieved out using 
trimethylsilyl iodide (TMSI). This strategy is summarised in Fig. 3.8. 
 
 
 
Figure 3.8 Fmoc/Cbz orthogonal strategy proposed for the PNA oligomerisation. The N-terminal Fmoc protecting groups 
can be deprotected with piperidine without affecting the base-stable Rink-amide MBHA resin and the Cbz protecting groups. 
The oligomer can be cleaved from the resin using TFA without deprotecting the Cbz groups which can be removed later in 
solution using TMSI. 
 
 3.2.2 Synthesis of PNA monomers 
 
This section presents the synthesis of the thymine and adenine monomers required for the SPPS of the 
target PNA 12mers. The structures of the target monomers are shown in Fig. 3.9. The monomers were 
prepared using a convergent synthesis where the carboxymethyl nucleobase derivatives and the AEG 
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unit were coupled together. The synthetic pathways involving the synthesis of the thymine (12) and 
adenine (13) monomers will be thoroughly described in the following sections.  
 
Figure 3.9 Molecular structures of the target thymine (12) and adenine (13) PNA monomers.  
 
 
 3.2.2.1 Synthesis of thymine monomer 12 
 
 Two components were required to prepare thymine monomer 12, the carboxymethyl 
functionalised nucleobase and the AEG unit. The nucleobase’s synthesis was tackled first, followed by 
the synthesis of the AEG unit. The two molecules were then coupled together to form the fully-
protected monomer, which was then freed at carboxylic position upon acidic treatment, yielding 12.  
 The synthetic pathway to produce the modified thymine is reported in Scheme 3.3. It involves the 
addition of methyl-α-bromoacetate to thymine 14 followed by saponification without isolating or 
purifying the ester intermediate, to afford thymine bearing an acetic acid moiety 16 in 62% yield over 
two steps.[53] 
 
Scheme 3.3 Synthetic pathway for the production of the modified nucleobase thymine 16. 
  
  
 The completion of the thymine monomer required the synthesis of the PNA backbone AEG, 
which was performed according to the procedure described by Thomson et al.[49] As shown in Scheme 
3.4, the synthesis involves the addition of tert-butyl-α-bromoacetate to ethylenediamine 17, with the 
latter in large excess during the reaction, to give mono-protected ethylenediamine 18. This step is 
followed by Fmoc protection of the remaining primary amine of the ethylenediamine, using N-(9-
fluorenylmethoxycarbonyloxy)succinimide (Fmoc-OSu) to obtain Fmoc/tBu-protected AEG unit 19 in 
58% yield over two steps.  
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Scheme 3.4 Synthetic steps involved in the production of PNA backbone unit AEG. 
 
 The next step was the coupling between thymine derivative 16 and the secondary amino group of 
AEG unit 19. As described in Scheme 3.5, the reaction is carried out in the presence of EDC with a 
slight excess of 16 yielding protected thymine monomer 20 in 82% yield after purification by silica gel 
chromatography. The thymine monomer 12 bearing a free carboxylic group for the PNA 
oligomerisation was isolated upon treatment with TFA. 
 
 
 
Scheme 3.5 Synthetic steps involved in the production of the PNA thymine monomer. 
 
 
 3.2.2.2 Synthesis of adenine monomer 13 
 
 For the synthesis of adenine monomer 13, the Fmoc/Cbz strategy was selected. It required the 
Fmoc protection on the N-terminal of the AEG moiety and Cbz protection on the exocylic amino 
groups of the adenine. The Cbz-protected adenine derivative 24 was synthesised following the 
procedure described by Debaene and Winssinger.[65] The synthetic pathway is described in Scheme 
3.6. The introduction of the tert-butyl acetate moiety to adenine 21 is achieved by deprotonation using 
sodium NaH, followed by the slow addition of tert-butyl-α-chloroacetate to the reaction mixture. 
Subsequently, the Cbz-protecting group is step-wise introduced on the primary amine using 
carbonyldiimidazole (CDI) as activating agent. Nucleophilic substitution of the benzyl alcohol on the 
carbonyl group eliminates the remaining imidazole group, affording Cbz-protected adenine 23 in 43% 
yield over two steps. The deprotection of the tert-butyl group using TFA gives protected adenine 24 
bearing a carboxylic moiety for the subsequent coupling with the PNA backbone. 
 
 
 
Scheme 3.6 Synthetic pathway for the production of the protected modified nucleobase adenine. 
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 The coupling of adenine derivative 24 to PNA backbone 19 was performed following the synthetic 
pathway described in Scheme 3.7. The carboxyl group on 24 is activated by the formation of an 
asymmetric acid anhydride using pivaloyl chloride, followed by the introduction in situ of the AEG 
unit 19, to afford the protected adenine monomer 25 in 69% yield. As described for the thymine 
monomer, the deprotection of the tert-butyl group using TFA gives the desired adenine monomer 13.  
 
 
 
Scheme 3.7 Synthetic steps involved in the production of the PNA adenine monomer. 
 
3.3 Isolation of the target PNA oligomers  
 
 3.3.1 PNA Oligomerisation via manual SPPS using the Fmoc/Cbz strategy 
 
 Having both the thymine and the adenine monomers, the SPPS was carried out performing the 
synthesis of the PNA 4-mer 26 (Fig. 3.10, sequence: T-A-A-T-Lys) in order to explore the 
oligomerisation process. 
 
Figure 3.10 Molecular structure of protected PNA 4-mer 26. 
  
 Concerning the SPPS protocol, several technical aspects of the synthesis have been taken into 
consideration: i) the loading of the resin with respect to the reactive amino groups was controlled to a 
lower suitable value for PNA synthesis, namely 0.4 mmol g-1 (instead of 0.52 mmol g-1 which was the 
loading of the selected Rink-amide MBHA), in order to avoid aggregation of oligomers and formation 
of side products; ii) coupling reactions were carried out in NMP instead of DMF because NMP is a 
better solvent for solubilising coupling agents (e.g. HBTU) and such solutions are more stable than the 
corresponding solutions in DMF; iii) the PNA monomer was added in a slight excess with respect to 
the coupling reagent (HBTU), since the latter is also reactive towards amino groups capping these 
reactive sites and preventing the desired coupling reactions; iv) the PNA monomer was also pre-
activated at 45 °C for 5 min with the coupling agent and base prior to its introduction to resin bearing 
the free amino groups. This ensured that all the PNA monomers’ carboxyl groups were activated prior 
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to being mixed with the free amino groups, and no free coupling agent was present in the coupling 
solution, thus preventing its reaction with the free amino groups on the growing oligomer; v) the 
deprotection of the Fmoc protecting groups had to be done as rapidly as possible. Indeed, as displayed 
in Scheme 3.8, this was done in order to minimise two known side reactions, N-acyl transfer[52] and N-
terminal deletion[49] reactions, which are known to occur under basic conditions along with the 
deprotected reaction. These reactions can markedly reduce the purity of the crude product. 
 
 
Scheme 3.8 Schematic representation of the parasite in the N-acyl transfer (a) and N-terminal (b) intramolecular amidation. B 
represents the nucleobases. 
 
 Taking into considerations these aspects, the SPPS composed by repetitive cycles of deprotection, 
coupling and capping reactions was used to prepare PNA 4-mer 26 (Scheme 3.9). 
 
 
Scheme 3.9 SPPS strategy for preparing PNA 4-mer 26. 
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 According to the conditions required for the orthogonal removal of the protecting groups, Rink-
amide MBHA resin was selected as a solid support for the growing PNA and the tetramer was 
prepared on a 250 mg scale of resin (0.13 mmol). The first step involved the deprotection of the Fmoc 
protecting groups of the resin using 20% piperidine in DMF. The reaction was carried out twice, first 
for two min, and then with a fresh solution for ten min. After the second exposure, the resin was 
washed thoroughly with DMF. At this point, a Kaiser test was carried out on a few beads of resin to 
confirm that the deprotection had proceeded correctly. This step was followed by the introduction of a 
lysine unit as the first monomer, since it has been reported that it enhances the solubility of PNA 
oligomers and it also helps to induce helix formation during PNA duplex hybridisation.[66] The lysine 
derivative of the resin was prepared by controlling the amount of lysine and HBTU added to the resin, 
in order to reduce the loading of the commercial Rink-amide MBHA from 0.52 mmol g-1 to 0.4 mmol 
g-1. Once this step was complete, removal of the N-terminal Fmoc protecting group of the lysine was 
carried as described for the resin deprotection step, followed by a coupling reaction using the 
appropriate PNA monomer. This reaction was performed using five equivalents of the PNA monomer 
dissolved in NMP, together with HBTU (4.5 eq) and N,N-diisopropylethylamine (DIEA, 12 eq).  
As already discussed, the mixture was activated at 45 °C for five min before being added to the resin 
bearing the free amino groups. The reaction was allowed to proceed at r.t. for 1 h, after which the resin 
was washed thoroughly using DMF. Once again, a Kaiser test was carried out on a small sample of the 
resin. If a positive test was obtained, the coupling was repeated. If a negative test was obtained, the 
capping procedure was performed. During the capping procedure the derivatised resin was exposed to 
acetic anhydride in NMP at r.t. for 5 min in order to block any minor traces of the free amino groups 
left on the growing oligomer, and prevent erroneous sequences from forming as side products. 
Following the capping, the cycle was restarted from the deprotection step. Once the desired length of 
the PNA oligomer was reached, the resin was cleaved using acidic conditions (4:1 TFA/m-cresol) to 
yield the crude PNA oligomer. The sample was analysed and purified by RP-HPLC (Fig. 3.11), and 
MALDI-TOF spectrometry was carried out in order to confirm the successful synthesis.  
  
 
Figure 3.11 HPLC chromatogram of purified PNA 4-mer 26. For the experimental conditions see Chapter V. 
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The mass spectrum of PNA 26 is displayed in Fig. 3.12. Unfortunately the major peak obtained was 
not the expected [M+H]+ mass ion. However, the presence of the [M+H]+ ion (m/z 1852.81) in a minor 
quantity suggests that the desired compound was isolated. The exact mass found for this peak is  
m/z 1852.7424, which corresponds to the [M+H]+ peak of PNA 26 [C89H98N25O21] having a 
calculated mass of m/z 1852.736. 
 
Figure 3.12 MALDI-TOF spectrum of purified PNA 4-mer 26. 
 
Furthermore, on closer analysis of the spectrum, it was clear that fragmentation of the compound 
occurred during the ionisation in the MALDI-TOF analysis. Specifically, the fragmentation was 
observed within the Fmoc and Cbz protecting groups that are cleaved at the carbon-oxygen bond of 
the carbamate moiety resulting in two fragments, F1 and F2 (Fig. 3.13). This could be due to the lack 
of easily ionisable functional groups which caused the fragments observed by MALDI-TOF analysis. 
 
 
Figure 3.13 Fmoc and Cbz fragmentations observed by MALDI-TOF analysis. 
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Taking into considerations these observations, two of the peaks observed in the mass spectrum 
could be assigned. Specifically, the peaks at m/z 1744.75 and m/z 1658.66 correspond to the 
ionisation-induced fragmentation of a Cbz ([M-F1]+ or [M-C7H7O]+) and a Fmoc ([M-F2]+ or [M-
C14H11O]+) protecting groups, respectively, at the positions indicated in Fig. 3.13. 
 Following the promising results of the first SPPS attempt, the idea was to extend the PNA 
synthesis and produce PNA 4-mer 27 bearing Rhodamine B on the ε-amino group of the lysine  
(Fig. 3.14, sequence: NH2-T-A-A-T-Lys-Rho). This molecule was designed with the aim of testing the 
functionalisation of PNA with a chromophore before synthesising the Rhodamine-bearing PNA 
dodecamer required for the chemical gradient characterisation. 
 
 
Figure 3.14 Molecular structure of PNA 4-mer bearing Rhodamine B. 
 
 PNA 27 was synthesised according to the cycle of reactions described in Scheme 3.10, using the 
Fmoc-Lys(Alloc)-OH as the starting monomer (instead of the Fmoc-Lys(Z)-OH) to perform the 
Rhodamine coupling with the growing PNA oligomer. After loading the resin with the protected lysine 
moiety, PNA deprotection, capping and coupling steps were performed as described for PNA 26 
(Scheme 3.10). Once reached the desired length of the PNA oligomer, Pd(0)-catalyzed removal of the 
Lys Alloc protecting group was performed before the resin cleavage. The coupling reaction between 
Rhodamine and PNA occured as the last synthetic step before the resin cleavage using Rhodamine  
(5 eq), HBTU (4.5 eq) and DIEA (12 eq). Unlike the coupling between two PNA monomers, this 
reaction was allowed to proceed at r.t. for 3 h which ensured the successful production of the 
fluorescent tetramer 27 (Scheme 3.10).  
 HPLC and MALDI-TOF analyses confirmed the synthesis of the desired PNA (Fig. 3.15-3.16). 
As shown in Fig. 3.9, the major peaks of the mass spectrum are all assigned to desired PNA tetramer 
27 which has a calculated mass for the cationic part of m/z 1920.8471 [C94H110N27O9]+. These include 
the M+ and [M+H]+ mass ions centred at m/z 1920.8500, and m/z 1921.8624, in addition to the [M-
F1]+ and [M-2F1]+ mass ions centred at m/z 1814.8047, and m/z 1706.8629, as the result of the Cbz 
fragmentation described for PNA 26 (Fig. 3.13). These data unambiguously confirms the obtention of 
the target, fully protected, PNA 4-mer bearing Rhodamine B. 
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Scheme 3.10 SPPS steps involved in the production of PNA 4-mer 27. 
 
 
  
 
 
Figure 3.15 HPLC chromatogram of purified PNA 4-mer 27. For the experimental conditions see Chapter V  
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Figure 3.16 MALDI-TOF spectrum of purified PNA 4-mer 27. 
 
 
 3.3.2 PNA Oligomerisation via semi-automated SPPS using the Fmoc/Cbz 
strategy 
 
 Following the positive results described in section 3.2.1, the preparation of two ssPNA 12-mers, 
the first bearing the chromophore (toward Au-bound supramolecular gradient assessment) and the 
second functionalised with the motogenic peptide IGDQ (toward Au-bound supramolecular motogenic 
gradient production) was the next focus. Indeed, this section describes the synthesis of such ssPNAs 
via semi-automated SPPS by using a peptide synthesiser. This new approach allowed us to improve 
and speed up the synthesis of PNA, by decreasing the coupling reaction time and increasing the yield 
and purity of the final compound. A schematic representation of the instrument is displayed in Fig. 
3.17. It is equipped with two reaction vessels (RV) to perform two simultaneous synthesis using the 
same or completely different chemistries, as well as twenty-four Aminoacid/Reagent vials and six 
Solvent/Reagent bottles. A measuring/pre-activation vessel (MV), which allows for measurement and 
delivery of precise amounts of solvents or reagents, is also part of the instrument, together with two 
interchangeable measuring vessels for accurately dispensing smaller volumes. In addition, both 
software and hardware configurations are compatible with standard Boc and Fmoc SPPS protocols, 
allowing also for the development of new and customised procedures. 
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Figure 3.17 Photograph of the solid-phase peptide synthesiser, showing both main instrument parts and accessories required 
for PNA synthesis. 
  
 The principle is quite simple: once designed the synthesis of the desired molecule, specific 
protocols containing the synthetic instructions are defined. Following such instructions, the synthesiser 
can automatically calculate, measure through MV, and deliver to each amino acid vial the exact 
amount of solvent required to prepare the reagent solutions. Such solutions can either be pre-activated 
within the amino acid vial or a portion of the stock solution can be transferred to the MV for pre-
activation. After that, the solutions are transferred to the RV for the coupling reactions to the resin. 
Once the desired length of the PNA oligomer is reached, the resin cleavage can be performed to obtain 
the crude product. 
 As summarised in Table 3.2, the semi-automated SPPS presents several advantages respect to the 
manual SPPS. According to producers’ optimised protocols, the deprotection step was performed three 
times during four min, instead of one cycle for five min and a second cycle for ten min. The coupling 
step was completed in twenty-five min, instead of 1 h. Regarding the coupling reagent, HBTU was 
replaced by O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU), 
which resulted more selective and efficient. Furthermore, since the final compounds were obtained in 
higher yield and purity without performing the capping step, this step was abandoned. Moreover the 
loading of the resin was increased from 0.4 mmol g-1 to 0.54 mmol g-1. All these aspects allow us to 
produce higher quantities of the PNA target oligomers. The only drawback of the instrument is its 
consumption, especially in washing solvents and thus wastes. Indeed as shown in Table 3.2, the 
double amount of DMF was used for each cycle. However going further with the synthesis we are now 
trying to optimise this synthetic limitation. 
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Table 3.2 Principal differences between the manual and the semi-automated SPPS. 
 
 MANUAL SPPS SEMI-AUTOMATED SPPS 
Resin loading 0.4 mmol g-1 0.54 mmol g-1 
Deprotection step 15 min over two steps 12 min over three steps 
Coupling step 1 h 25 min  
Capping step 10% acetic anhydride in NMP - 
Washing procedures ca. 75 mL per cycle ca. 150 mL per cycle 
 
 
 According to the procedures described, PNA 28 (Fig. 3.18, sequence: NH2-A-T-T-A-A-A-T-A-
T-T-T-Lys) was the first to be synthesised in order to explore both the semi-automated SPPS and the 
elongation process to achieve the desired PNA 12-mer required for the hybridisation with the 
complementary ssDNA-SH. 
 
 
Figure 3.18 Molecular structure of protected PNA 12-mer 28. 
 
 
 The crude PNA oligomer was cleaved from the resin using acidic conditions. Specifically, a 
freshly prepared cleavage “cocktail” solution of TFA, TIS and water (95: 2.5: 2.5) was added to the 
resin and the cleavage reaction was allowed to proceed at r.t for 90 min. The product was precipitated 
with Et2O and isolated by centrifugation to form a pellet. The HPLC chromatogram displayed in Fig. 
3.19 shows the presence of a pure compound which was analysed by MALDI-TOF spectrometry. 
The analysis of the mass spectrum of purified PNA dodecamer 28 suggested us that the 
fragmentation of the Cbz protecting groups occurred after mass ionisation, as already described for 
protected PNA 26 (Fig. 3.20). Indeed, the M+ and [M+H]+ centred peaks are not intense. The 
measured masses for these peaks are m/z 4188.6 and m/z 4189.6216, which correspond to 
[C186H214N66O51] and [C186H215N66O51] (calculated theoretical masses of m/z 4188.6214 and m/z 
4189.6293, respectively). The peaks centred at m/z 3649.5439 and m/z 3671.5217 correspond to the 
ionisation-induced fragmentation resulting in [M-5F1]+ and [M-5F1+Na]+ ions, respectively. 
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Figure 3.19 HPLC chromatogram of purified protected PNA 12-mer 28. For the experimental conditions see Chapter V. 
 
 
Figure 3.20 MALDI-TOF spectrum purified PNA 4-mer 28. 
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This mass spectrum suggest that the desired compound had been isolated, however, definitive 
proof was still required in order to be completely certain of the structural assessment. Since ionisation 
by ESI-MS was not possible for this molecule, the only manner to be completely certain of the 
dodecamer structure was to render it more easily ionisable. This could be achieved by the complete 
deprotection of the dodecamer sequence which was also required for the hybridisation process 
between PNA and DNA. 
 
 3.3.2.1 Cbz deprotection of the PNA dodecamer 
 
 The removal of the Cbz protecting groups of PNA 28 was achieved treating the oligomer with 
TMSI at 50 °C for 16 h. The whole protocol is carefully described in the experimental part. As shown 
in Fig. 3.21, the HPLC chromatogram after purification of the oligomer displays a single major 
product at a very shorter retention time (RT= 13.29 min) compared to the corresponding protected 
PNA 12-mer (RT= 26.69 min) that indicates a drastic increase in product’s polarity.  
 
 
 
Figure 3.21 HPLC chromatogram of  purified deprotected PNA 12-mer 29. For the experimental conditions see Chapter V. 
 
 The molecule was subsequently analysed by MALDI-TOF spectrometry. In this case the mass 
spectrum clearly shows the presence of the desired PNA 29 (Fig. 3.22). 
 
 
Figure 3.22 Molecular structure of deprotected PNA 12-mer. 
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The analysis of the mass spectrum (Fig 3.23) allowed us to assign the two major peaks to the fully 
deprotected PNA dodecamer 29 [C138H178N66O39] (calculated theoretical mass of m/z 3383.3974). 
The measured masses for these peaks are m/z 3384.4102 and m/z 3407.4102 which correspond to 
[C138H179N66O39] and [C138H178N66O51Na] (calculated theoretical masses of m/z 3384.4052 and  
m/z 3407.3872, respectively). With this data, it was finally confirmed that the semi-automated SPPS 
worked as expected, and the desired PNA 12-mers, protected and deprotected, were successfully 
synthesised. 
 
 
 
Figure 3.23 MALDI-TOF spectrum of purified deprotected PNA 4-mer 29. 
 
  
 3.3.2.2 Semi-automated SPPS of the target PNA oligomers 
 
 Having obtained the target PNA dodecamers 28 and 29, the focus of the project was placed on the 
attachment of the chromophores and the motogenic peptide to the PNA 12-mers in order to first 
characterise the chemical gradient, and then induce the cellular migration.  
 The idea was to attempt the synthesis of PNA 12-mers 30 (Fig. 3.24, sequence: Rho-A-T-T-A-A-
A-T-A-T-T-T-Lys) and 31 (Fig. 3.25, sequence: IGDQ-A-T-T-A-A-A-T-A-T-T-T-Lys) bearing the 
Rhodamine B and the IGDQ peptide at the N-terminal group, respectively. Since the clearest HPLC 
and mass characterisations were obtained after the Cbz deprotection, for the next PNA oligomers the 
SPPS was followed by the removal of the Cbz in solution after which the crude compounds were 
purified and analysed by RP-HPLC and MALDI spectrometry. 
 
 
 
Figure 3.24 Molecular structure of deprotected PNA 12-mer bearing the Rhodamine B. 
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Figure 3.25 Molecular structure of deprotected PNA 12-mer bearing the IGDQ peptide. 
 
 
 Concerning the synthesis of the fluorescent oligomer 30, the PNA functionalisation with 
Rhodamine as well as the full deprotection of the Cbz groups, were successfully achieved following 
the procedures described above. Indeed, the HPLC analysis (Fig. 3.26) showed the production of a 
pure compound which was analysed by MALDI-TOF technique.  
 
 
 
Figure 3.26 HPLC chromatogram of purified deprotected PNA 12-mer 30. For the experimental conditions see Chapter V. 
  
 The mass spectrum displayed in Fig 3.27 confirmed the synthesis of the desired PNA oligomer as 
indicated by the presence of both the M+ and [M+Na]+ mass ions at m/z 3808.6436 and m/z 
3832.9133, which corresponded to [C166H207N68O41]+ and [C116H206N68O41Na]+ ions, respectively. 
Regarding the synthesis of the motogenic oligomer 31, the attachment of the four AA I, G, D, and 
Q, as well as the complete removal of the Cbz protecting groups was carried out using the semi-
automated SPPS optimised conditions. The HPLC chromatogram displayed in Fig. 3.28 shows the 
presence of a pure compound, characterised by a lower retention time (RT = 16.13 min) compared to 
PNA 29 (RT = 17.39 min), due to the presence of IGDQ AA (instead of Rhodamine B) which increase 
the polarity of the deprotected PNA oligomer. Purified PNA 31 is currently under MALDI-TOF 
investigation. 
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Figure 3.27 MALDI-TOF spectrum of purified deprotected PNA 12-mer 30. 
 
 
 
 
 
Figure 3.28 HPLC chromatogram of purified deprotected PNA 12-mer 31. For the experimental conditions see Chapter V. 
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 The synthetic strategies used to produce PNA 12-mers 30 and 31 are thoroughly described in the 
experimental section of this doctoral dissertation. 
 Having synthesised PNA 12-mer bearing the chromophore Rhodamine B, Au-bound 
supramolecular monodirectional gradients with the complementary ssDNA-SH will be produced. 
Thanks to the Rhodamine moiety, fluorescence microscopy techniques might be used to visualise the 
chemical gradient along the surface and allow to better modulate the original ssDNA-SH gradient 
density. Once performed MALDI-TOF analysis of PNA bearing IGDQ 31, direct screening of cellular 
behaviour onto motogenic-PNA containing Au surfaces will be carried out, as a complementary way 
to direct screen the best chemical gradient conditions to induce the cellular migration.  
 
3.4 Preliminary studies of DNA/PNA hybridisation 
 
 3.4.1 Binding properties and sequence-selectivity of PNAs 
  
 PNA oligomers hybridise to complementary DNA and RNA sequences in a sequence-dependent 
manner, following the Watson-Crick hydrogen bonds and π-π stacking interactions.[67, 68] Due to the 
lack of negatively charged sugar-phosphate backbone, PNA skeleton is neutral allowing the binding to 
complementary polyanionic DNA to occur without repulsive electrostatic interactions which are 
present in the DNA/DNA duplex. The thermodynamic parameter which allows evaluating the stability 
of every nucleic acid duplex is the melting temperature (Tm), which is defined as the temperature at 
which half of the double strands are present as separated strands. PNA/DNA duplexes thermal 
stability, measured by Tm assessment, is higher than natural DNA/DNA duplex with same base 
sequence. In contrast to DNA/DNA double helix structure in which the two strands are always in an 
antiparallel orientation (with the 5’-end of one strand opposed to the 3’- end of the other), PNA/DNA 
hybrids  can be formed in two different orientations,[6] namely parallel and antiparallel (Fig. 3.29).  
  
 
Figure 3.29 Parallel and antiparallel orientations of PNA/DNA duplexes where the PNAC-terminus corresponds to the 3' end 
and the N-terminus to the 5' end of normal oligonucleotides. 
 
Antiparallel orientation is favoured, and antiparallel PNA/DNA hybrids are considerably more 
stable than the corresponding DNA/DNA complexes. This higher stability results in an augment of Tm 
of approximately 1 °C/base.[33] Moreover, antiparallel PNA/RNA duplexes are even more stable, with 
a Tm increase of about 1.5 °C/base relative to DNA/RNA hybrids.[69] Consequently, PNA/RNA 
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duplexes are on average 0.2 ± 0.5 °C/base more stable than the corresponding PNA/DNA duplexes.[70] 
The stability of parallel PNA/DNA and PNA/RNA duplexes is almost exactly the same of 
(antiparallel) DNA/DNA and DNA/RNA duplexes, respectively. There are dramatic differences in the 
kinetics of formation of duplexes of differing orientation. A kinetic study of PNA complex formation, 
carried out by Rose et al.[71] using capillary electrophoresis, showed that the antiparallel complex was 
formed immediately (< 30 s), whereas the formation of the parallel complex required several hours. 
 An especially interesting aspect of PNA/DNA duplex formation is its dependence on ionic 
strength. In a careful study reported by Tomac et al.,[72] the Tm of DNA/DNA hybrids was shown to 
increase considerably (more than 20 °C for dsDNA 10-mer) with increasing salt concentration (0.01 to 
0.5 M NaCl), whereas the Tm of PNA/DNA duplexes decreases (ca. 8 °C), so that duplex stability is 
almost identical at 0.5 M NaCl. Increasing in the salt concentration even further has only a weak 
destabilising effect on both PNA/DNA and DNA/DNA duplexes. The contrasting effect of ionic 
strength on duplex formation can be explained by the association of counter ions in the case of 
DNA/DNA duplex formation, and by displacement of counter ions in the case of PNA/DNA duplex 
formation.[73] 
 One of the most important features of the PNA/DNA duplexes is that stability is highly affected 
by the presence of a single mismatched base pair. For example, considering a 15-mer DNA sequence 
(3’-TGTACGTCACAACTA-5’), a substitution of a thymine with a guanine on the target DNA causes 
a decrease of only 4 °C in the DNA/DNA Tm, whereas the Tm of PNA/DNA (antiparallel) drops of 13 
°C.[74] Thus, PNA probes are very sequence-selective and are superior to DNA probes in recognising 
single-base mispairing.[75, 76]  
 
3.4.2 UV-Vis detection of DNA/PNA duplex 
 
 Prior to generating the dynamic, bidirectional supramolecular gradient composed by DNA/PNA 
hybrids along the Au surfaces, preliminary studies on the hybridisation process between ssDNA-SH 
and ssPNA were carried out in solution, in order to characterise such duplexes and determine their 
physicochemical properties. Specifically, ssPNA 12-mer 30 functionalised with Rhodamine B was the 
first used to study the hybridisation with the complementary ssDNA 12-mer thiolated at 5' terminal 
group that was selected for the chemical gradient production along the Au surfaces [(ssDNA-SH 
sequence: 3'-A-T-A-A-T-T-T-A-T-A-A-A(CH2)6-SH-5'].  
 In order to establish the experimental conditions required for the hybridisation (such as DNA and 
PNA concentrations), UV-Vis spectra of ssDNA-SH, ssPNA 30, and DNA/PNA duplex, were 
recorded at 25 °C. As illustrated in Fig 3.30, for the two individual species (ssDNA-SH and ssPNA) an 
absorbance maximum at 260 nm was detected, due to the to in-plane transitions of the π electrons of 
the bases.[77] 
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Figure 3.30 UV-Vis spectra of ssDNA-SH (black profile) and ssPNA 30 (red profile). Measurements were carried out at 
25°C for solutions containing each strand at a 5 μM concentration in phosphate buffered saline (PBS 100 mM NaCl, 10 mM 
NaH2PO4·H2O, pH = 7). 
 
 Since the absorbance of two single strands is higher than the absorbance of the same strands 
forming a double helix (hyperchromic shift due to the fact that unstacked bases absorb more light than 
stacked bases),[78] the cooperative melting of a DNA/PNA duplex can be monitored as an increase of 
absorption as a function of the temperature. Therefore, we then measured the Tm of our DNA/PNA 
complex by slowly heating the sample in PBS solution, while recording its absorbance at a wavelength 
of 260 nm. Under these conditions, after absorbance data normalisation, and by detecting the 
temperature where normalised absorbance is equal to 0.5, Tm can be assessed. As displayed in Fig. 
3.31, normalised absorbance is very low in the range 20 -30 °C, raises from 40 to 70 °C and tends to 
reach a plateau above 75 °C, showing the typical sigmoid patter of nucleic acid duplex melting studies. 
From the same picture, half of the normalised absorbance corresponds to a Tm of 61 °C. 
 
Figure 3.31 UV melting profile of DNA/PNA duplex in PBS at duplex concentration = 5 µM. 
 
 Following these preliminary results, we are currently focused in the production and 
characterisation of the monodirectional supramolecular gradient composed by DNA/PNA duplexes 
that we will use for inducing and monitoring the movement of the cells. 
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4. Conclusions and perspectives 
 
 In this conclusive chapter the outcomes of this doctoral thesis are discussed. Framed in a more 
general project, aimed at generating a dynamic supramolecular gradient for controlling the 
bidirectional cellular migration along the Au surfaces, in this doctoral thesis we have designed a 
simpler model system based on a static monodirectional biochemical gradient through the formation of 
SAMs. This permitted the logical construction of an engineered system able to induce and direct the 
cellular migration. The results obtained in this simpler proof of concept system allowed us to start 
expanding the scientific challenge and face the synthesis of modified PNA oligomers able to hybridise 
the complementary ssDNA-SH SAMs toward the dynamic supramolecular bidirectional gradient. 
 For the static monodirectional gradient, the first target molecule was the thiolated pentapeptide 
IGDQK-SH, which bears the motogenic portion IGDQ for inducing the movement of the cells and the 
thiol group for the Au surface functionalisation (Fig. 4.1). 
  
 
 
Figure 4.1 Molecular structure of IGDQK-SH peptide 1. 
 
 Since the cells are sensitive not only to chemical gradients, but also to changes in substrate 
stiffness and topological features, we have also developed a systematic approach to produce flat and 
homogeneous Au surfaces, with respect to the height profiles and absence of surface-adhered organic 
contaminants, respectively. To achieve this, the as-received Au surfaces were first heated at 450 °C for 
30 min, and incubated in the UV/Ozone cleaning system at r.t. for 10 min (prior to SAMs formation), 
and then analysed by using AFM and WCA techniques. According to the results obtained in terms of 
low surface RMS roughness and WCA values (RMS = 1.26 nm over 10 μm, WCA< 6°), we employed 
the selected Au substrates first to monitor the cells by using an optical microscope over the desired 
time lapse (five days for general SAMs stability reasons), and then to explore their ability to maintain 
the viability properties by using CLSM analysis. To evaluate the cellular migration stemming from 
cells connected to both physiological and pathological (cancer-related) conditions, fibroblasts and 
MDA-MB-231 cells were selected, respectively. These cell lines were first interfaced with model 
surfaces functionalised with C8H17-S∙Au. By using optical microscope imaging we were able to 
monitor them under the chosen time span, assessing both their ability to survive and proliferate onto 
such functional surfaces. Subsequently, CLSM investigations of both the cell lines after staining of 
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key biological features (nucleus and actin filaments), showed the retention of the proper cellular 
features upon interaction with our functionalised surfaces over the chosen time lapse. 
 Following these preliminary results, the production of a static monodirectional ∂ IGDQK-S∙Au 
along the Au surfaces was successfully achieved by using the method developed by Spencer et al., and 
tested for evaluating cell migratory response. Unfortunately, we were not able to induce cellular 
migration under such conditions. AFM analysis suggested a poor surface organisation of IGDQK-SH 
onto such surfaces, resulting in large peptide aggregates which increase along the direction of the 
chemical gradient. This poor organisation was probably due to both the strong interactions between 
the charged AA groups and the Au surface, and the intermolecular interactions between IGDQK-SH 
molecules, which forced the peptide to lay down when adsorbed onto the surface. Computational 
analyses confirmed our hypothesis showing that a single peptide immobilised onto the Au substrate 
tends to assume a lying down orientation pointing the hydrophobic residues Isoleucine (ILE) and 
Glycine (GLY) towards the surface, while exposing the hydrophilic AA Glutamine (GLN). Due to this 
peptide conformation, cell receptors probably were not able to detect and bind to the motogenic 
sequence IGDQ. 
 Following these observations and taking into considerations several examples reported in the 
literature concerning the production of mixed SAMs composed by biomolecules (e.g. peptides, 
oligomucleotides) and alkanethiols, our idea was to generate mixed ∂ IGDQK-S∙Au in the presence of 
two different n-alkanethiols: C8H17-SH and MT(PEG)4-SH. By acting as fillers, they should prevent 
nonspecific interactions between IGDQK-SH and the Au surfaces, as well as intermolecular 
interactions between peptide’s molecules, allowing to finely modulating IGDQK-SH surface density 
and form ordered mixed SAMs. Furthermore, they were selected for their different affinity and 
interaction with cells. Indeed, it is known that poly-ethylene glycol (PEG)-modified surfaces are able 
to resist the non-specific adsorption of biomolecules and cells, while more hydrophobic surfaces 
(C8H17-S∙Au) are useful tools for cell migration, adhesion and proliferation studies. In order to 
produce mixed ∂ IGDQK-S∙Au, we used two different methods, namely full immersion and double 
gradient approaches, and we characterised such surfaces by WCA, AFM and XPS techniques, prior to 
the cell deposition. In all cases, ΔWCA between the initial and the final points of the Au surfaces were 
observed, indicating a gradual change in surface wettability from hydrophobic to hydrophilic or vice 
versa, due to the presence of a chemical gradient along such surfaces. Depending from the 
complementary n-alkanethiol and the gradient preparation method employed to backfill the Au 
surfaces, differences in terms of surface wettability and organisation were observed, but linear 
increases of nitrogen atomic percentages were found only after the production of the monoidirectional 
∂ IGDQK-S∙Au. Specifically, Au surfaces functionalised by mixed gradients produced employing the 
full immersion approach resulted more homogeneous and organised with the most significant ΔWCA. 
Moreover, among the two alkanethiols, C8H17-S∙Au showed a higher degree of surface organisation, 
as revealed by AFM analyses. This trend was confirmed by the cellular migratory responses.  
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Indeed, both the cell lines showed an enhanced and more significant migration onto functionalised Au 
surfaces with ∂ IGDQK-S∙Au / C8H17-S∙Au. This behaviour was attributed to the different interactions 
between IGDQK-SH and the alkanethiols that can determine different IGDQK-SH orientations and 
conformations. Indeed, computational analysis showed that in the presence of the two alkanethiols, 
IGDQK-SH adopts different arrangements. Specifically, despite in both of the situations it shows a 
folded conformation within each corresponding layer of the filler, when surrounded by C8H17-S∙Au 
the peptide’s conformation is more extended. Therefore, the AA sequence IGDQ results more exposed 
to the solvent interface allowing the cells to recognise such motogenic portion and thus migrate 
following the ∂ IGDQK-S∙Au.  
 Additionally, comparing the two cell lines an interesting aspect emerged. In all the observed 
conditions, MDA-MB-231 cells showed an enhanced and more significant migratory activity 
suggesting a selective stimulation of IGDQK-SH towards the cancer cells. This result might suggest a 
role of the IGD motif in the stimulation of the cancer cells towards their enhanced motility and 
metastatic progression in-vivo.  
 To further rationalise these data, we are currently performing phosphorylation studies of the 
protein FAK125, main responsible for cell motility machinery activation, through Western Blotting 
investigations onto both cell lines under IGDQK-SH stimulation. 
 Having defined a systematic approach for producing a static haptotactic chemical gradient and 
inducing the cellular migration by using IGDQK-SH as a motogenic agent, the synthesis of the 
modified PNA oligomers was attempted. The idea was to produce first two ssPNAs functionalised 
with different chromophores for the bidirectional DNA gradient characterisation, and then two 
ssPNAs bearing the motogenic peptide IGDQ for controlling the cell migration. 
 The Fmoc/Cbz strategy was chosen to selectively remove the different protecting groups, and 
following the isolation of PNA 4-mers 26 and 27, the preparation of two ssPNA 12-mers, the first 
bearing the chromophore Rhodamine B (30) and the second functionalised with the motogenic peptide 
IGDQ (31) was successfully achieved via semi-automated SPPS (Fig 4.2). 
 In parallel to the synthetic work, preliminary studies on the hybridisation process between 
ssDNA-SH and ssPNA were performed in solution by using UV-Vis spectroscopy, in order to 
characterise such duplexes prior to generating the bidirectional supramolecular gradient composed by 
DNA/PNA hybrids along the Au surfaces. PNA functionalised with Rhodamine B 30 was the first 
used to study the hybridisation step, in order to determine the physicochemical properties of the 
resulting duplexes. Upon recording the UV spectra of ssDNA and ssPNA to evaluate the conditions 
required for the hybridisation, we successfully monitored the formation of DNA/PNA duplex by 
measuring the melting temperature (Tm). This parameters allowed us to characterise and determine the 
stability of our DNA/PNA hybrids that melt at Tm = 61 °C. 
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Figure 4.2 Molecular structures of PNA 12-mers bearing Rhodamine B (a) and IGDQ (b). 
 
  
 We are currently focused in the production and characterisation of the monodirectional 
supramolecular gradient composed by DNA/PNA duplexes that we will use for inducing and 
monitoring the movement of the cells. 
 Once the best conditions of chemical gradient and cell migration properties will be established, 
we will synthesise the two ssPNA 12-mers, different from base sequence, bearing either the 
chromophore 3-Carboxycoumarin or the tetrapeptide IGDQ (Fig. 4.3). The former will be used to 
characterise the supramolecular bidirectional gradient in the presence of the other Rhodamine-tagged 
PNA strand, while the latter for achieving the reversible cellular migration along the engineered Au 
surfaces. 
 
 
 
 
 
Figure 4.3 Molecular structures PNA 12-mers bearing 3-Carboxycoumarin (a) and IGDQ (b). 
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5. Experimental part 
5.1 Materials  
CHEMICALS were purchased from Sigma Aldrich, Acros Organics, Thermo Scientific, ABCR, 
Carbosynth and were used as received. Resins for solid phase synthesis were purchased from Peptides 
International. Gold-coated cover slips (15 mm round glass cover slips coated with 100 Å of Au over 
20 Å of a titanium layer, 0.13-0.16 mm thickness) were purchased from Platypus technologies. 
Solvents were purchased from Sigma Aldrich, while deuterated solvents from Eurisotop. Anhydrous 
solvents as Et2O, CH2Cl2 and CH3CN were distilled from Na/benzophenone, phosphorus pentoxide 
and CaH2, respectively. Anhydrous DMF was purchased from Acros Organics. Hydrogen peroxide 
(H2O2, 35%) was obtained from Acros Organic, whereas sulphuric acid (H2SO4, 95%) was purchased 
from Fisher Scientific. Absolute EtOH for thiol solutions was obtained from Fisher Scientific, while 
water for the storage of the Au functionalised surfaces was always taken from a Milli-Q Elga system. 
Anhydrous conditions were achieved by drying Schlenk line or 2-neck flasks by flaming with a heat 
gun under vacuum and then purging with Argon. The inert atmosphere was maintained using Argon- 
filled ballons equipped with a syringe and needle that was used to penetrate the silicon stoppers used 
to close the flasks’ necks. Additions of liquid reagents were performed using dried plastic or glass 
syringes. 
Biochemicals: ssDNA 12-mer thiolated at 5' terminal group [sequence: 3'-A-T-A-A-T-T-T-A-T-A-A-
A-(CH2)6-SH-5'] was purchased from Eurogentec. Roswell Park Memorial Institute medium  
(RPMI 1640), Basal Medium Eagle, CO2-independent medium and trypsin-ethylenediaminetetraacetic 
acid (EDTA) were obtained from Gibco. T75 flasks were purchased from Corning. Cytotoxicity test 
through MTS bioreduction assay CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay 
was purchased from Promega. Rhodamine-Phalloidin (R415) and 4’,6-diamidino-2-phenylindole 
(DAPI, 4083) were purchased from Invitrogen and Cell signalling technology, respectively. 
 
5.2 Instrumentation 
 
Thin layer chromatography (TLC) assessments were performed on pre-coated aluminum sheets with 
0.20 mm Machevery-Nagel Alugram SIL G/UV254 with fluorescent indicator UV254. 
Column chromatography (CC) was carried out using Merck Gerduran silica gel 60 (particle size 40-
63μm). 
Melting Points (m.p.) were measured on a Büchi Melting Point B- 545 in open capillary tubes and 
have not been corrected. 
 
Nuclear magnetic resonance (NMR) 1H and 13C spectra were obtained on a 400 MHz NMR  
(Jeol JNM EX-400) or 270 MHz (Jeol JNM EX-270). Chemical shifts were reported in ppm according 
to tetramethylsilane using the solvent residual signal as an internal reference (d-chloroform: δH = 7.26 
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ppm, δC = 77.16 ppm; d6-DMSO: δH = 2.50 ppm, δC = 39.52 ppm. Coupling constants ( J ) are given 
in Hz. Resonance multiplicity was described as s (singulet), d (doublet), t (triplet), q (quartet), quin 
(quintet), m (multiplet) and br (broad signal). Proton decoupling was employed for all 13C spectra.
  
 
Infrared spectra (IR) in KBr were recorded on a Perkin-Elmer spectrum RX I FT-IR System. 
 
Mass spectrometry was generally performed by the Centre de spectrométrie de masse at the 
Université de Mons were they performed ESI-MS and MALDI-MS on using the following 
instrumentation. ESI-MS measurements were performed on a Waters QToF2 mass spectrometer 
operating in positive mode. The analyte solutions were delivered to the ESI source by a Harvard 
Apparatus syringe pump at a flow rate of 5 L min-1. Typical ESI conditions were: capillary voltage 3.1 
kV; cone voltage 20-50 V; source temperature 80 °C; desolvation temperature 120 °C. Dry nitrogen 
was used as the ESI gas. For the recording of the single-stage ESI-MS spectra, the quadrupole  
(rf-only mode) was set to pass ions from 50 to 1000 Th, and all ions were transmitted into the pusher 
region of the time-of-flight analyzer where they were mass analysed with 1 s integration time. 
MALDI-MS were recorded using a Waters QToF Premier mass spectrometer equipped with a 
nitrogen laser, operating at 337 nm with a maximum output of 500 mW delivered to the sample in 4 ns 
pulses at 20 Hz repeating rate. Time-of-flight mass analyses were performed in the reflectron mode at 
a resolution of about 10,000. The matrix solution (1 μL) was applied to a stainless steel target and air 
dried. Analyte samples were dissolved in a suitable solvent to obtain 1 mg mL-1 solutions. 1 μL 
aliquots of those solutions were applied onto the target area already bearing the matrix crystals, and air 
dried. For the recording of the single-stage MS spectra, the quadrupole (rf-only mode) was set to pass 
ions from 100 to 1000 Th, and all ions were transmitted into the pusher region of the time-of-flight 
analyser where they were mass analysed with 1 s integration time.   
 
HPLC analyses and purifications were performed on a Varian 940-LC liquid chromatograph system. 
The analytical HPLC column used was a Varian Pursuit C18, 5μ, 4.6 × 250 mm column. The 
preparative HPLC column used was a Varian Pursuit C18, 5μ, 21.2 × 250 mm column. 0.1% TFA in 
H2O and 0.1% TFA in CH3CN were used as eluents in all cases. 
 
Absorption UV-Vis spectra and Melting analyses of DNA and PNA species were recorded on a 
Varian Cary 5000 Bio UV-Vis spectrophotometer using quartz cuvettes (path length = 1 cm). 
 
5.3 Methods 
Semi-automated SPPS of IGDQK-SH and PNA oligomers  
The synthesis of IGDQK-SH and PNA oligomers 29, 30 and 31 were performed on a Focus XC 
automated peptide synthesiser (model P\N 300530, aapptec). The instrument is equipped with two  
25 mL Reaction Vessels as well as twenty-four 90 mL Aminoacid/Reagent vials and six 
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Solvent/Reagent bottles. A measuring/pre-activation vessel, which allows for measurement and 
delivery of precise amounts of solvents or reagents, is also part of the instrument, together with two 
interchangeable measuring vessels (a 90 mL single arm measuring vessel and a 20 mL dual arm 
measuring vessel) for accurately dispensing smaller volumes. 
 
Hybridisation Procedure  
Hybridisation mixtures of ssDNA-SH and modified ssPNA were formed by combining equimolar 
amounts of two complementary DNA and PNA species in PBS (100 mM NaCl, 10 mM 
NaH2PO4·H2O, pH = 7) at 25 °C, annealing the resulting mixture at 90 °C for 10 min, and allowing 
the solution to slowly cool to r.t. 
  
UV Melting Analysis  
UV melting experiments were performed in PBS (100 mM NaCl, 10 mM NaH2PO4·H2O, pH = 7). An 
equal amount of the two complementary DNA and PNA strands was dissolved in the required solvent. 
Strand concentrations were 5 μM in each component. Thermal denaturation profiles (Abs vs. T) of the 
DNA-PNA duplexes were measured at 260 nm with a Varian Cary 5000 Bio UV-Vis 
spectrophotometer equipped with a Peltier heater/cooler temperature controller. The temperature was 
increased from 20 to 90 °C at a rate of 0.5 °C/min, and the UV absorbance was recorded every 0.5 °C. 
The melting temperature was determined from the maximum of the first derivative of the melting 
curves. 
 
General protocols for cleaning and patterning the Au surfaces 
All the glassware used for the Au functionalisation were pre-treated and cleaned with piranha solution 
(50% H2SO4 : 50% H2O2 v/v). Before the SAMs production, Au surfaces were thoroughly cleaned by 
first heating at 450 °C for 30 min (model HT40L, France Etures), and after incubation in the 
UV/Ozone cleaning system at r.t. for 10 min (model PSD-UV3, Novascan technologies). In order to 
follow and direct the cellular migration Au surfaces were patterned with a self-adhesive polymeric 
PVC mask purchased from Intercoat. The desired PVC mask was designed by Xurography technique 
which employs the use of a cutting plotter for cutting graphics in adhesive vinyl films. Before 
chemical and biological evaluations, all functionalised Au surfaces were stored in aqueous media at  
4 °C. This procedure allowed the storage of chemical gradients for up to five days.[1] 
 
Chemical gradients preparation 
The gradient of SAMs were generated by varying the immersion time in alkanethiol-containing 
solutions along the longitudinal axis of the Au-coated cover slips The immersion of the substrates was 
controlled by a computer-driven linear-motion drive (model T-NA08A50, Zaber technologies), with a 
variable speed in the range between 0.22 μ s-1 and 8 mm s-1. Before chemical characterisations, the 
surfaces were rinsed with absolute EtOH and dried with nitrogen. 
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Water contact angle (WCA) measurements 
The hydrophobicity variation due to the IGDQK-SH chemical gradients was determined by WCA 
measurements as a function of position along the longitudinal axis of the Au surfaces. Static contact 
angle analysis were performed with 2 μL droplets for water, and carried out on a TBU90E Dataphysics 
contact angle goniometer. 
 
Tapping mode atomic force microscopy analysis (TM-AFM) 
TM-AFM measurements on the Au substrates were carried out on air at 298 K by using a Nanoscope 
V (model MMAFMLN, Digital Instrument Metrology Group). The tips used in all measurements were 
antimony-doped silicon cantilevers (T = 3.5–4.5 µm, L = 115–135 µm, fo = 271–305 kHz,  
k = 20–80 N m-1, Bruker) at a resonant frequency of ca. 280 kHz. The collected images were then 
analyzed with WsxM 5.0 software (Nanotec Electronica S. L.) to acquire the cross-sectional values 
and profiles of SAMs and processed images.[2]  
 
X-ray photoelectron spectroscopy (XPS) analysis 
XPS studies were performed to investigate the chemical composition of the functionalised Au surfaces 
and monitor the IGDQK-SH nitrogen increase along the chemical gradient. For each sample, the 
analyses were performed on twenty-one different spots using an ESCA SPECTROMETER where the 
photon source is a monochromatised Al Ka line (hn = 1486.6 eV) applied with a take-off angle of  
35 °C. The survey spectra are the result of the accumulation of 5 scans where the EV Step-1 is 0.08. 
The C 1s core level peak was taken as reference at 284.7 eV. 
 
Optical microscopy imaging 
Once cells were deposited onto the Au surfaces, they were monitored through an inverted transmitted-
light microscope (model Leitz Labovert FS, Alliance Analytical Inc.), recording the images as a 
function of the position along the Au substrates on a time lapse of five days (t = 0, 48, 96 and 120 h 
after cell deposition). 
 
Cell culture 
Human epithelial cells from breast adenocarcinoma (MDA-MB-231, ATCC® HTB-26™) and human 
dermal fibroblasts, isolated from fetal skin (AG04431, Corriel Institute for Medical Research, USA) 
were maintained in culture in 75 cm2 polystyrene flasks (Corning) with 15 - 20 mL of Roswell Park 
Memorial Institute 1medium (RPMI 1640, Invitrogen) or Basal Medium Eagle (Invitrogen UK), 
respectively. All cells media were supplemented with 10% of fetal calf serum (Invitrogen) and cells 
were grown under an atmosphere containing 5 % CO2. 
 
General procedure for cell deposition onto the Au surfaces 
As produced Au functional surfaces were left for 10 min inside pure MeOH, before being slowly dried 
inside an incubator (no CO2 supply) for about 20 min. In the meantime MDA-MB-231 cells or human 
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skin fibroblasts, at about 80% confluence, were independently trypsinised for 3 min and 7 min, 
respectively, and then centrifuged twice and resuspended in their own medium (RPMI + 10% fetal 
serum for MDA-MB-231 and BME + 10% fetal serum supplemented with 2 mM L-Glutamine for the 
fibroblasts). Cells suspension were adjusted to an average amount of 1.1 - 1.3 MCells mL-1 for MDA-
MB-231 and 250-350 KCells mL-1 for the fibroblasts, after that 0.6 µL of such suspensions were 
deposited on to each deposition spot on the Au surfaces. After an average time of 3 ± 0.5 min, the 
respective growth mediums were slowly added to the wells containing the functional surfaces (average 
speed of 2 - 2.2 mL min-1), and the cells were kept under an atmosphere containing 5 % CO2 for 120 h. 
Every 48 h medium renewal was performed, and optical microscopy images were taken respectively 
at, t = 0, 48, 96 and 120 h after the cell deposition. 
 
MTS protocol  
MDA-MB-231 cells, at about 80% confluence, were trypsinised for 3 min and then centrifuged twice 
and resuspended in their own medium (RPMI + 10% fetal serum). The cells suspension was adjusted 
to an average amount of 20 KCells mL-1, and 300 µL of such suspension were deposited in each well 
of a 96 well plate, resulting in about 6 KCells well-1. 16 h after such deposition, each well was rinsed 
with 200 µL RPMI + 10% fetal serum and then the same medium alone (for controls) or IGDQK-SH 
in such medium at a final concentration of 0.1 or 1 µM were added in the wells using 200 µL of 
volume for each well. After 24, 48 and 72 h, the wells were rinsed with 200 µL of CO2-independent 
medium (supplemented with 2 mM L-Glutamine and 10 % fetal serum) and then 166 µL of such 
medium and 33 µL of the active mixture, as indicated by cytotoxicity text manufacturer, were added 
for each well. After 3 h of gently agitation at 37 °C, the absorbance of each well was read at 490 nm, 
and used for the calculation of the % viable cells according to manufacturer indications. Results are 
expressed with standard deviation after averaging the measured absorbance in quadruplicate. The 
average absorbance of cells that received medium only for a given exposition time (24, 48 or 72 h) 
was used as a reference for 100% of cell growth. 
 
Cell staining for confocal 
Cell staining on individual modified functional Au surfaces was carried out 120 h after initial cell 
deposition, and required three washings of 2 min each with 1 mL of warm PBS. After that, cells were 
fixed 10 min with PBS containing 4% paraformaldehyde solution. Again, three cycles of washing with 
warm PBS (2 min) were performed. In order to ensure membrane permeabilization, a warm PBS 
solution of BSA (2%) and Triton-X (0.2 %) was added for each substrate-containing well and the 
whole system was kept at r.t. for 3 h protected from light. After that, three cycles of washing with 
warm PBS (2 min) were performed, and then the substrates were interfaced with 60 µL of a solution of 
rhodamine-phalloidin (7 µL) in PBS/BSA/Triton-X (200 µL) for 10 min at r.t. and protected from 
light. Again, three cycles of washing with warm PBS (2 min) were carried out. Finally, the substrates 
were interfaced with 60 µL of a solution of DAPI (12 µL) in PBS/BSA/Triton-X (200 µL) for 20 min 
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at r.t. and protected from light. At last, after three cycles of washing with warm PBS (2 min) the 
substrates were allowed to dry and mounted to glass slides with Muviol to allow for confocal 
microscope imaging. 
 
Molecular Dynamics (MD) studies 
MD simulations were carried out on the model systems carefully described in Chapter III. 
Parameterization. IGDQK-SH starting structure was parameterized with protonated Isoleucine 
(NH3+), deprotonated Aspartate (COO-) and one neutral sulfur atom, resulting in an uncharged 
molecule. Charges were computed using the restrained electrostatic potential (RESP) approach,[3] 
applying the antechamber module available in AMBER12,[4] and the force field (ff) parameters were 
assigned to the peptide according to the AMBER parmSS99 ff.[5] Only for the MD simulation of 
IGDQK-SH in MeOH, the terminal thiol group was explicitly parameterized as a thiolated species SH. 
Similarly, C8H17-SH and MT(PEG)4-SH were parameterised using the general Amber ff (gaff).[6] The 
parameters for the non-bonded intermolecular interactions between self-assembled molecules and Au 
atoms (Au-S) were the distance of 2.682 (Å) between the Au-S bond, and a Lennard-Jones potential of 
9.033 kcal mol-1, as reported in the Dreiding force field.[7] The Au-Au bond distance was set  
at 2.884 (Å) and Au atoms were held steady by setting the force imposed by organic molecules to 
zero. Freezing the Au atoms is justified by reported evidences that demonstrate their relaxation has a 
negligible effect on the conformation of the SAMs. The Au-Au interactions were neglected by 
excluding them from the neighbor list. 
Force field based MD simulations 
10 ns classical MD simulations were performed for all the systems. The AMBER 12 package[4] was 
employed, and in all the cases the initial structures were relaxed by short minimization runs of 2000 
steps, using the conjugate gradient energy minimization algorithm (convergence criterion 1.0E-4 kcal 
mol-1 Å). The MD simulations were performed at constant volume (NVT) and temperature (298 K) 
using Nosé-Hoover thermostat[8] with a 2 fs time step. Periodic boundary conditions were applied. 
Non-bonded cut-off of 8 Å was set and Particle Mesh Ewald (PME) summation[9] was used to 
calculate the long-range electrostatic interactions. The bonds involving hydrogen atoms were kept 
fixed using the SHAKE algorithm, and the Au atoms were hold fixed along all the simulations.  
 
Calculated properties 
In the different systems the RMSD on the Cα of the AA, C, and N atoms of the IGDQK-SH backbone, 
was calculated over the MD trajectories. The Rg of the peptide along the simulations was also 
calculated together with the intermolecular H-bonds involved in the interactions among within the 
SAMs. The ptraj module of AMBER12[4] was used for all the above properties.  
Poisson Boltzmann Calculations 
Electrostatic surface potentials for IGDQK-SH was calculated by solving the Poisson-Boltzmann 
equation with the APBS program.[10] The results were visualized using a VMD (v 1.8.7) interface.[11] 
   126
Chapter V 
 
Cluster analysis was performed on the 10 ns MD simulation of IGDQK-SH in MeOH using the ptraj 
module of AMBER 12.[4] 
 
 
5.4 Experimental procedures 
 5.4.1 Synthetic procedures regarding Chapter II 
 
1-thioacetate decanoic acid (3) 
 
 
 
To a solution of 1-bromide decanoic acid (1 g, 3.98 mmol) in anhydrous DMF (6 mL), potassium 
thioacetate (0.65 g, 5.57 mmol) was added at 0 °C and the resulting suspension was stirred under 
Argon at r.t. for 16 h. Notably, after few hours the reaction colour changed from white to intense 
orange. The solvent was evaporated under vacuum and the resulting solid was dissolved in CH2Cl2 
(15 mL), washed with water (10 mL × 3) and dried over MgSO4. Evaporation of the solvent under 
vacuum yielded compound 3 (0.95 mg, 94%) as a deep orange solid. M.p. 36-38 °C; 1H NMR (400 
MHz, CDCl3): δ 2.85 (t, J = 7.3 Hz, 2H; CHb), 2.36-2.30 (m, 5H; CHa & CH l), 1.63-1.54 (m, 4H; CHc 
& CH i), 1.30 (m, 10H; CHd, CHe, CHf, CHg & CHh); 13C NMR (400 MHz, CDCl3): 196.35, 178.44, 
44.3, 33.87, 30.8, 29.62, 29.35, 29.28, 29.25, 29.14, 28.88, 24.8. IR (cm1): ν 2918.9, 2854.1, 1698.4, 
1472.6, 1429.3, 1410.7, 1353.6, 1297.0, 1268.2, 1236.8, 1209.8, 1186.8, 1137.5, 1103.1, 959.9, 714.8, 
680.9, 629.8, 478.3. MS (ESI): found 246 [M]+, C12H22O3S requires = 246.13. 
 
L(+)-isoleucine (I) glycine (G) L(-)-aspartic acid (D) L(-)-glutamine (Q) L(-) lysine (K) 1-thiol 
decanoic acid (1) 
 
 
 
 
IGDQK-SH was synthesised in a 0.13 mmol scale using a five-fold excess of protected Aminoacids 
(AA, 0.8 mmol) relative to the Rink-amide MBHA resin (250 mg, 0.54 mmol g-1). Before starting the 
synthesis, all the AA and 1-thioacetate decanoic acid were dissolved in NMP (4 mL, 0.2 M), and 
HATU (0.4 M in DMF), DIEA (2.5 M in NMP) and 20% piperidine in DMF solutions were freshly 
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prepared. The resin was kept in the synthesiser and swelled in NMP (6 mL) at r.t for 15 min. Fmoc 
deprotection was achieved by using 20% piperidine in DMF (6 mL) three times for 4 min each. 
Afterwards, the downloading of the resin was performed by coupling reaction using Fmoc-Lys(Alloc)-
OH (3 mL of 0.2 M), HATU (2 mL of 0.4 M) and DIEA (1 mL of 2.5 M). All the reagents were mixed 
at r.t for 1 min and then added to the resin. The reaction was mixed at r.t for 25 min and the resin was 
after washed (6 mL NMP × 2, 15 mL DMF × 2). The loaded resin was first coupled with 1-thioacetate 
decanoic acid on the α-amino group (α-NH2) of the lysine and after with I, G, D, and Q, on the ε-
amino group of the lysine (ε-NH2). After Fmoc removal on the α-NH2, 1-thioacetate decanoic acid (3 
mL of 0.2 M) was coupled to the resin by using HATU (2 mL of 0.4 M) and DIEA (1 mL of 2.5 M). 
The reaction was mixed at r.t. for 6 h and the resin washed (6 mL NMP × 2, 15 mL DMF × 3, 15 mL 
NMP × 2). At this step, Alloc deprotection on the ε-NH2 was performed in manual mode, adding to 
the resin first phenylsilane (3.2 mmol) at r.t. for 5 min and after [Pd(PPh3)]4 (0.056 mmol) at r.t. for  
30 min, both of them previously dissolved in CH2Cl2. The resin was filtered and washed (5 mL 
CH2Cl2 × 5, 15 mL DMF × 2, 20 mL NMP × 2). The deprotected resin was coupled [(3 mL of 0.2 M of 
each AA starting from G to I, HATU (2 mL of 0.4 M) and DIEA (1 mL of 2.5 M)], washed and 
deprotected in automatic way to obtain the thioester-group protected IGDQK. 
Thioester deprotection.[12]Removal of the thioester group was successfully performed in manual mode 
adding to the resin a solution of pyrrolydine in DMF (8 mmol). The reaction was mixed at r.t for 18 h 
and the resin was after washed (6 mL DMF × 5, 4 mL NMP × 4). 
Resin cleavage. When the synthesis was completed, a freshly prepared cleavage cocktail solution of 
TFA, TIS, water, and EDT (92.5:2.5:2.5:2.5) was added to the resin (2 mL) and the cleavage reaction 
was allowed to proceed at r.t for 90 min. The product was precipitated with Et2O (30 mL) and isolated 
by centrifugation to form a pellet. The pellet was washed twice with Et2O and dried under Argon 
yielding 1 (40 mg, 42% after RP-HPLC purification) as a white solid. 
RP-HPLC analysis and purification. Crude peptide was analysed and purified by RP-HPLC. The 
gradient was from 0.1% TFA in water to 0.1% TFA in CH3CN over 38 min. The flow rates for 
analytical and preparative HPLC were 1 mL min-1 and 21 mL min-1, respectively. According to these 
parameters, IGDQK-SH detected at 220 nm was eluted at 18.06 min retention time.  
MS (MALDI-HRMS): found 745.4198 [M+H]+, [C33H61N8O9S] requires = 745.4204; found 767.4086 
[M+Na]+, [C33H60N8O9NaS] requires = 767.4102; found 783.3839 [M+K]+, [C33H60N8O9KS]  
requires = 783.3841. 
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MALDI-TOF analysis (a) and HPLC chromatogram (b) of purified IGDQK-SH 1. HPLC conditions: Agilent Zorbax SB- 
C18, 5 μm, 4.6×250 mm, eluents from 0.1% TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were 
monitored at 260 nm. 
 
Preparation of SAMs of pure n-alkanethiols [(C8H17-SH and MT(PEG)4-SH)] and mixed SAMs 
with IGDQK-SH and n-alkanethiols 
The stock solutions of C8H17-SH, MT(PEG)4-SH and IGDQK-SH were prepared in absolute EtOH at 
a concentration of 100 µM. All other solutions were obtained by further dilution of the corresponding 
stock solution. Pure and mixed SAMs were generated by immersing the fleshly cleaned Au surfaces 
into a 7 µM solution of C8H17-SH at r.t. for 18 h, or dipping them first into a 7 µM solution of C8H17-
SH at r.t. for 10 min and after into a 1 µM solution of IGDQK-SH at r.t. for 5 min, respectively. After 
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adsorption, the samples were rinsed with EtOH and dried with nitrogen. This procedure was repeated 
by using MT(PEG)4-SH instead of C8H17-SH. All the substrates were characterised by AFM, WCA 
and cellular migration experiments, showing always a negative cell migratory response, as expected.  
 
Chemical gradient production of IGDQK-SH SAMs  
Following the approach reported by Spencer et al,[13] the gradient of IGDQK-SH SAMs was generated 
by varying the immersion time in 1 µM IGDQK-SH-containing solution along the longitudinal axis of 
the Au substrate (15 mm in length). The immersion of the substrates was controlled by a computer-
controlled linear-motion actuator with a speed established at 14 µm s-1 (15 min in time to achieve the 
complete immersion of the Au surface). Afterwards, in order to obtain upright oriented IGDQK-SH 
SAMs on the Au surfaces two approaches were employed: i) Au substrates were fully immersed in one 
of the complementary 7 µM n-alkanethiol solution at r.t. for 10 min (full immersion method); ii) Au 
substrates were gradually immersed in one of the complementary 3 µM n-alkanethiol solutions in the 
same way as in the IGDQK-SH gradient generation, changing the speed of the linear actuator to 62 µm 
s-1 (double gradient method). After the gradient generation, Au surfaces were rinsed with EtOH, dried 
with nitrogen and stored in water at 4 °C for characterisation studies and cell migration experiments. 
All the surfaces were characterised by AFM, WCA and XPS.  
 
5.4.2 Synthetic procedures regarding Chapter III 
 
Thymin-1-ylacetic acid (16) 
 
 
To a suspension of thymine (10 g, 79.3 mmol) and K2CO3 (10.96 g, 79.3 mmol) in anhydrous DMF 
(240 mL), methyl-α-bromoacetate (7.5 mL, 79.3 mmol) was added and the mixture was stirred 
vigorously under Argon at r.t. for 16 h. The suspension was filtered and evaporated to dryness under 
vacuum. The solid residue was cooled to 0 °C, treated with water (75 mL) and 4 M aqueous HCl 
(3.2 mL), and stirred for 30 min. The precipitate was collected by filtration and washed with water 
(40 mL × 3). The solid was treated with water (80 mL) and 2 M NaOH (aqueous, 40 mL) at reflux for 
10 min. The mixture was cooled to 0 °C, treated with 4 M HCl (aqueous, 27.0 mL), and stirred for 30 
min. The precipitate was collected by filtration, washed with water (40 mL × 3), and dried over P2O5 
overnight, to afford 16 (9.0 g 62%) as a white solid. M.p. 274-277 °C; 1H NMR (400 MHz, d6-
DMSO): δ 11.35 (s, 1H; NHa), 7.50 (s, 1H; CHc), 4.37 (s, 2H; CHd), 1.75 (s, 3H; CHb), COOH proton 
was not observed; 13C NMR (400 MHz, d6-DMSO): δ 169.69, 164.38, 150.99, 141.82, 108.33, 40.14, 
11.94. Spectral characterisation in agreement with previously reported data.[14] 
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tert-Butyl N-(2-aminoethyl) glycinate (18) 
 
 
 
 
To a vigorously stirred solution of ethylenediamine (60 mL, 900 mmol) in CH2Cl2 (400 mL),  
tert-butyl- α-chloroacetate (14.5 mL, 102 mmol) in CH2Cl2 (80 mL) was added at 0 °C over 5 h. The 
resulting mixture was allowed to warm slowly to r.t. (ca. 3 h), and then stirred for 18 h. The reaction 
mixture was washed with water (100 mL × 3), and the combined aqueous wash was back-extracted 
with CH2Cl2 (100 mL). The organic phase was dried over MgSO4 and filtered. This solution was used 
without further purification in the next step to synthesise compound 19. For characterisation purpose, a 
sample was obtained by concentration of a 1 mL aliquot to dryness under vacuum, yielding 26 mg as a 
clear oil (0.026 g mL-1 × 580 mL = 15.1 g, ca. 85% from tert-butyl-α-chloroacetate). M.p. 228-230 
°C; 1H NMR (400 MHz, CDCl3): δ 3.27 (s, 2H; CHe), 2.79 (m, 2H; CHb), 2.67 (m, 2H; CHc), 2.24 (s, 
3H; NHa & NHd), 1.44 (s, 9H; CHf); 13C NMR (400 MHz, CDCl3): δ 172.04, 81.3, 51.66, 49.03, 
45.66, 41.62, 28.23. Spectral characterisation in agreement with previously reported data.[15] 
 
tert-Butyl N-[2-(N-9-fluorenylmethoxycarbonyl)aminoethyl] glycinate (19) 
 
 
To a solution of 18 (15.1 g, 86.8 mmol) and DIEA (15 mL, 86 mmol) in CH2Cl2 (580 mL), Fmoc-
OSu  
(29 g, 86 mmol) in CH2Cl2 (160 mL) was added dropwise over 5 h and the he resulting solution 
stirred at r.t. for 16 h, and then washed with 1 N aqueous HCl (100 mL × 5), and brine (100 mL). The 
organic layer was dried over MgSO4 and partially concentrated under vacuum (ca. 100 mL). Cooling 
to -18 °C overnight resulted in a precipitate which was collected by filtration and washed with CH2Cl2 
until the filtrate was colorless. The solids were dried under vacuum to give 19·HCI (28.5 g, 79%) as a 
white solid. When needed, 19·HCl was converted to the free base form: 19·HCI (1g, 2.3 mmol) was 
dissolved in CHCl3 (ca. 50 mL), washed with aqueous saturated NaHCO3 (300 mL), dried over 
MgSO4, and concentrated under vacuum to give 19 as a clear oil in the free base form. 1H NMR (400 
MHz, CDCl3): δ 7.75 (d, J = 7.6 Hz, 2H; CHa), 7.61 (d, J = 7.3 Hz, 2H; CHd), 7.40 (t, J = 7.6 Hz, 2H; 
CHb), 7.31 (t, J = 7.3 Hz, 2H; CHc), 5.36 (br s, 1H; NHg), 4.39 (d, J = 6.8 Hz, 2H; CHf),  
4.22 (t, J = 6.8 Hz, 1H; CHe), 3.29 (m, 4H; CHh & CHk), 2.77 (m, 2H; CH i), 1.48 (s, 9H; CH l), NH j 
proton was not observed; 13C NMR (400 MHz, CDCl3): δ 164.63, 156.93, 43.89, 141.17, 127.6, 
127.09, 125.47, 119.81, 84.78, 67.28, 53.4, 48.81, 48.25, 47.3, 40.03, 29.67, 27.94. Spectral 
characterisation in agreement with previously reported data.[15] 
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tert-Butyl N-[2-(N-9-fluorenylmethoxycarbonyl)aminoethyl]-N-[(thymin-1-yl)acetyl] glycinate 
(20)  
 
 
To a solution of 19 (8.6 g, 21.71 mmol) in anhydrous DMF (117 mL), thymin-1-ylacetic acid (16, 8.5 
g, 46.67 mmol) was added and the resulting mixture stirred until complete dissolution of the acid. 
EDC (8.5 g, 44.72 mmol) was then added in two equal portions over 30 min, and the mixture stirred 
overnight. The solution was concentrated under vacuum, and water (100 mL) was added to the 
resulting thick oil. The mixture was shaken vigorously for several min to precipitate a fine white solid. 
The solids were collected by filtration, washed with cold water (235 mL), and dried under vacuum. 
The crude compound was purified by flash chromatography (CH2Cl2/MeOH 95:5) to yield 20 (10.2 g, 
82%) as a white solid. An analytically pure sample was obtained by recrystallisation using 
CH2Cl2/EtOAc/Hexane 1:1:1. (Several days at 18 °C are required for recrystallisation). Rf = 0.45 
(CH2Cl2/MeOH 95:5). M.p. 167-169 °C; 1H NMR (400 MHz, CDCl3): δ 8.41/8.39 (2 × s (rotamers), 
1H; NHa), 7.75 (d, J = 7.5 Hz, 2H; CHe), 7.60 (t, J = 7.3 Hz, 2H; CHh), 7.39 (t, J = 7.3 Hz, 2H; CHf), 
7.30 (t, J = 7.4 Hz, 2H; CHg), 6.98/6.84 (2 × s (rotamers), 1H; CHc), 5.97/5.36 (2 × ×  br s (rotamers), 
1H; NHk), 4.47-4.37 (m, 4H; CHj & CHn), 4.21 (t, J = 6.5 Hz, 1H; CH i), 4.07/3.94 (2 × s (rotamers), 
2H; CHd), 3.53- 3.48 (m, 4H; CH l & CHm), 1.89/1.86 (2 × s (rotamers), 3H; CHb), 1.47/1.46 (2 × s 
(rotamers), 9H; CHo); 13C NMR (400 MHz, CDCl3): (rotamers observed) δ 168.79, 168.63, 164.29, 
162.81, 156.83, 151.22, 151.12, 143.88, 141.37, 141.27, 127.85, 127.77, 127.19, 127.13, 120.07, 
110.86, 110.66, 83.74, 82.76, 66.85, 49.89, 48.91, 47.75, 47.32, 39.39, 39.12, 36.73, 31.68, 28.09, 
12.39. Spectral characterisation in agreement with previously reported data.[15] 
 
N-[2-(N-9-Fluorenylmethoxycarbonyl)aminoethyl]-N-[(thymin-1-yl)acetyl] glycine (12)  
 
 
To a solution of compound 6 (100 mg, 0.18 mmol) in CH2Cl2 (1 mL), TFA (1 mL) was added 
portion-wise at 0 °C over 10 min, and the resulting mixture stirred at r.t. for 2 h. The solvent was 
evaporated under vacuum and co-evaporated three times using toluene to remove any residual TFA 
yielding 12 (900 mg, quantitative) as a white solid. No further purification was necessary. (If the 
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product contains impurities, a recrystallisation using CH2Cl2 can be performed to purify the 
compound). M.p. 216-219 °C; 1H NMR (400 MHz, d6-DMSO): δ 11.30/11.29 (2 × s (rotamers), 1H; 
NHa), 7.88 (d, J = 7.3 Hz, 2H; CHe), 7.65 (d, J = 7.3 Hz, 2H; CHh), 7.41-7.20 (m, 6H; CHc, CHf, CHg 
& CHk), 4.65/4.47 (2 × s, 2H; CHn), 4.34-4.20 (m, 3H; CH i & CH j), 3.98 (s, 2H; CHd), 3.41-3.24 (m, 
4H; CH l & CHm), 1.73 (s, 3H; CHb); 13C NMR (400 MHz, d6-DMSO): δ 171.02, 170.39, 167.9, 
167.22, 164.39, 156.9, 150.98, 143.86, 142.11, 140.76, 127.62, 127.04, 125.13, 120.13, 108.06, 65.50, 
49.5, 48.2, 47.3, 11.91. Spectral characterisation in agreement with previously reported data.[15] 
 
6-N-(Benzyloxycarbonyl)-9-(tert-butoxycarbonylmethyl)adenine (23) 
 
 
To a solution of adenine (20.0 g, 148 mmol) in DMF (350 mL), NaH (60% in mineral oil, 6.88 g, 172 
mmol) was added in two portions at 1 h intervals. After 3 h tert-butyl-α-chloroacetate (23.2 mL, 163 
mmol) was added drop-wise at 0 °C over 30 min and the resulting mixture allowed to warm to r.t. and 
stirred for 12 h. The solvent was then removed under vacuum and water (160 mL) was added, 
decanted after brief stirring. The resulting sticky oil was dissolved in boiling EtOH and stirred 
overnight to obtain 19.915 g (54% yield) of tert-butyl adenine-9-acetate as a solid. The crude material 
was dissolved in DMF (160 mL), treated with carbonyldiimidazole (19.44 g, 120 mmol), and heated 
slowly until 105 °C. After 2 h, the temperature was decreased to 95 °C before adding benzyl alcohol 
(12.4 mL, 120mmol) and the mixture stirred for 12 h. Precipitation from water (400 mL) yielded 23 
(24.80 g , 43% overall for two steps) as a white/beige solid. M.p. 141-143 °C; 1H NMR (400 MHz, 
CDCl3): δ 8.77 (s, 1H; CHb), 8.63 (br, 1H; NHa), 7.98 (s, 1H; CHc), 7.44-7.36 (m, 5H; CHg, CHh 
& CH i), 5.30 (s, 2H; CHf), 4.86 (s, 2H; CHd), 1.47 (s, 9H; CHe); 13C NMR (400 MHz, CDCl3): δ 
166.14, 153.16, 152.06, 151.30, 149.60, 143.40, 135.48, 128.83, 128.80, 128.69, 120.88, 83.89, 67.94, 
45.03, 28.12. Spectral characterisation in agreement with previously reported data.[15] 
 
6-N-(Benzyloxycarbonyl)-9-(carboxymethyl)adenine (24) 
 
 
Compound 23 (6.629 g, 17.3 mmol) was dissolved in CH2Cl2 (65 mL), and TFA (65 mL) was added 
slowly at 0 °C over 20 min. The reaction mixture was stirred at r.t. for 2 h. The solvent was then 
evaporated under vacuum and co-evaporated three times using toluene to remove any residual TFA. 
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Trituration with Et2O afforded 24 (5.655 g, quantitative) as a white/beige solid. M.p.139-143 °C; 1H 
NMR (400 MHz, d6-DMSO): δ 8.63 (s, 1H; CHb), 8.46 (s, 1H; CHc), 7.47-7.29 (m, 5H; CHf, CHg & 
CHh), 5.22 (s, 2H; CHe), 5.09 (s, 2H; CHd), COOH & NHa protons were not observed; 13C NMR (400 
MHz, d6-DMSO): δ 169.05, 152.24, 151.59, 149.37, 144.89, 136.34, 128.42, 128.01, 127.87, 122.48, 
119.56, 66.32, 64.56, 44.3. Spectral characterisation in agreement with previously reported data.[15] 
 
 
tert-Butyl N-[2-(N-9-fluorenylmethoxycarbonyl)aminoethyl)-N-{(6-N(benzoxycarbonyl) adenine-
9-yl)acetyl} glycinate (25) 
 
 
 
To a suspension of 24 (400 mg, 1.25 mmol) in anhydrous CH3CN (3.3 mL), N-ethylmorpholine 
(NEM, 319 μL, 2.50 mmol) and pivaloyl chloride (as a drop-wise addition, 185 μL, 1.5 mmol) were 
sequentially added at 0 ºC and the resulting mixture stirred for 20 min. Compound 19 (0.505 g,  
1.28 mmol) was the added and the reaction continued at r.t. for 90 min. The resulting mixture was 
diluted with CH2Cl2 (12 mL) and washed with 20% aqueous citric acid (10 mL) followed by saturated 
NaHCO3 (10 mL). The organic phase was dried over MgSO4, concentrated under vacuum, and 
purified by silica gel chromatography (EtOAc), yielding 25 (600 mg, 69%) as a white crystalline solid. 
Rf = 0.44 (CH2Cl2/MeOH 95:5). M.p. 190-193 °C; 1H NMR (400 MHz, d6-DMSO): δ 10.68 (br s, 1H; 
NHa), 8.59/8.55 (2 × s (rotamers), 1H; CHb), 8.33 (s, 1H; CHc), 7.87 (d, J = 7.3 Hz, 2H; CHn), 7.68 (t, 
J = 7.1 Hz, 2H; CHq), 7.50-7.20 (m, 9H; CHk, CH l, CHm, CHo & CHp), 5.35/5.23 (2 × s (rotamers), 
2H; CHd), 5.15 (s, 2H; CH j), 4.40-4.20 (m, 5H; CHr, CHs & CHh), 3.97 (s, 1 H; CHg), 3.56 (m 
(rotamers), 1H; CHf), 3.38 (m (rotamers), 1H; CHg), 3.13 (m (rotamers), 1H; CHf), 1.49/1.36 (2 × s 
rotamers, 9 H; CH i), NHe proton was not observed; 13C NMR (400 MHz, d6-DMSO): δ 168.56, 
167.91, 166.96, 166.51, 156.39, 152.34, 152.14, 151.45, 149.33, 145.13, 143.84, 140.73, 136.37, 
128.39, 127.81, 127.59, 125.0, 121.11, 81.90, 80.97, 66.21, 65.48, 49.46, 48.76, 47.07, 46.72, 27.63. 
Spectral characterisation in agreement with previously reported data.[15] 
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N-[2-(N-9-fluorenylmethoxycarbonyl)aminoethyl)-N-{(6-N(benzoxycarbonyl)adenine-9-yl) 
acetyl} glycinate (13) 
 
To a solution of compound 25 (1.29 g, 1. 83 mmol) in CH2Cl2 (13 mL), TFA (13 mL) was added 
portion-wise at 0 °C over 10 min, and the mixture was stirred at r.t. for 2 h. The solvent was 
evaporated under vacuum and co-evaporated three times using toluene to remove any residual TFA 
affording 13 (1.19 g, quantitative) as a white solid. No further purification was necessary. M.p. 198-
200 °C; 1H NMR (400 MHz, d6-DMSO): δ 8.56/8.54 (2 × s (rotamers), 1H; CHb), 8.39 (s, 1H; CHc), 
7.86 (d, J = 7.1 Hz, 2H; CHn), 7.67 (t, J = 7.8 Hz, 2H; CHq), 7.55-7.25 (m, 9H; CHk, CH l, CHm, CHo 
& CHp), 5.35/5.22 (2 × s (rotamers), 2H; CHd), 5.17 (s, 2H; CH j), 4.43-4.18 (m, 5H; CHr, CHs & 
CHh), 4.0 (s, 1 H; CHg), 3.54 (m (rotamers), 1H; CHf), 3.35 (m (rotamers), 1H; CHg), 3.13 (m 
(rotamers), 1H; CHf), COOH proton was not observed; 13C NMR (400 MHz, d6-DMSO): (rotamers 
observed) δ 170.95, 170.43, 167.0, 166.56, 156.3, 156.44, 152.5, 152.24, 151.59, 149.33, 143.9, 
140.78, 136.41, 128.44, 127.89, 127.65, 127.09, 125.1, 122.9, 120.1, 66.27, 65.5, 63.7, 46.9, 46.7, 
43.8. Spectral characterisation in agreement with previously reported data.[15]  
 
 5.4.3 Manual solid phase PNA synthesis procedures 
 
RESIN PREPARATION 
Resin – Rink-amide MBHA resin (250 mg, 0.52 mmol g-1 loading). 
 
Swelling – The resin was immersed in CH2Cl2, and after allowing the suspension to stand at r.t. for 16 
h the resin was filtered. 
 
Deprotection of the N-terminal Fmoc protecting group – 20% piperidine in DMF (4 mL) was added to 
the resin. After 5 min of shaking, the resin was filtered. Once again, 20% piperidine in DMF (4 mL) 
was added to the resin. After 10 min of shaking, the resin was filtered. The resin was then washed 
(DMF × 2, CH2Cl2 × 2, DMF) and each washing was agitated for 5 s before draining. A qualitative 
Kaiser test was then applied to a sample of the resin to determine if the deprotection had been 
successful. If a positive test was observed, then the monomer coupling procedure was performed. If a 
negative or partial positive test was observed, the whole deprotection procedure was repeated. 
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Lysine coupling and control of the resin loading – The resin loading is 0.4 mmol g-1 and the coupling 
conditions are reported in the following Table. 
 
Fmoc-Lys(Z)-OH or Fmoc-Lys(Alloc)-OH and HBTU were dissolved in NMP. DIEA was added and 
the mixture was stirred for 5 min at 45 °C before being added to the deprotected resin. The resultant 
resin suspension was agitated using Argon bubbling at r.t. for 1 h. The solution was then filtered and 
the resin was washed (DMF × 5) and each washing was agitated for 5 s before draining. The 
remaining unreacted terminal amino groups on the resin were then capped by exposing the resin to 
10% acetic anhydride in NMP (2.5 mL) at r.t. for 30 min. The solution was then filtered and the resin 
was washed (DMF × 5). At this point the resin was assumed to have a loading of 0.4 mmol g-1. 
Therefore, since 250 mg of resin were used, the scale of the PNA oligomerisation was 0.1 mmol. At 
this point, a qualitative Kaiser test was then applied to a sample of the resin to determine if the 
coupling and capping procedures had been successful. If a positive test was observed, then the capping 
procedure was performed once again. If a negative test was observed, the PNA oligomerisation could 
be started. 
 
PNA OLIGOMERISATION CYCLES 
 
Weighing – Before starting the oligomerisation, the solids (PNA monomer and HBTU) were  
pre-weighed and mixed into vials labelled according to their position in the sequence. 
Deprotection of the N-terminal FMOC protecting group – 20% piperidine in DMF (4 mL) was added 
to the resin. After 2 min of shaking, the resin was filtered. Once again, 20% piperidine in DMF (4 mL) 
was added to the resin. After 10 min of shaking, the resin was filtered. The resin was then washed 
(DMF × 2, CH2Cl2 × 1, DMF) and each washing was agitated for 5 s before draining. A qualitative 
Kaiser test was then applied to a sample of the resin to determine if the deprotection had been 
successful. If a positive test was observed, then the monomer coupling procedure was performed. If a 
negative or partial positive test was observed, the whole deprotection procedure was repeated. 
Reagent\Solvent Equivalents Molecular weight (g mol-1) 
Moles 
(mmmol) 
Mass 
(mg) 
Volume 
(μL) 
Rink-amide MBHA resin 1.0 0.52 mmol g-1 0.13 250 - 
L(-)-Fmoc-Lys(Z)-OH  
or 
L(-)-Fmoc-Lys(Alloc)-OH 
0.92 
502.56 
452.50 
0.12 
60.30 
54.30 
- 
HBTU 0.77 379.29 0.10 37.93 - 
DIEA 9.20 124.29 1.20 155.0 208.9 
NMP - - - - 1800 
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Monomer coupling – The monomer coupling reactions were performed with the following reagent 
quantities. 
When 5 min were remaining in the final deprotection with 20% piperidine, the coupling solution was 
prepared. The pre-weighed mixture of PNA monomer and HBTU was dissolved in NMP. DIEA was 
added and the resultant solution was stirred at 45 °C for 5 min before being added to the deprotected 
resin. (Note: the addition to the resin should be done as soon as the resin deprotection is complete to 
prevent side reactions from occurring). The resultant resin suspension was agitated using argon 
bubbling at r.t. for 1 h. The solution was then filtered and the resin was washed (DMF × 5). Each 
washing was agitated for 5 s before draining. A qualitative Kaiser test was then applied to a sample of 
the resin to determine if the coupling had been successful. If a negative test was observed, then the 
capping procedure was performed. If a positive or partially positive test was observed, the whole 
coupling procedure was repeated with a fresh coupling solution. 
Capping – The resin was exposed to 10% acetic anhydride in NMP (2.5 mL). The resultant resin 
suspension was agitated using argon bubbling at r.t. for 5 min. The solution was then filtered and the 
resin was washed (DMF × 5) and each washing was agitated for 5 s before draining. The deprotection, 
coupling, capping cycle was repeated until the desired oligomer sequence was complete. If the process 
was not continuous, or upon completing the sequence, then the resin was stored suspended in 1:1 
CH2Cl2/DMF at 4 °C. 
 
PNA ISOLATION 
 
Resin cleavage – The derivatised resin (250 mg) was stirred in TFA/m-cresol 4:1 (2.5 mL) at r.t. for  
1 h. The colour of the resin was observed to change from its original clear/yellowish colour to red. The 
resin was filtered and the filtrate was concentrated using a stream of nitrogen until all volatiles were 
removed. An excess of ice-cold Et2O (ca. 5-fold) was then added to the filtrate yielding a precipitate. 
The suspension was centrifuged (5 min at 5000 rpm) to give a white pellet and the supernatant 
solution was decanted carefully. To the pellet was added further ice-cold Et2O, and after vortexing to 
Reagent\Solvent Equivalents Molecular weight (g mol-1) 
Moles 
(mmmol) 
Mass 
(mg) 
Volume 
(μL) 
Rink-amide MBHA 
resin bearing lysine 1.0 0.4 mmol g
-1 0.10 250 - 
PNA monomers: 
Thymine 
Adenine 
 5.0 
 5.0 
 506.51 
 649.23 
 0.50 
 
 253.25 
 324.62 
- 
HBTU 4.5 379.29  0.45 170.7 - 
DIEA  12.0 124.29  1.20 155.0 208.9 
NMP - - - - 1800 
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resuspend the pellet, the centrifugation and decantation was repeated. This was repeated once more  
(3 centrifugations in total) to give the crude PNA, which was dried under vacuum. 
PNA HPLC analysis and purification – Crude PNA oligomers that were isolated, as well as purified 
PNA oligomers were analysed by RP-HPLC using 0.1% TFA in H2O (A) and 0.1% TFA in CH3CN 
(B) as eluents. The flow rates were 1 mL and 21 mL min-1 for the analytical and preparative HPLC, 
respectively. The gradient of the eluents is described in the table below. 
 
 
 
 
 
 
 
 
 
 
 
 
PNA identification – Analysis of the purified PNA oligomers was carried out by MALDI-TOF MS. 
  
 5.4.4 Semi-automated solid phase PNA synthesis procedures 
  
PNA was synthesised in a 0.12 mmol scale using a five-fold excess of protected PNA monomers 
(thymine and adenine) relative to the Rink-amide MBHA resin (300 mg, 0.41 mmol g-1). Before 
starting the synthesis, all the PNA monomers were dissolved in NMP (2.4 mL, 0.26 M), and HATU 
(0.3 M in DMF), DIEA (2 M in NMP) and 20% piperidine in DMF solutions were freshly prepared. 
The resin was kept in the synthesiser and swelled in NMP (6 mL) at r.t. for 15 min. Fmoc deprotection 
was achieved by using 20% piperidine in DMF (6 mL) three times for 4 min each. Afterwards, the 
downloading of the resin and the monomer coupling reactions were performed with the following 
reagent quantities. 
Time (min) Gradient 
 From  To 
 0-5 100% A  0% B 
 5-30 0% A  100% B 
 30-40 0% A  100% B 
 40-45 100% A  0% B 
 45-50 100% A  0% B 
Reagent\Solvent Equivalents Molecular weight (g mol-1) 
Moles 
(mmmol) 
Mass 
(mg) Volume (μL) 
Rink-amide MBHA 
resin bearing lysine 1.0 0.41 mmol g
-1 0.12 300 - 
Fmoc-Lys(Z)-OH  5.00 502.56 0.61 309.0  
PNA monomers: 
Thymine 
Adenine 
 5.00 
 5.00 
 506.51 
 649.23 
 0.61 
 
253.25 
324.62 
- 
HATU 4.5 380.20 0.55 209.11 - 
DIEA  12.0 124.29 1.48 183.95  247.91 
NMP - - - - 2400 
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Fmoc-Lys(Z)-OH (2.4 mL of 0.26 M) was coupled to the resin by using HATU (2.4 mL of 0.3 M) and 
DIEA (1 mL of 2.0 M). All the reagents were mixed at r.t. for 1 min and then added to the resin. The 
reaction was mixed at r.t. for 25 min and the resin was after washed (6 mL NMP × 2, 15 mL DMF × 
2). After Fmoc removal on the α-NH2 of the lysine, the resin was coupled (2.4 mL of 0.26 M of each 
PNA monomers), HATU (1.8 mL of 0.3 M) and DIEA (1 mL of 2.5 M), washed and deprotected in 
automatic way to obtain the Fmoc-protected PNA oligomer. 
Resin cleavage – The derivatised resin (300 mg) was stirred in solution of TFA, TIS, and water,  
(2.0 mL, 95:2.5:2.5) at r.t. for 90 min. The resin was filtered and the filtrate was concentrated using a 
stream of nitrogen until all volatiles were removed. An excess of ice-cold Et2O (ca. 5-fold) was then 
added to the filtrate yielding a precipitate. The suspension was centrifuged (5 min at 5000 rpm) to give 
a white pellet and the supernatant solution was carefully decanted. To the pellet was added further ice-
cold Et2O, and after vortexing to resuspend the pellet, the centrifugation and decantation was repeated. 
This was repeated once more to give the crude PNA, which was dried under vacuum. 
PNA oligomers were anlaysed and purified by RP-HPLC according to the procedures described in 
section 5.4.3.  
 
 
 5.4.5 Isolated PNA oligomers 
 
PNA tetramer – sequence: T-A-A-T-Lys (26) 
 
 
 
 
PNA 26 was synthesised according to the procedures described in section 5.4.3., and isolated as a 
white solid (37.8 mg, 15%). HPLC retention time: 30.3 min. MS (MALDI- HRMS): found 1852.7424 
[M+H]+, [C89H98N25O21] requires = 1852.7369; found 1744.75 [M-F1]+, [C82H90N25O20] requires = 
1744.68; found 1656.65 [M-F2]+, [C75H86N25O20] requires = 1656.64. Refer to Fig. 3.13 for structures 
of F1 and F2. 
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HPLC chromatogram of purified PNA 26. Conditions: Agilent Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% 
TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were monitored at 260 nm. 
 
 
 
MALDI-TOF-MS analysis of purified PNA 26 showing the fragmentation observed. 
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PNA tetramer – sequence: NH2-T-AA-T-Lys-Rho (27) 
 
 
 
 
 
 
PNA 27 was synthesised according to the procedures described in section 5.4.3., and isolated as a pink 
solid (32 mg, 12%). Coupling reaction between PNA 27 and Rhodamine was successfully achieved by 
using Rhodamine (239.51 mg, 0.5 mmol), HBTU (170.7 mg, 0.45 mmol), and DIEA (208.9 μL, 1.20 
mmol) stirring the reaction at r.t. for 3h. HPLC retention time: 20.81 min. MS (MALDI-HRMS): 
found 1920.8500 M+, [C94H110N27O9]+ requires = 1920.8471; found 1921.8624 [M+H]+, 
[C94H111N27O9]+ requires = 1921.8544. 
 
 
 
 
 
HPLC chromatogram of purified PNA 27. Conditions: Agilent Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% 
TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were monitored at 260 nm and 540 nm. 
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MALDI-TOF-MS analysis of purified PNA 27 showing the fragmentation observed. 
 
 
PNA dodecamer – sequence: NH2-A-T-T-A-A-A-T-A-T-T-T-Lys (28) 
 
 
 
 
PNA 28 was synthesised according to the procedures described in section 5.4.4 and isolated as a white 
solid (15.2 mg, 6%). HPLC retention time: 26.69 min. MS (MALDI- HRMS): found 4189.6216 
[M+H]+, [C186H215N66O51] requires = 4189.6293. 
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HPLC chromatogram of purified PNA 28. Conditions: Agilent Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% 
TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were monitored at 260 nm. 
 
 
MALDI-TOF-MS analysis of purified PNA 28 showing the fragmentation observed. 
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Deprotected PNA dodecamer – sequence: NH2-A-T-T-A-A-A-T-A-T-T-T-Lys (29) 
 
 
 
 
 
Cbz deprotection was performed in solution adding trimethylsilyl iodide (TMSI, 55 μL, 0.390 mmol) 
to a solution of PNA 29 (10.9 mg, 0.0026 mmol) in anhydrous DMF (100 μL). The reaction was 
stirred at 50 °C for 16h. Anhydrous MeOH (63.3 μL, 1.56 mmol) was then added and the resultant 
mixture was stirred at r.t. for 30 min. The volatile components were removed under vacuum leaving an 
oily residue which was then precipitated with Et2O (45 mL). The suspension was centrifuged (5 min at 
5000 rpm) and the supernatant was decanted. The precipitation, centrifugation and decantation was 
repeated twice more. The residue was dried under vacuum, analysed and purified by RP-HPLC, 
affording PNA 29 (8 mg, 91%) as a white solid. HPLC retention time: 13.29 min. MS (MALDI- 
HRMS): found 3384.4102 [M+H]+, [C138H179N66O39] requires = 3384.4052. 
 
 
 
 
 
 
HPLC chromatogram of purified PNA 29. Conditions: Agilent Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% 
TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were monitored at 260 nm. 
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MALDI-TOF-MS analysis of purified PNA 29. 
 
  
PNA dodecamer – sequence: Rho-A-T-T-A-A-A-T-A-T-T-T-Lys 
 
 
 
PNA 12-mer was synthesised according to the procedures described in section 5.4.4. Coupling 
reaction between PNA and Rhodamine was successfully achieved by using Rhodamine  
(2.4 mL of 0.26 M), HATU (2.4 mL of 0.3 M) and DIEA (1 mL of 2.5 M) stirring the reaction at r.t. for 
90 min. Due to the lack of easily ionisable functional groups, the exact mass was not observed 
performing MALDI-TOF analysis. The mass spectrum showed a fragmentation pattern related to the 
loss of some Cbz protecting groups. The complete deprotection of the functionalised PNA confirmed 
the synthesis of the desired compound. 
 
 
Deprotected PNA dodecamer – sequence: Rho-A-T-T-A-A-A-T-A-T-T-T-Lys (30) 
 
 
 
Cbz deprotection on PNA bearing Rhodamine B was performed as described for PNA 29. The residue 
was analysed and purified by RP-HPLC, to obtain PNA 30 (14 mg, 91%) as a pink solid. HPLC 
retention time: 17.39 min. MS (MALDI- HRMS): found 3808.6436 M+, [C166H207N68O41]+  
requires = 3808.6203; found 3832.9133 [M+Na]+, [C116H206N68O41Na]+ requires = 3832.8977. 
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HPLC chromatogram of purified PNA 30. Conditions: Agilent Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% 
TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were monitored at 260 nm and 540 nm. 
 
 
 
MALDI-TOF-MS analysis of the purified PNA 30. 
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PNA dodecamer – sequence: IGDQ-A-T-T-A-A-A-T-A-T-T-T-Lys 
 
 
 
 
PNA 12-mer was synthesised according to the procedures described in section 5.4.4. Coupling 
reactions between PNA and the AA (I, G, D, Q) were performed with the following reagent quantities. 
 
 
  
 
Deprotected PNA dodecamer – sequence: IGDQ-A-T-T-A-A-A-T-A-T-T-T-Lys (31) 
 
 
Cbz deprotection on PNA 123 was performed as described for PNA 30. The residue was analysed and 
purified by RP-HPLC. HPLC retention time: 16.13 min.  
 
 
 
 
Reagent\Solvent Equivalents Molecular weight (g mol-1) 
Moles 
(mmol) 
Mass 
(mg) 
Volume 
(μL) 
Rink-amide MBHA resin 
bearing lysine 1.0 0.41 mmol g
-1 0.12 300 - 
L(-)-Fmoc-Lys(Z)-OH 5.0 502.56 0.61 309.0  
AA: 
L(-)-Fmoc-Gln-OH 
L(-)-Fmoc-Asp(OtBu)-OH 
L(-)-Fmoc-Gly-OH 
L(+)-Boc-Ile-OH 
5.0 
5.0 
5.0 
5.0 
 
368.40 
411.45 
297.31 
231.29 
 
0.61 
 
 
226.60 
253.10 
 182.85 
 142.50 
- 
HATU 4.5 380.20 0.55 209.11 - 
DIEA 12.0 124.29 1.48 183.95  247.91 
NMP - - - - 2400 
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HPLC chromatogram of purified PNA 31. Conditions: Agilent Zorbax SB- C18, 5 μm, 4.6 × 250 mm, eluents from 0.1% 
TFA in H2O to 0.1% TFA in CH3CN, flow 1 mL min-1, r.t. The eluents were monitored at 260 nm. 
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A.1 WCA and AFM data 
 
 
 
Table A1. Surface properties characterisation. 
 
[a] ∂ IGDQK-S∙Au with immersion speed established at 14 µm s-1. 
[b] ∂ C8H17-S∙Au with immersion speed established at 62 µm s-1. 
. 
 
 
 
 
    
 
SAMPLE Position RMS Roughness[nm] Kurtosis Skewness 
Average 
height [nm] 
∂ IGDQK-S∙Au[a] /  
C8H17-S∙Au 
1 mm 1.4 176.3 8.4 10.9 
5 mm 1.3 94.8 6.1 3.6 
9 mm 2.0 179 9.9 13.1 
∂ IGDQK-S∙Au /  
∂ C8H17-S∙Au[b] 
1 mm 11.9 11.7 2.1 36.7 
5 mm 15.9 8.4 2.3 27.6 
9 mm 14.1 10.5 2.5 32.3 
∂ IGDQK-S∙Au / 
MT(PEG)4-S∙Au 
1 mm 4.32 55.8 6.4 14.6 
5 mm 3.17 175.3 11.4 1.1 
9 mm 3.82 70.1 2.8 6.3 
∂ C8H17-S∙Au 
1 mm 9.8 14.6 2.0 33.6 
5 mm 6.5 38.4 4.1 23.4 
9 mm 7.1 25.7 2.8 31.2 
∂ IGDQK-S∙Au  
1 mm 12.4 13.2 2.8 31.2 
5 mm 11.3 19.0 3.7 23.2 
9 mm 14.6 8.2 2.2 37.8 
C8H17-S∙Au 
1 mm 7.6 24.8 3.2 27.7 
5 mm 7.4 36.6 5.1 15.3 
9 mm 7.8 38.4 5.2 19.8 
IGDQK-S∙Au 
1 mm 5.2 68.0 6.2 14.9 
5 mm 5.3 61.6 5.5 21.8 
9 mm 3.7 53.1 5.1 12.4 
 
 IGDQK-S∙Au /    
C8H17-S∙Au  
1 mm 7.9 3.9 0.9 11.1 
5 mm 3.8 4.8 -1.1 17.1 
9 mm 3.1 74.7 5.9 5.9 
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Table A2. Static WCA(°) of pure thiols SAMs.* 
  
SAMPLE Position WCA (°) Δ (°)[a] 
∂ IGDQK-S∙Au[b] 
 
1 mm 
5 mm 
9 mm 
40.1 ± 2.3 
36.5 ± 1.3 
35.2 ± 2.0 
-4.9 
∂ C8H17-S∙Au[c] 
 
1 mm 
5 mm 
9 mm 
38.2 ± 0.7 
48.0 ± 3.0 
51.5 ± 2.5 
13.3 
IGDQK-S∙Au 
1 mm 
5 mm 
9 mm 
41.2 ± 0 
41.8 ± 0 
42.0 ± 0 
0.8 
C8H17-S∙Au 
1 mm 
5 mm 
9 mm 
74.2  ± 0 
73.3  ± 0 
73.0  ± 0 
-1.2 
IGDQK-S∙Au /    
C8H17-S∙Au 
 
1 mm 
5 mm 
9 mm 
51.1 ± 0.2 
51.2 ± 0.2 
51.2 ± 0.3 
0.1 
 
 * Each value is the average of three measurements on the sample. 
[a] WCA(°) difference between the initial point (1 mm) and the final point (9 mm) of the  
Au surfaces. 
[b] ∂ IGDQK-S∙Au with immersion speed established at 14 µm s-1. 
[c] ∂ C8H17-S∙Au with immersion speed established at 62 µm s-1. 
 
 
 
A.2 AFM analysis 
 
 
 
Figure A1. TM-AFM images (above) with their relative cross-section profiles (below) towards IGDQK-S∙Au. 
  
   151 
Appendix 
 
 
Figure A2. TM-AFM images (above) with their relative cross-section profiles (below) towards C8H17-S∙Au. 
 
 
 
Figure A3. TM-AFM images (above) with their relative cross-section profiles (below) towards IGDQK-S∙Au / 
C8H17-S∙Au. 
 
 
Figure A4. TM-AFM images (above) with their relative cross-section profiles (below) towards the ∂ C8H17-S∙Au.  
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A.3 Cellular migration images 
 
 
 
Figure A5. Software edited and original optical microscopy images of MDA-MB-231 (a, c) and fibroblasts (b, d) onto 
IGDQK-S∙Au. 
 
 
 
Figure A6. Software edited (a) and original (b) optical microscopy images of MDA-MB-231 onto MT(PEG)4-S∙Au. 
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Figure A7. Software edited and original optical microscopy images of MDA-MB-231 (a, c) and fibroblasts (b, d) onto 
C8H17-S∙Au. 
 
 
 
Figure A8. Software edited (a) and original (b) optical microscopy images of MDA-MB-231 onto ∂ IGDQK-S∙Au / 
MT(PEG)4-S∙Au. 
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Figure A9. Software edited and original optical microscopy images of MDA-MB-231 (a, c) and fibroblasts (b, d) onto  
∂ IGDQK-S∙Au[b] / C8H17-S∙Au 
 
 
Figure A10. Software edited and original optical microscopy images of MDA-MB-231 (a, c) and fibroblasts (b, d) onto 
 ∂ IGDQK-S∙Au / ∂ C8H17-S∙Au 
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Figure A11. Software edited and original optical microscopy images of MDA-MB-231 (a, c) and fibroblasts (b, d) onto  
∂ C8H17-S∙Au 
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A.4 NMR Characterisation 
Mol. 3: 1H-NMR and 13C-NMR 
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Mol. 16: 1H-NMR and 13C-NMR  
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Mol. 18: 1H-NMR and 13C-NMR 
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Mol. 19: 1H-NMR and 13C-NMR 
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Mol. 20: 1H-NMR and 13C-NMR 
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Mol. 12: 1H-NMR and 13C-NMR  
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Mol. 23: 1H-NMR and 13C-NMR 
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Mol. 24: 1H-NMR and 13C-NMR 
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Mol. 25: 1H-NMR and 13C-NMR 
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Mol. 13: 1H-NMR and 13C-NMR 
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